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PoPulation aGeinG
Population ageing is the shift in the distribution of a country’s population towards older ages 
and is caused by declined fertility rates and increased longevity. This phenomenon is cur-
rently occurring in nearly all countries in the world, is unprecedented in human history, and 
has major implications for all aspect of life (1). Worldwide, declines in fertility and increases 
in longevity have resulted in a steady rise in the proportion of older persons aged 60 and 
over, passing from 8 percent in 1950, to 11 percent in 2009, to 22 percent expected in 2050 
(1). In the developed world, the very old (age 80+) is the fastest growing population group 
and, according to Statistics Netherlands, the pace at which population ageing is occurring is 
currently increasing (2-3). That is, between 2006-2010, the Dutch population aged 65 and over 
increased by 250.000 persons, whereas between 2011-2015, the increase is expected to double 
and be 500.000 (3). 
Further greying of the population will inevitably occur the next decades. Nevertheless, the 
extent to which it will occur is uncertain and will particularly depend on future trends in 
mortality. Regarding the extent past declines in old age mortality will continue into the fu-
ture, there is ongoing debate, which has its focus on the issue if there is a limit to human life 
span and whether or not we are approaching this limit. Essentially, two main perspectives are 
distinguished in the debate. Proponents of the limited-lifespan paradigm put forward that 
ageing is a natural phenomenon that can be influenced only limitedly (4-9). They claim that 
from an evolutionary perspective, the human body is not designed for extended survival but 
for reproduction. Therefore, biological and practical constraints will slow down future gains 
in life expectancy and the limit to human life expectancy will soon be reached. Adherents of 
the mortality-reduction paradigm argue that there is no reason to believe that past mortality 
declines will soon come to an end and that, most likely, the long and favourable trends for 
life expectancy will continue in the future (10-13). Their prognosis is based on best practice, 
that is, the highest life expectancy observed somewhere in the world in a given year. Their 
arguments are further substantiated by referring to trends in sub populations with extreme 
good health, to rapid mortality declines including in countries with already low levels of old 
age mortality, and to foreseen biomedical progress.  
societal cHallenGes of PoPulation aGeinG
The shift of a country’s population towards older ages poses great financial and social chal-
lenges (14). Among the main financial challenges are how to keep the current health care 
system affordable and how to secure the sustainability of the public pension system (15). 
With respect to the first, a substantial increase in health care expenditures is expected the 
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next decades, not only as a result of an increasing number of elderly people, who have higher 
disease risks than younger people, but also as a result of increasing costs per person, among 
others due to new and more expensive medical technology. According to projections of the 
National Institute of Health and the Environment, the expenditures will annually increase by 
3.4% until 2030 (16). Consequently, health care expenditures are expected to put an increas-
ing claim on the national budget (17). In 2010, healthcare accounted for 7.4% of the Gross 
Domestic Product, whereas in 2015 this is expected to have increased to 10.9% (17). Major 
reforms such as budget restraints are already being implemented with the aim to keep health 
care affordable (18). 
The second challenge, the sustainability of the pension system, is importantly related to the 
structure of the system. In the current system, pension premiums paid by the Dutch working 
population are at the same time used to pay pensions of others. When the age distribution of 
a population shifts upward this implies that the number of pension receivers increase while 
the number of those who pay premiums decrease. Currently, there are four employees to 
every single elderly person, but, until 2040, this is expected to decline to only two employees 
(19). Furthermore, ongoing increases in the life expectancy have resulted in a steady rise of 
the average number of pension years. That is, since the current pension system was initiated 
in 1957, the pension age in the Netherlands has remained 65, while the life expectancy at 
age 65 has increased with 3.5 years for males and 5.5 years for females (20). Currently, there 
is intense debate how to secure the sustainability of the pension system. Discussion points 
include the linkage of the pensionable age to trends in the life expectancy, linkage of the 
height of pensions to future economic developments and how to achieve an equitable distri-
bution of risks and benefits between older and younger generations (21). 
In addition to the financial issues, population ageing poses major social challenges, such as 
how to keep the growing population of elderly healthy and how to prevent strong declines 
in the quality of life. Currently, about half of the Dutch (non-institutionalized) population of 
65 years and older has at least one chronic condition and around 20% of the elderly have 
multiple chronic conditions (22). One third of this population is disabled in hearing, seeing, 
mobility or ADL and, among persons aged 80 years and older, there are more individuals 
with disability than without (22). As the risk of the onset of disease and disability increase 
with age, greying of the population is expected to lead an eminent increase in the number 
of persons that are diseased or disabled (22). Substantial inequalities exist in the occurrence 
of disease and disability. Among persons with an elementary education only, the prevalence 
of mobility disabilities is two times higher and of ADL disabilities almost five times higher 
than among persons with a tertiary education (22). Therefore, the negative health effects of 
population ageing may be much stronger among low socioeconomic groups than among 
high socioeconomic groups. In addition to the health consequences in terms of disease and 
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disability, population ageing may result in a strong increase in the number of individuals who 
have mental health problems, such as memory problems and dementia, or have feelings of 
depression or helplessness (22-23). Increasing trends in physical and mental functioning may 
lead to an increased demand for formal and informal care, while at the same time sources of 
support decline.    
A keyword in solutions proposed to tackle the challenges of population ageing is ‘participa-
tion’ (22,24-25). Among others, it has been suggested that healthy elderly could participate 
to provide the (professional) care and support that is needed to take care of the dependent 
elderly. A raise in the legal pension age and longer working could result in higher lifetime 
pension premiums and lower pension payments and could contribute to a solution to the 
pension problem. Although there is no clear consensus about the health effects of working 
longer, some studies show that labour participation is protective for mental and physical 
health declines, suggesting that it might also help to prevent or delay the onset of disease 
among the elderly (26-31). Elderly persons often have knowledge and competencies that 
younger persons are lacking. Society could benefit from the capacities that are specific to 
old age by increased participation of elderly in social, cultural and political aspects of society 
as well as in family and community life (25, 32-33). For persons to participate until older age, 
however, a certain level of physical and mental functioning is essential. Being unhealthy 
has been shown to lead to job loss and work disablement as well as to fewer contacts with 
persons within organisations, friends, and acquaintances (34-37). Therefore, improving health 
and reducing disability among the elderly are of paramount importance for healthy ageing. 
Moreover, it has been argued that investing in the health of future generations may help to 
preserve ‘human capital’ and can stimulate economic growth (38). In short, successful ageing, 
defined as ageing free of diseases and risk factors for disease, while maintaining an adequate 
level of physical and cognitive functioning and being actively engaged with life is a major 
challenge for coming generations (39-40). 
PoPulation aGeinG anD HealtH
The extent to which future generations will be able to participate actively in society and 
to work until older ages will not merely depend on the extent persons will live longer in 
the future, but, more importantly, on the extent people will live longer in good health. With 
regard to future morbidity developments, two main scenarios have been suggested (4,41). 
The pessimistic scenario, which was proposed by Gruenberg in 1977, is known as the expan-
sion of morbidity hypothesis (41). According to this hypothesis, further increase in the life 
expectancy will mainly be due to improvements in life saving treatment of persons who are 
ill. Furthermore, when persons live longer, a larger proportion will be exposed to nonfatal 
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disabling diseases of old age. Therefore, according to the expansion hypothesis, population 
ageing will inevitably increase the years lived in ill health. The optimistic scenario is known as 
the compression of morbidity hypothesis and encompasses a reduction in the years spent in 
ill health (4). In its original form, the theory stated that there is a genetically endowed limit to 
the life of human species and that the average life expectancy is rapidly approaching its limit. 
Due to further lifestyle improvements, the age at first morbidity onset would be postponed, 
which, in combination with a fixed length of life, would lead to a shorter time spent in ill 
health. In its more evolved form, the theory comprises that an absolute compression of mor-
bidity will be achieved when the average age at first morbidity onset will increase more than 
the average age at death. A third, intermediate hypothesis is that of dynamic equilibrium 
(42). This hypothesis proposes that increased survival will produce an increase in the years 
lived with illness, but that the period spent with severe levels of illness will remain constant, 
because the progression of chronic diseases will be reduced.  
To assess possible trends in morbidity, ‘disability’ has been conceptualised, which is a generic 
measure of consequences of chronic diseases and ageing on the functioning of a person. 
This measure is particularly relevant for populations of elderly for whom good physical 
functioning and maintaining independence in daily life is not guaranteed. Successful ageing 
includes a reduction in the burden of disability in a situation of increasing life expectancy. 
For investigating developments in the burden of disability, it is not sufficient to merely look 
at the age specific prevalence of disability. That is, in a situation of increasing life expectancy, 
a decreasing age specific prevalence of disability does not always mean a reduction in the 
years lived with disability because part of the extra years lived may be years with disability. 
Therefore, in addition to prevalence measures, it is recommended to use summary measures 
of population health that at the same time reflect survival and physical functioning (43). Such 
measures include life expectancy with disability (LED) and disability free life expectancy 
(DFLE) which represent the years lived with and without disability. 
Since the various theories on morbidity developments were conceived in the 1970s/1980s, 
researchers have aimed to investigate according to which of the hypotheses morbidity was 
developing and whether a compression of morbidity was occurring. Research showing that 
good health habits can lead to greatly increased functional ability showed that, in theory, 
a compression of morbidity is feasible (5, 44). Whether a compression indeed occurred was 
investigated in trend studies. Most of the trend studies in the US showed declines in physical 
and sensory functional limitations during the 1980s, 1990s and the early twentieth century 
(45-50). A few studies found no significant change in physical limitations for ages 40-59 for 
1997-2006 and no change in hearing problems for 1997-2004 (48, 50). Similar to the declines in 
functional limitations, most studies showed declines in the prevalence of iADL and ADL dis-
abilities (48, 51-54). Data from the important National Long-Term Care Survey showed that for 
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the period 1982-2004, mortality declined about 1% a year and that declines in disability aver-
aged 1.27% (51). Although the quality of some studies was less than desirable and differences 
exist in period, definition of disability, treatment of the institutionalized population, and age 
standardizing of results, the general impression from the several studies performed in the US 
is that compression of morbidity has occurred (55). For (Western) Europe, the evidence is less 
consistent. For Austria, the UK and Spain, there is evidence for a compression (56-58). A recent 
meta-analysis in the Netherlands showed no evidence for declines in the prevalence of 10 
out of twelve activity limitations and suggested expansion (59). For France, an analysis using 
various national datasets showed patterns diverging according to the underlying disability 
measure, which connects most closely to dynamic equilibrium (60). Some years ago, a syn-
thesis of evidence was conducted within the REVES network on health expectancy (61). It was 
suggested that part of the cross-national differences in disability trends is related to severity 
of disability (61). Severe disability would develop more favourably than mild disability, which 
gave the overall impression of a dynamic equilibrium in Europe (61). However, the evidence 
was not very strong and it is unclear whether the conclusions also hold for more recent years. 
For the coming decades, a compression of mild and severe disability would obviously be 
advantageous given the positive effects on the quality of life and the positive influence that 
can be expected for care expenditures. An increase in the years lived free of disabilities would 
allow individuals to work longer in good health and to participate until older ages. However, 
it is currently unclear whether a compression or an expansion is to be expected.   
researcH questions
Important suggestions how to investigate future developments of morbidity when a further 
increase in the life expectancy is expected come from health economics research. Studies 
in this field of research investigated how strong health care costs are related with age (time 
since birth) and time to death and it was shown that a substantial part of costs for health care 
is reserved to the end of life. Given this relationship of costs with the end of life, a further 
increase in the life expectancy is expected to combine with a shift of health care costs to-
wards older ages and an increase in the life time costs that is only moderate (62-65). A similar 
relationship with approaching death could also exist for the occurrence disability. Describing 
current associations of disability with age (time since birth) and time to death could shed 
important new light on potential future developments of disability.    
Quantification of disease burden using generic measures such as disability is important to 
obtain an overall impression of a populations (future) health status. In addition, for health 
policy decisions and future health care planning it is important to know frequencies of occur-
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rence for specific diseases. Underlying cause of death statistics are often used to quantify the 
burden of a specific disease and are a frequent basis for policy decisions. However, as these 
statistics are intended to represent primary causes of death, the burden of diseases that 
are no direct cause of death but contribute as a secondary cause may be underestimated. 
Combined use of individually linked data sources may yield a more complete overview of 
(co-) occurrences of diseases at the end of life.
Insight in the causes of disability is essential. The expected increase in the number of elderly 
persons may lead to an inevitable increase of disability in the population, but interventions 
effectively targeting the determinants of disability could potentially prevent part of the 
expected increase. A variety of diseases and risk factors have been shown associated with 
disability onset and years lived with disability (5, 66-71). However, it is not fully understood 
which diseases and risk factors contribute most to disability and among which groups the 
largest reductions could be achieved. 
As groups with a low socioeconomic position have a substantially higher burden of dis-
ability than groups with a high socioeconomic position, these groups also have substantial 
potential for reductions in the burden of disability (68-72). Disability reductions among low 
socioeconomic groups could contribute to reducing health inequalities. Currently, it is insuf-
ficiently known which diseases contribute most to socioeconomic inequalities in the burden 
of disability. To effectively target inequalities in the burden of disability, knowing which 
diseases contribute most to the inequalities is crucial, as well as elucidating whether diseases 
contribute most by differences in their prevalence or by differences in the extent they lead to 
disability (disabling impact).
The research questions assessed in this thesis are:
1. What is the current burden of disease and disability?
2. Which determinants explain the current burden of disability? 
For research question 1 a specific focus will be on the occurrence of disease and disability in 
relationship with the end of life. The focus for research question 2 will be on diseases and life 
style factors as determinants of (inequalities in) the burden of disability. The following sub 
questions will be addressed:  
1. What is the prevalence of diseases and co-occurrences in the last two years of life?
2.  To what extent is the occurrence of disability associated with age (time since birth) 
and time to death?
3. Which diseases contribute most to the burden of disability?
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4.  Which diseases contribute most to educational inequalities in the burden of dis-
ability?
5.  Which lifestyle factor is most important for spending many years with disability: 
obesity, smoking or heavy drinking?
outline of tHe tHesis
This thesis is divided into two main parts that correspond with the two research questions. 
Part i Disease and disability occurrence
In chapter 2, the prevalence of diseases most common at the end of life is assessed as well 
as the prevalence of their most common co-occurring conditions. Nation-wide individually 
linked information is used regarding underlying and secondary cause of death and diagnosis 
of hospital discharge within two years prior to death. It is assessed whether multiple causes 
of death (underlying + secondary) provide complete information on end of life disease oc-
currence or whether substantial additional information is contained in hospital discharge 
records. 
Chapter 3 consists of two parts. In part 3.1, the prevalence, incidence and severity of ADL and 
OECD disabilities (functional limitations) are described in relationship with age (time since 
birth) and time to death. This is done for various age groups and for groups in presence of 
various chronic conditions. Aiming to test the key assumption of the theory of a dynamic 
equilibrium, which is that mild disability is related most strongly with age and severe disabil-
ity most strongly with time to death, part 3.2 describes relationships of ADL disabilities with 
age and time to death for three severity levels of disability. The agreement of our findings 
with observed disability trends is discussed as well as the implications for future disability 
developments. Data from six annual waves of the Dutch GLOBE longitudinal study and a 
subsequent 12-year mortality follow-up are used.
Part ii explaining the burden of disability
The contribution of chronic diseases to the burden of ADL disability is investigated in chapter 
4 using data from the Dutch POLS survey 2001-2007. Using an additive regression model and 
accounting for co-morbidity, the disabling impact of selected chronic diseases is calculated. 
The disabling impact and information on diseases present in individuals are used to partition 
the prevalence of disability and years lived with disabilities into contributions of specific 
diseases.
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In chapter 5 it is assessed to what extent diseases contribute to educational inequalities in 
the prevalence of OECD disabilities. Pooled data of seven subsequent years (2001-2007) from 
the Dutch POLS survey and a methodology similar to that in chapter 4 is used. However, in 
this analysis disease contributions to the prevalence of disability are estimated for groups dif-
fering according to their highest level of education obtained. Furthermore, it is investigated 
to what extent disease contributions to inequalities are due to differences in the disabling 
impact. 
Chapter 6 addresses which lifestyle factor (obesity, smoking or heavy drinking) is associated 
most with living many years with ADL disability using a Sullivan life table approach. Fur-
thermore, it is assessed whether Sullivan life table estimates are improved by stratification 
according to age at death. Data from the Dutch POLS Survey 1997-1999 with mortality follow-
up until 2006 are used
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introduction The end phase of life is characterized by substantial health declines and com-
plex multi-morbid disease patterns. The primary aim of this paper is to investigate whether 
multiple causes of death provide a complete overview of disease occurrence at the end of life, 
or whether individual linkage with hospital discharge records provides substantial additional 
information. A secondary aim is to provide the prevalence for the diseases most common at 
the end of life as well as for their co-occurrences, using the individually linked data. 
methods Nationwide multiple causes of death information was individually linked with 
diagnoses of discharge within two years prior to death available through the National Medi-
cal (hospital) Registration for all Dutch inhabitants aged 50-84, who died in 2005 (n=86,987). 
The change in disease prevalence and ranking with and without using hospital discharge 
information was assessed. The two year period prevalence was provided for the diseases 
most common at the end of life, as well as for their three most prevalent co-occurrences, 
using all information combined.
results For some diseases, especially for neoplasms, information from hospital discharge 
records added only little to the information provided in multiple causes of death. Other 
conditions, such as cataract and anaemia were hardly mentioned as a cause of death, but had 
a high prevalence (4.7 and 3.8 in males and 5.1 and 4.3 in females) when including hospital 
diagnoses. Although the order of the ranking of the 5 most common diseases changed, the 
content of the top 5 remained unaffected, with the exception of heart failure in women (from 
rank 12 to 5). In males, diseases most prevalent at the end of life were pneumonia (14%), 
cancer of trachea, bronchus and lung (13%), acute myocardial infarction (12%), COPD and 
bronchiectasis (12%) and cerebrovascular disease (11%). In females, these were cerebrovas-
cular disease (13%), pneumonia (12%), dementia (11%), diabetes (11%) and heart failure (9%). 
70-80% of all deaths had one or more concurrent conditions and 20-30% even had three or 
more co-occurring conditions. 
conclusion Multiple causes of death do not provide complete information regarding disease 
occurrence prior to death. Using individual information from hospital records in addition re-
sults in higher estimates of disease prevalence and co-occurrences. Although this affects the 
order of ranking of the most common conditions, it does not lead to substantially different 
conclusions regarding which diseases are most important. 
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introDuction 
Cause of death statistics are of major importance for quantifying burden of disease and are 
often relied on for policy decisions. Cause of death statistics originated in the era of infectious 
diseases, in which most persons died due to one major cause and at a relatively young age. 
It was therefore that burden of disease could validly be quantified according to frequencies 
of the underlying cause of death, which was conceptualized as “the disease or injury that 
initiated the train of morbid events leading directly to death“ (1). Now, after completion of 
the epidemiologic transition, persons tend to die at older ages and, in most instances, in pres-
ence of multiple co-occurring conditions (2-6). To illustrate, it has been estimated that 55-98% 
of the elderly who have a chronic condition have at least one other disease (3). Consequently, 
it is increasingly recognized that analysis of underlying causes of death alone might not be 
sufficient to represent the complex burden of multi morbidity at the end of life (7-8). 
To enable analyses of multi disease patterns, “secondary causes of death” were conceptual-
ized, which represent “consequences or complications of the underlying cause of death, or 
another disease present at the moment of death that may have contributed to death“ (1). 
Recent multiple causes of death analysis for the US among others revealed that diseases such 
as anaemia, pneumonia, diabetes and chronic lower respiratory diseases frequently occur at 
the end of life, but are poorly represented as underlying cause of death (9-10). Using multiple 
instead of underlying causes of death resulted in altered conclusions regarding the relative 
importance of specific diseases (10). Similar results were found also for other countries (11-12). 
Although multiple causes of death analyses are expected to yield more accurate information 
regarding end of life disease burden, they may still not provide a complete overview of dis-
ease presence during the last years of life. Because causes of death statistics encompass dis-
eases that contribute to death, the burden of non-lethal conditions may be underestimated 
or disregarded. Furthermore, some studies show a decline in the number of co-occurrences 
reported for ages of 80 years and older, which may indicate less accurate report of secondary 
causes of death among the oldest old (12). Demographic characteristics and non-medical 
factors such as place of death have been shown related with fewer co-occurrences, which 
also suggests variation in the accuracy of secondary causes of death (13). Moreover, a study 
of Johansson et al. showed that for one third of the persons who resided in hospital within 
one year prior to death, the main diagnosis of discharge was not mentioned on the death 
certificate, either as an underlying or contributing cause of death (14). 
Although the latter study shows that a substantial part of the diseases present at the end of 
life is not represented in cause of death statistics, it also shows that improved estimates can 
expectedly be obtained by employing information from hospital discharge records in addi-
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tion. The primary aim of this study is to investigate whether multiple causes of death provide 
complete information regarding disease occurrence at the end of life, or whether individual 
record linkage with the Dutch hospital information system provides relevant additional 
information. A secondary aim is to provide the prevalence for the diseases most common at 
the end of life as well as for their co-occurrences, using the full linked data. 
Our study population consists of all Dutch inhabitants who died in 2005 at age 50-84. For 
each individual, multiple causes of death data are linked with data from the National Medical 
Registration, which provide information on the presence of diseases clinically diagnosed 
within two years prior to death. In the Netherlands, causes of death are manually coded with-
out use of an automated coding system, and the number of secondary causes is restricted to 
a maximum of three. 
metHoDs
Study population
For our analyses, we used nation wide individually linked data from the National Medical 
Registration and the Cause of Death Registration. As we intended to use data as recent as 
possible, but the coverage of the National Medical Registration strongly declined in the years 
after 2005, we chose all persons who resided in the Netherlands and died in 2005 (n=136 385) 
as our base population. From this base population, persons aged 50 and older were selected 
(n=128 049, 78%). Whereas the number of co-occurrences is generally expected to steadily 
increase with age, in our data, the number showed a decline at age 85 and above (Figure 2.1) 
(12,15). As this decline was expected to reflect limitations of our data rather than an actual 
decline, the analysis was restricted to age 50-84. The study population consisted of 48 671 
males and 38 316 females who on average died at age 72.0 and 73.6. 
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Data sources
Data from the Dutch Cause of Death registration and the National Medical Registration were 
individually linked on the basis of personal identification numbers contained in both sources 
(16-17). The Cause of Death registration is governed by Statistics Netherlands. Data are col-
lected through a legislative system in which a physician or autopsist provides one underlying 
and up to three secondary causes of death on a death certificate for every decedent. Coding 
of causes of death is done by Statistics Netherlands according to WHO coding rules given in 
the 10th revision of the International Classification of diseases (1). In our analysis, multiple 
causes of death data consisted of the underlying and secondary causes of death reported for 
each individual.
Data on the diagnosis of discharge for, in principal, every person who resided in a Dutch 
hospital within two years prior to death were available through the National Medical Regis-
tration. This registration is governed by Dutch Hospital Data and contains information on the 
main reason for admission as recognized at the end of hospitalization or responsibility period 
for both clinical and one-day admissions. Coding of the diagnoses is according to the Clinical 
Modification of the 9th International Classification of Diseases (ICD-9-CM).
Disease groups were defined on the basis of ICD-9-CM and ICD-10 codings using a classifica-
tion according to the International Shortlist for Hospital Morbidity Tabulation (ISHMT), ver-
sion 2008-11-10 (18). This list was developed in the Hospital Data Project (HDP) of the European 
Union Health Monitoring Programme and is an international agreed standard (18). The dis-
ease groups ‘other malignant neoplasms’, ‘other ischemic heart diseases’ and ’other diseases 
of the circulatory system’ were rest groups but nevertheless had a high prevalence. Therefore, 
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Figure 2.1 Percentage of decedents with at least one additional diagnosis as compared to their underlying cause of death and numbers died in 
hospital, by age and gender, the Netherlands, 2005.
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these groups were further split into more specific diseases. Diseases classified as ‘unknown 
and unspecified causes of morbidity (including those without a diagnosis)’, ‘other symptoms, 
signs and abnormal clinical and laboratory findings’, ‘complications of surgical and medical 
care, not elsewhere classified’, ‘medical observation and evaluation for suspected diseases 
and conditions’, ‘other medical care (including radiotherapy and chemotherapy sessions)’ and 
‘other factors influencing health status and contact with health services’ were excluded from 
the analysis. Following this approach, individual information regarding end of life disease 
occurrence for 147 diseases was available as underlying cause of death, secondary cause of 
death and hospital diagnosis within 2 years prior to death. The prevalence of diseases and 
their co-occurrences is presented for the 20 diseases most common according to information 
from underlying and secondary cause of death and hospital diagnosis combined. 
Statistical analysis
To assess whether hospital records provide information regarding end of life morbidity that 
is additional to information from multiple causes of death, disease occurrence was studied 
according to the number of mentions as underlying or secondary cause of death combined. 
Subsequently, it was assessed to what extent disease prevalence and rankings changed 
when individual hospital discharge information was also included. Correlations between 
cause of death rankings and rankings according to the full linked data were calculated using 
the Spearman’s rank correlation coefficient (rs). Two year period prevalences were estimated 
as the number of persons who had a specific disease according to the full linked data, divided 
by the total number of individuals in the study population. Double mentions of diseases in 
the various data sources were accounted for. To investigate whether differences according to 
age exist in the extent hospital records provide information additional to multiple causes of 
death, the analysis was also performed among subgroups aged 50-74 and 75-85.    
Using the full linked information, the prevalence of ‘more than one’ to ‘more than four’ mor-
bidities was presented by 5 year age categories. Furthermore, for each of the 20 diseases 
most common, the prevalence of their three most frequent co-occurrences was provided 
conditional on the presence of the index disease. That is, each disease that, in addition to 
the index disease, at any moment had occurred in the last two years of life was considered a 
co-occurrence. 
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results
In males, including information from hospital discharge records resulted in higher preva-
lence estimates as compared to estimates based on multiple causes of death, for each of the 
twenty diseases most common at the end of life (Table 2.1a). For some diseases, the discharge 
records added to a limited extent only (less than 10% increase of prevalence), as was the case 
for malignant neoplasms of the lung and prostate, diabetes, dementia and hypertension. 
For other diseases, the increase was stronger. For heart failure and conduction disorders, for 
instance, the increase was from 3.8% to 9.0% and from 4.5% to 8.8%. Anaemia and cataract 
were common conditions with a prevalence of 3.8% and 4.7% according to the full linked 
data, but were hardly or not at all represented as a cause of death. 
Table 2.1a Estimated disease prevalence during last 2 years of life, based on individually linked information regarding underlying cause of 
death, secondary cause of death and hospital diagnosis, males aged 50-84, 2005, the Netherlands. 
 
Prevalence (ranking) based on 
isolated data sources
Prevalence (ranking) based on 
individually linked data sources
 
Underlying 
cause of 
death
Secondary 
cause of 
death
Hospital 
diagnosis
Underlying 
or secondary 
cause of death
Underlying/secondary 
cause of death or 
hospital diagnosis
Pneumonia 3.0 (9) 7.5 (1) 6.0 (3) 10.6 (3) 14.4 (1)
Malignant neoplasms trachea, bronchus and lung 11.8 (1) 0.5 (35) 7.7 (1) 12.3 (1) 12.9 (2)
Acute myocardial infarction 8.7 (2) 1.7 (12) 3.8 (8) 10.3 (4) 12.3 (3)
COPD and bronchiectasis 5.7 (4) 5.2 (3) 4.4 (7) 10.9 (2) 12.2 (4)
Cerebrovascular disease 5.9 (3) 2.9 (7) 5.9 (4) 8.6 (5) 10.6 (5)
Heart failure 2.8 (10) 1.0 (21) 6.5 (2) 3.8 (15) 9.0 (6)
Conduction disorders, cardiac arrhythmias 3.6 (7) 0.9 (24) 4.9 (5) 4.5 (10) 8.8 (7)
Diabetes 2.6 (12) 5.6 (2) 1.4 (26) 8.2 (6) 8.8 (8)
Other forms of chronic IHD 3.4 (8) 2.8 (8) 2.2 (14) 6.3 (7) 7.9 (9)
Other diseases respiratory system 1.1 (24) 2.7 (9) 3.5 (11) 3.8 (16) 6.6 (10)
Dementia 1.8 (18) 4.4 (4) 0.5 (69) 6.2 (8) 6.4 (11)
Diseases of arteries, arterioles and capillaries‡ 2.3 (14) 1.1 (19) 3.6 (9) 3.4 (17) 5.6 (12)
Malignant neoplasms prostate 3.7 (6) 1.1 (16) 2.1 (15) 4.9 (9) 5.2 (13)
Septicaemia 0.7 (33) 3.8 (5) 1.0 (39) 4.4 (11) 5.0 (14)
Malignant neoplasms colon, rectum, anus 3.9 (5) 0.4 (36) 3.1 (12) 4.3 (12) 5.0 (15)
Other heart diseases§ 2.5 (13) 1.6 (13) 1.4 (25) 4.0 (13) 5.0 (16)
Cataract 0.0 (-) 0.0 (-) 4.7 (6) 0.0 (-) 4.7 (17)
Other diseases nervous system and senses 1.6 (21) 1.8 (11) 1.7 (23) 3.3 (18) 4.5 (18)
Hypertensive diseases 0.6 (35) 3.4 (6) 0.2 (91) 4.0 (14) 4.2 (19)
Anaemia 0.1 (53) 0.3 (45) 3.5 (10) 0.4 (57) 3.8 (20)
Note: Prevalence based on underlying and secondary cause of death combined can be lower than the prevalences based on the two data sources 
in isolation added because of overlap in diagnosis. 
‡ excluding atherosclerosis
§ excluding conduction disorders, arrhythmias and heart failure
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Using hospital discharge information in addition to multiple causes of death resulted in rank 
changes of up to nine positions, as was the case for heart failure. The diseases that were 
among the twenty most common conditions at the end of life, however, remained largely un-
changed, except for anaemia and cataract. The correlation (rs) between the ranking according 
to multiple causes of death and according to the full linked data was 0.80. Underlying causes 
of death used in isolation gave a poorer reflection of disease occurrence at the end of life 
(rs=0.72). Six of the twenty diseases most common at the end of life according to the full 
linked data were not among the twenty most common underlying causes of death. 
Similar to males, higher prevalence estimates were obtained when using hospital discharge 
information in addition to multiple causes of death in females (Table 2.1b). For dementia, lung 
cancer, breast cancer, hypertensive diseases and septicaemia, the estimates increased less 
than 10%. For heart failure and other endocrine, nutritional and metabolic disorders, the es-
timates more than doubled, that is from 4.4% to 9.4% and from 2.5% to 5.0%. As represented 
by a prevalence of 5.1% and 4.1%, cataract and anaemia were common conditions but were 
poorly reflected as a cause of death. 
In females, the ranking of diseases was affected to a limited extent when discharge informa-
tion was added to multiple causes of death. Heart failure was affected most and increased 
seven ranks. The diseases that were among the twenty most common conditions at the end 
of life remained unchanged, except for anaemia and cataract, which were predominantly 
represented as a hospital diagnosis. The correlation between ranking according to multiple 
causes of death and according to the full linked data was high (rs=0.81). Six of the twenty dis-
eases most common according to full linked information were not represented as a common 
underlying cause of death. This was also represented in a relatively low correlation (rs=0.71). 
An analysis among subgroups of similar size aged 50-74 and 75-84 suggested that the extent 
hospital diagnoses provide additional information to multiple causes of death is similar across 
age groups (results not shown). That is, in both age groups three out of twenty diseases most 
common according to information from cause of death and hospital registrations combined 
were not represented in the diseases most common according to causes of death only. This 
was true for both males and females. Furthermore, also the correlation between the ranking 
according to causes of death and cause of death and hospital registrations was similar for 
both age groups (males: rs50-74=0.82, rs75-84=0.83; females: rs50-74=0.82, rs75-84=0.84).     
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Table 2.1b Estimated disease prevalence during last 2 years of life, based on individually linked information regarding underlying cause of 
death, secondary cause of death and hospital diagnosis, females aged 50-84, 2005, the Netherlands. 
 
Prevalence (ranking) based on 
isolated data sources
Prevalence (ranking) based on 
individually linked data sources
 
Underlying 
cause of 
death
Secondary 
cause of 
death
Hospital 
diagnosis
Underlying 
or secondary 
cause of death
Underlying/secondary 
cause of death or 
hospital diagnosis
Cerebrovascular disease 8.2 (1) 3.3 (7) 6.7 (1) 11.4 (1) 13.0 (1)
Pneumonia 3.0 (11) 6.2 (3) 4.1 (5) 9.3 (4) 11.8 (2)
Dementia 3.7 (7) 7.0 (1) 0.5 (71) 10.7 (2) 11.0 (3)
Diabetes 3.3 (10) 6.9 (2) 1.5 (26) 10.1 (3) 10.8 (4)
Heart failure 3.5 (8) 0.9 (22) 6.2 (2) 4.4 (12) 9.4 (5)
Acute myocardial infarction 6.5 (3) 1.4 (14) 2.8 (11) 7.8 (6) 9.2 (6)
COPD and bronchiectasis 4.7 (5) 3.4 (6) 3.4 (9) 8.1 (5) 9.1 (7)
Malignant neoplasms trachea, bronchus and lung 6.8 (2) 0.2 (54) 4.6 (4) 7.0 (7) 7.3 (8)
Malignant neoplasms breast 6.0 (4) 0.9 (21) 2.4 (13) 6.9 (8) 7.3 (9)
Conduction disorders, cardiac arrhythmias 3.3 (9) 1.0 (18) 3.4 (7) 4.4 (13) 7.3 (10)
Hypertensive diseases 0.7 (35) 4.7 (4) 0.2 (88) 5.4 (9) 5.6 (11)
Malignant neoplasms colon, rectum, anus 4.3 (6) 0.3 (44) 3.3 (10) 4.7 (10) 5.4 (12)
Septicaemia 0.8 (28) 3.8 (5) 1.0 (36) 4.6 (11) 5.1 (13)
Cataract 0.0 (-) 0.0 (-) 5.1 (3) 0.0 (-) 5.1 (14)
Other diseases respiratory system 0.9 (26) 2.2 (8) 2.4 (14) 3.1 (17) 5.0 (15)
Other heart diseases‡ 2.7 (12) 1.5 (13) 1.3 (28) 4.2 (14) 5.0 (16)
Other endocrine, nutritional, metabolic diseases 0.5 (42) 2.0 (9) 2.7 (12) 2.5 (20) 5.0 (17)
Other forms of chronic IHD 2.0 (16) 1.6 (11) 1.1 (34) 3.6 (15) 4.4 (18)
Other diseases nervous system and senses 1.7 (18) 1.6 (12) 1.8 (17) 3.2 (16) 4.4 (19)
Anaemia 0.2 (57) 0.5 (33) 3.8 (6) 0.7 (46) 4.3 (20)
Note: Prevalence based on underlying and secondary cause of death combined can be lower than the prevalences based on the two data sources 
in isolation added because of overlap in diagnosis. 
‡excluding conduction disorders, arrhythmias and heart failure
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Figure 2.2 represents the prevalence of multi morbidity at the end of life by age. In males, 
65-80% of all deaths had one or more co-occurring conditions and 20-30% even had three or 
more co-occurrences. The prevalence of multi morbidity was higher towards older ages. The 
prevalence of multi morbidity among females was slightly lower than among males, but the 
pattern was similar. 
Tables 2.2a and 2.2b represent the diseases most common at the end of life, together with the 
prevalence of their three most common co-occurrences. In males, the diseases most common 
at the end of life were pneumonia (14.4%), lung cancer (13.9%), acute myocardial infarction 
(12.3%), COPD and bronchiectasis (12.2%) and cerebrovascular disease (11.6%). Pneumonia 
was the most common co-occurring condition for nine of twenty conditions and occurred 
particularly frequently in combination with septicaemia (29%), COPD and bronchiectasis (28%), 
dementia (26%), other diseases of the nervous system and senses (22%), and other diseases of 
the respiratory system (21%). Diabetes occurred particularly frequently in combination with acute 
myocardial infarction (18%) and heart failure (16%) and was a frequent concurrence to hyperten-
sive diseases (24%). Among persons who had cancer, the prevalence of each co-occurrence was 
relatively low. 
In females, cerebrovascular disease (13.0%), pneumonia (11.8%), dementia (11.0%), diabetes 
(10.8%) and heart failure (9.4%) were the most prevalent conditions at the end of life. Pneumo-
nia as well as diabetes were the most common co-occurring condition for 6 of the 20 diseases. 
Diabetes occurred particularly frequently in combination with cardiovascular disease. Of all 
decedents with diabetes, 16% had cerebrovascular disease, 15% heart failure and 15% acute 
myocardial infarction. In 28% of the persons who had hypertensive diseases, diabetes was 
a co-occurrence. Among persons with breast and colon cancer, the prevalence of the main 
co-occurrences was low (<=7%).
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figure 2.2 Prevalence of more than one, two, three or four morbidities during the last two years of life, by age and gender, the Netherlands, 
2005.
234 35
Disease prevalence in the last two years of life
2
Ta
bl
e 2
.2
a E
sti
m
at
ed
 pr
ev
ale
nc
e o
f m
os
t c
om
m
on
 di
se
as
es
 an
d t
he
ir c
o-
oc
cu
rre
nc
es
 du
rin
g t
he
 la
st 
tw
o y
ea
rs 
of
 lif
e, 
m
ale
s a
ge
d 5
0-
84
, 2
00
5, 
th
e N
et
he
rla
nd
s. 
Di
se
as
e
Pr
ev
al
en
ce
 (%
)
M
os
t c
om
m
on
 co
-o
cc
ur
re
nc
es
 (p
re
va
le
nc
e)
Pn
eu
m
on
ia
14
.4
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(2
4%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
3%
)
M
al
 n
eo
pl
as
m
s t
ra
ch
ea
, b
ro
nc
hu
s a
nd
 lu
ng
 (1
2%
)
M
al
 n
eo
pl
as
m
s t
ra
ch
ea
, b
ro
nc
hu
s a
nd
 lu
ng
12
.9
Pn
eu
m
on
ia
 1
3%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
0%
)
Ot
he
r d
ise
as
es
 re
sp
ira
to
ry
 sy
st
em
 (7
%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n
12
.3
Di
ab
et
es
 (1
3%
)
He
ar
t f
ai
lu
re
 (1
1%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
0%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is
12
.2
Pn
eu
m
on
ia
 (2
8%
)
He
ar
t f
ai
lu
re
 (1
3%
)
M
al
 n
eo
pl
as
m
s t
ra
ch
ea
, b
ro
nc
hu
s a
nd
 lu
ng
 (1
1%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e
10
.6
Pn
eu
m
on
ia
 (1
8%
)
De
m
en
tia
 (1
0%
)
Di
ab
et
es
 (1
0%
)
He
ar
t f
ai
lu
re
9.
0
Ot
he
r f
or
m
s o
f c
hr
on
ic 
IH
D 
(1
8%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
7%
)
Pn
eu
m
on
ia
 (1
6%
)
Co
nd
uc
tio
n 
di
so
rd
er
s, 
ca
rd
ia
c a
rrh
yt
hm
ia
s
8.
8
He
ar
t f
ai
lu
re
 (1
5%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(1
3%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
2%
)
Di
ab
et
es
8.
8
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(1
8%
)
He
ar
t f
ai
lu
re
 (1
6%
)
Pn
eu
m
on
ia
 (1
4%
)
Ot
he
r f
or
m
s o
f c
hr
on
ic 
IH
D
7.
9
He
ar
t f
ai
lu
re
 (2
0%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(1
5%
)
Di
ab
et
es
 (1
5%
)
Ot
he
r d
ise
as
es
 re
sp
ira
to
ry
 sy
st
em
6.
6
Pn
eu
m
on
ia
 (2
1%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
8%
)
M
al
 n
eo
pl
as
m
s t
ra
ch
ea
, b
ro
nc
hu
s a
nd
 lu
ng
 (1
4%
)
De
m
en
tia
6.
4
Pn
eu
m
on
ia
 (2
6%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
6%
)
Ot
he
r d
ise
as
es
 n
er
vo
us
 sy
st
em
 an
d 
se
ns
es
 (1
0%
)
Di
se
as
es
 ar
te
rie
s, 
ar
te
rio
le
s a
nd
 ca
pi
lla
rie
s‡
5.
6
Ot
he
r f
or
m
s o
f c
hr
on
ic 
IH
D 
(1
2%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
2%
)
Di
ab
et
es
 (1
2%
)
M
al
ig
na
nt
 n
eo
pl
as
m
s p
ro
st
at
e
5.
2
Pn
eu
m
on
ia
 (1
1%
)
An
ae
m
ia
 (1
0%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(8
%
)
Se
pt
ica
em
ia
5.
0
Pn
eu
m
on
ia
 (2
9%
)
He
ar
t f
ai
lu
re
 (1
0%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
0%
)
M
al
ig
na
nt
 n
eo
pl
as
m
s c
ol
on
, r
ec
tu
m
, a
nu
s
5.
0
Pa
ra
lyt
ic 
ile
us
 an
d 
in
te
st
in
al
 o
bs
tru
ct
io
n§
 (8
%
)
An
ae
m
ia
 (7
%
)
Ot
he
r m
al
 n
eo
pl
as
m
s d
ig
es
tiv
e 
or
ga
ns
¶ 
(7
%
) 
Ot
he
r h
ea
rt 
di
se
as
e£
5.
0
He
ar
t f
ai
lu
re
 (2
4%
)
Ot
he
r f
or
m
s o
f c
hr
on
ic 
IH
D 
(1
5%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
4%
)
Ca
ta
ra
ct
4.
7
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
8%
)
Pn
eu
m
on
ia
 (1
7%
)
M
al
 n
eo
pl
as
m
s t
ra
ch
ea
, b
ro
nc
hu
s a
nd
 lu
ng
 (1
3%
)
Ot
he
r d
ise
as
es
 n
er
vo
us
 sy
st
em
 an
d 
se
ns
es
4.
5
Pn
eu
m
on
ia
 (2
2%
)
De
m
en
tia
 (1
5%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
2%
)
Hy
pe
rte
ns
ive
 d
ise
as
es
4.
2
Di
ab
et
es
 (2
4%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(2
3%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(2
0%
)
An
ae
m
ia
3.
8
Pn
eu
m
on
ia
 (1
7%
)
M
al
 n
eo
pl
as
m
s p
ro
st
at
e 
(1
4%
)
M
al
 n
eo
pl
as
m
s t
ra
ch
ea
, b
ro
nc
hu
s a
nd
 lu
ng
 (1
3%
)
Ab
br
ev
iat
ion
s: 
m
al 
=
 m
ali
gn
an
t
‡ e
xc
lud
ing
 at
he
ro
scl
er
os
is
§ w
ith
ou
t h
er
nia
¶ e
xc
lud
ing
 oe
so
ph
ag
us
, s
to
m
ac
h,
 pa
nc
re
as
, c
olo
n,
 re
ctu
m
 an
d a
nu
s
£ e
xc
lud
ing
 co
nd
uc
tio
n d
iso
rd
er
s, 
ar
rh
yt
hm
ias
 an
d h
ea
rt 
fai
lur
e
236
Ta
bl
e 2
.2
b 
Es
tim
at
ed
 pr
ev
ale
nc
e o
f m
os
t c
om
m
on
 di
se
as
es
 an
d t
he
ir c
o-
oc
cu
rre
nc
es
 du
rin
g t
he
 la
st 
tw
o y
ea
rs 
of
 lif
e, 
fem
ale
s a
ge
d 5
0-
84
, 2
00
5, 
th
e N
et
he
rla
nd
s.
Di
se
as
e
Pr
ev
al
en
ce
 (%
)
M
os
t c
om
m
on
 co
-o
cc
ur
re
nc
es
 co
nd
iti
on
s (
pr
ev
al
en
ce
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e
13
.0
Di
ab
et
es
 (1
3%
)
De
m
en
tia
 (1
3%
)
Pn
eu
m
on
ia
 (1
2%
)
Pn
eu
m
on
ia
11
.8
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
9%
)
De
m
en
tia
 (1
7%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
3%
)
De
m
en
tia
11
.0
Pn
eu
m
on
ia
 (1
8%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
5%
)
Di
ab
et
es
 (1
1%
)
Di
ab
et
es
10
.8
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
6%
)
He
ar
t f
ai
lu
re
 (1
5%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(1
5%
)
He
ar
t f
ai
lu
re
9.
4
Di
ab
et
es
 (1
8%
)
Ot
he
r h
ea
rt 
di
se
as
es
‡ 
(1
5%
)
Pn
eu
m
on
ia
 (1
3%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n
9.
2
Di
ab
et
es
 (1
7%
)
He
ar
t f
ai
lu
re
 (1
2%
)
Hy
pe
rte
ns
ive
 d
ise
as
es
 (1
1%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is
9.
1
Pn
eu
m
on
ia
 (2
5%
)
He
ar
t f
ai
lu
re
 (1
2%
)
Di
ab
et
es
 (1
2%
)
M
al
 n
eo
pl
as
m
s t
ra
ch
ea
, b
ro
nc
hu
s a
nd
 lu
ng
7.
3
Pn
eu
m
on
ia
 (1
0%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
0%
)
Ot
he
r d
ise
as
es
 re
sp
ira
to
ry
 sy
st
em
 (6
%
)
M
al
ig
na
nt
 n
eo
pl
as
m
s b
re
as
t
7.
3
Pn
eu
m
on
ia
 (7
%
)
Di
ab
et
es
 (6
%
)
An
ae
m
ia
 (6
%
)
Co
nd
uc
tio
n 
di
so
rd
er
s, 
ca
rd
ia
c a
rrh
yt
hm
ia
s
7.
3
He
ar
t f
ai
lu
re
 (1
5%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
5%
)
Di
ab
et
es
 (1
1%
)
Hy
pe
rte
ns
ive
 d
ise
as
es
5.
6
Di
ab
et
es
 (2
8%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(2
4%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(1
8%
)
M
al
ig
na
nt
 n
eo
pl
as
m
s c
ol
on
, r
ec
tu
m
, a
nu
s
5.
4
An
ae
m
ia
 (7
%
)
Pa
ra
lyt
ic 
ile
us
 an
d 
in
te
st
in
al
 
ob
st
ru
ct
io
n§
 (7
%
)
Ot
he
r m
al
 n
eo
pl
as
m
s d
ig
es
tiv
e 
or
ga
ns
¶ 
(7
%
) 
Se
pt
ica
em
ia
5.
1
Pn
eu
m
on
ia
 (2
3%
)
Di
ab
et
es
 (1
1%
)
Ot
he
r d
ise
as
es
 o
f u
rin
ar
y s
ys
te
m
 (9
%
)
Ca
ta
ra
ct
5.
1
Di
ab
et
es
 (1
5%
) 
He
ar
t f
ai
lu
re
 (1
5%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
4%
)
Ot
he
r d
ise
as
es
 re
sp
ira
to
ry
 sy
st
em
5.
0
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
6%
)
CO
PD
 an
d 
br
on
ch
ie
ct
as
is 
(1
5%
)
Pn
eu
m
on
ia
 (1
5%
)
Ot
he
r h
ea
rt 
di
se
as
es
‡
5.
0
He
ar
t f
ai
lu
re
 (2
7%
)
Di
ab
et
es
 (1
4%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(1
2%
)
Ot
he
r e
nd
oc
rin
e, 
nu
tri
tio
na
l, m
et
ab
ol
ic 
di
se
as
es
5.
0
Di
ab
et
es
 (2
2%
)
He
ar
t f
ai
lu
re
 (1
4%
)
Hy
pe
rte
ns
ive
 d
ise
as
es
 (1
4%
)
Ot
he
r f
or
m
s o
f c
hr
on
ic 
IH
D
4.
4
He
ar
t f
ai
lu
re
 (2
1%
)
Di
ab
et
es
 (2
1%
)
Ac
ut
e 
m
yo
ca
rd
ia
l in
fa
rc
tio
n 
(1
6%
)
Ot
he
r d
ise
as
es
 n
er
vo
us
 sy
st
em
 an
d 
se
ns
es
4.
4
Pn
eu
m
on
ia
 (1
7%
)
De
m
en
tia
 (1
5%
)
Ce
re
br
ov
as
cu
la
r d
ise
as
e 
(1
3%
)
An
ae
m
ia
4.
3
He
ar
t f
ai
lu
re
 (1
7%
)
Pn
eu
m
on
ia
 (1
4%
)
Di
ab
et
es
 (1
3%
)
Ab
br
ev
iat
ion
s: 
m
al 
=
 m
ali
gn
an
t
‡ e
xc
lud
ing
 co
nd
uc
tio
n d
iso
rd
er
s, 
ar
rh
yt
hm
ias
 an
d h
ea
rt 
fai
lur
e 
§ w
ith
ou
t h
er
nia
¶ e
xc
lud
ing
 oe
so
ph
ag
us
, s
to
m
ac
h,
 pa
nc
re
as
, c
olo
n,
 re
ctu
m
 an
d a
nu
s
37
Disease prevalence in the last two years of life
2
Discussion
Summary of results
Multiple causes of death do not provide complete information regarding disease occurrence 
prior to death, but additional information is contained in hospital discharge records. Employ-
ing this information results in higher prevalence estimates and, in some instances, in consid-
erable changes in ranking. The content of the top 5, however, is unaffected, except for heart 
failure in women. Using the full linked data, pneumonia, lung cancer, acute myocardial infarc-
tion, COPD and bronchiectasis and cerebrovascular disease are the most common conditions 
among male decedents. In females, these conditions are cerebrovascular disease, pneumo-
nia, dementia, diabetes and heart failure. The condition that most frequently occurred as 
the main co-occurrence to the 20 most common conditions in males was pneumonia and in 
females these were pneumonia and diabetes. 
Methodological considerations 
Cause of death registration comprises three steps that each contribute to its validity: the 
diagnostic process, completion of a death certificate, and coding of the statements on the 
death certificate (1). Some clues about the validity of the diagnostic process come from 
autopsy studies (19-20). These studies show that for 25% of the autopsies, a primary cause of 
death is found that is clinically undetected (19-20). However, as autopsies are probably most 
often performed among cases for which the clinical diagnosis was difficult, these results are 
probably not generalizable to our population. Nonetheless, diagnostic constraints may have 
affected our results to some extent.
The validity of certification and coding of causes of death in the Netherlands was studied by 
Mackenbach et al., using COPD and cancer case histories to be certified by physicians and 
coded by the National Statistics office (21). It was shown that on 12% of the certificates COPD 
had falsely remained unmentioned, either as an underlying or secondary cause of death, but 
for cancer, this was true for only 2% (21). These results suggest that some diseases, such as 
cancers, are more adequately certified than others, such as COPD (21). Although the study 
showed that coding practices of Statistics Netherlands partly adjusted for inaccurate certi-
fication, we cannot exclude that the prevalence of COPD was underestimated to a certain 
extent in the cause of death registration. Our results show that using additional information 
from hospital discharge records at least partially corrects for such underestimation. The inter 
coder reliability of underlying causes of death was studied by Harteloh et al. (22). It was found 
that for major causes of death such as cancers and acute myocardial infarction, the inter 
coder agreement was high (>= 90%), but for diseases such as diabetes and hypertension, the 
agreement was substantially lower (53% and 71%) (22). Low inter reliabilities for these condi-
tions imply a considerable random variation in coding decisions. Although it is expected that 
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a substantial part of the variation is adapted for by mentions as a secondary cause of death, 
it cannot be excluded that variation in inter reliability has affected our prevalence estimates, 
particularly those based on underlying cause of death only. 
Variation in diagnostic processes may have influenced disease occurrences according to 
hospital discharge information in a way similar to for cause of death registration (19-20). A 
study on the reliability of the Dutch National Medical Registration showed that 99% of the 
diagnoses of discharge was recorded correctly in the register (23). 
To categorize ICD codings into a convenient number of chronic conditions that were still 
specific enough, and to achieve concordance between ICD-10 codings in the cause of death 
registration and ICD-9-CM in the hospital registration, we chose to use the ISHMT. This cat-
egorization was chosen because it represents not only major causes of death but also less 
lethal conditions. It is good to realize that the choice of disease categorization may have 
influenced the prevalence and ranking of the conditions, as well as the total number of 
diseases and therefore the prevalence of co-occurrences (15). 
As we used two year period prevalence in our study, all diseases reported present at any mo-
ment during the last two years of life were assumed to co-exist. As most conditions at the end 
of life have a quite long duration, this assumption is expected reasonably valid. However, in 
some instances, the existence of diseases may have been subsequent instead of concurrent. 
In the Netherlands, causes of death are coded manually and the number of secondary 
causes is restricted to a maximum of three. This may limit the generalizability of our results 
to countries that have an automated coding system and allow more than three contributing 
causes, such as the US and a number of European countries (24-15). A recent study investigat-
ing discontinuities related with implementation of automated coding in trends of 13 causes 
of death found no discontinuities for Sweden, France and Germany (25). In England, the 
only discontinuity relevant to our study was for heart failure (25). In an Australian study, a 
reasonably good concordance between manual and automated coding was found for most 
conditions, except for mental disorders such as dementia (26). These studies suggest that 
automated coding has no large influence on the extent multiple causes of death data repre-
sent end of life morbidity, except for a few conditions such as dementia and heart failure. In 
our data, the maximum of three secondary causes of death was provided for less than 6% of 
the deaths. If the tendency of certifiers to report multiple causes of death in other countries 
is similar to that in the Netherlands, this suggests that the possibility of reporting more than 
three secondary causes in practice may not result in a substantial extra number of diseases 
reported. Therefore, also the restriction in the number of conditions that can be reported as 
a cause of death may not largely affect the generalizability of our results. 
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Comparison with previous studies
Our study was among the first to investigate whether multiple causes of death provide 
complete information regarding disease presence prior to death. Together with a few earlier 
studies, our results show that hospital discharge records contain information regarding dis-
ease presence prior to death that is not contained in cause of death registrations and that the 
amount of extra information contained varies according to disease (14,27). Adding to previous 
studies, we showed that employing the extra information from hospital discharge records 
results in larger prevalence estimates for each of the twenty conditions most common at the 
end of life. The ranking of some diseases was substantially affected by including the hospital 
information, whereas for other diseases, the ranking was hardly or not at all affected. 
In a recent Dutch study, incidence rates of coronary heart disease, acute myocardial infarc-
tion, unstable angina pectoris and heart failure estimated on the basis of hospital and cause 
of death record linkage were validated against the cardiovascular registry of the Dutch 
Maastricht cohort study (28). A high percentage of the cases of cardiovascular disease were 
only found in the cardiovascular registry and not in the cause of death or hospital data, vary-
ing from 14.2% for acute myocardial infarction to 47.5% for heart failure. This suggests that 
even though hospital registries contain substantial information regarding disease presence 
additional to information from underlying and secondary causes of death, the individually 
linked data of these sources combined may still be incomplete. However, in this study, disease 
information from death certificates was available for a minor part of the population (3.7%) as 
most participants were survivors. As in our study deaths only were included, cause of death 
information was available for the whole study population, which probably has resulted in 
information much more complete. The differences in disease prevalence with and without 
cause of death information, as well as results from international studies including a larger 
proportion of deaths, confirm this (29-31). 
Interpretation of findings
Cause of death statistics originate from the era before the epidemiologic transition and are 
among the oldest and most widely applied indicators of population health. After completion 
of the epidemiologic transition, in the era of chronic diseases, it was recognized that cause of 
death statistics might less accurately reflect population health, and it was advocated to use 
measures representing non-fatal disease consequences in addition (32). Comparing disease 
ranking based on underlying cause of death only with ranking based on the full linked data, 
our results suggest that, indeed, underlying cause of death statistics do not very accurately 
reflect burden of disease in the population in terms of disease prevalence. Using multiple 
causes of death, however, seems to provide a rather accurate reflection. That is, although 
using hospital discharge information in addition to multiple causes of death data results in 
some change of the ranking, almost all diseases most common at the end of life are also 
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represented in the top 5 based on multiple causes of death. Nonetheless, these results should 
be interpreted with some reservation. Where cause of death statistics importantly focus on 
lethal conditions, the same might to some extent be true for hospital statistics. It is plausible 
that persons who have a life-threatening condition have a higher hospitalization rate than 
persons who have a non-lethal condition. Although using individually linked cause of death 
and hospital data is expected to reflect end of life disease burden more accurately than cause 
of death data only, our analysis might still to some extent underestimate the burden of non-
lethal conditions.
Previous studies reported a decline in the number of secondary causes of death for ages 
older than 80, and it was speculated that this is related with physicians not feeling the need 
to provide an extensive explanation of deaths at very old age (12). Aiming at a more complete 
overview of end of life morbidity, also among the oldest old, we linked cause of death reg-
istrations with hospital discharge records. Unfortunately, it appeared that not only report of 
secondary causes of death declined at ages older than 85 but also the number of diseases 
reported in hospital records. It appears that doctors may not only feel less need to provide 
an expansive explanation on the death certificate, but that also their tendency to opt for 
extensive diagnostic procedures in the hospital is less strong for persons at older ages. This 
hypothesis is supported in our data by strong declines towards older ages in the number 
of persons dying in the hospital and strong increases in the number of deaths in homes for 
the elderly. That is, the percentage of persons that died in a home for the elderly increased 
from 15% at age 70-74 to 35% at age 95-100. At age 95-100, almost 75% died in a nursing 
home or home for the elderly. We found that the extent to which hospital diagnoses provide 
information additional to multiple causes of death does not differ among groups aged 50-74 
and 75-84. This suggests that although cause of death and hospital registrations may provide 
less complete disease information for persons aged 85 and older, the relative extent multiple 
causes of death represent end of life morbidity may not decline for these ages.
The occurrence of one disease simultaneously to another can find its origin in etiology, that 
is, multiple diseases can result from a common risk factor or are different expressions of one 
pattern of physical decline, but can also refer to age patterns in the occurrence of unrelated 
diseases (33). It has been shown that common chronic diseases co-occur more frequently 
in one individual than expected on the basis of chance only (34). The large dataset used 
in our study offers great opportunities to study patterns in the occurrence of diseases and 
co-morbidities and requires further analysis. As previous studies found a somewhat higher 
prevalence of co-morbidity among females than among males, the lower prevalence among 
females in our study was unexpected (2, 4, 35). The difference with other studies may be 
related with the number and types of diseases distinguished (15). 
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Implications; conclusion
It was investigated whether multiple causes of death provide a complete overview of disease 
occurrence at the end of life. It is concluded that underlying cause of death statistics are not 
a very accurate representation of end of life morbidity and that statistics based on multiple 
causes of death are more accurate. Therefore, for health policy decisions, it is recommended 
to use multiple causes of death. We showed that, for most individuals, the end phase of life 
is characterized by the occurrence of multiple chronic conditions and that the burden of 
disease at the end of life is high. The next decades, the number of people in their last phase of 
life is expected to increase substantially due to ageing of the population. In the Netherlands, 
for instance, between 2010 and 2050, the annual number of decedents is expected to increase 
by almost 60% (36). The future health system should be prepared to provide adequate and 
sufficient care to support a worthy end of life for these elderly individuals. 
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introduction This paper aims to assess whether disability occurrence is related more strongly 
to proximity to death than to age.
methods Self reported disability and vital status were available from six annual waves and 
a subsequent 12-year mortality follow-up of the Dutch GLOBE longitudinal study. Logit and 
Poisson regression methods were used to study associations of disability occurrence with 
age and with proximity to death.
results For disability in activities of daily living (ADL), regression models with proximity to 
death had better goodness of fit than models with age. With approaching death, the odds for 
ADL disability prevalence and incidence rates increased 20.0% and 18.9% per year, whereas 
severity increased 4.1% per year. For the ages younger than 60, 60–69 and older than 70
years, the odds for ADL disability prevalence increased 6.4%, 16.0% and 23.0% per year. 
Among subjects with asthma/chronic obstructive pulmonary disease, heart disease and 
diabetes increases were 25.1%, 19.5% and 22.7% per year. Functional impairments were more 
strongly related to age.
conclusion The strong association of (ADL) disability occurrence with proximity to death 
implies that a substantial part of the disability burden may shift to older ages with further 
increases in life expectancy.
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introDuction
Life expectancy in Western societies has shown substantial increases during the 20th century. 
In the Netherlands, between 1950 and 2005, life expectancy increased with 6.8 years in males 
and with 8.9 years in females (1). Worldwide, comparable increases in life expectancies oc-
curred (2,3). This trend is not expected to come to an end in the near future. Instead, the 
average length of life is expected to further increase with approximately 5 years between 
2005 and 2050 (2–5). 
One of the key issues in public health is whether these extra life years gained will be years in 
good health or, otherwise, will be spent in ill health or disability (6-8). The alternative scenarios 
for future trends in disability occurrence are crucial not only for chances of individual lifelong 
well-being (9), but will also influence future demands for health care recourses (10-11). 
The future burden of disability among elderly populations may expand at a relative low pace 
if the disability occurrence among the elderly would, along with the increasing length of life, 
shift towards ever older ages. The possibility of such a concomitant shift is suggested by end-
of-life studies showing that trajectories of functional decline may be linked to the end phase 
of life (12-19). As life expectancy increases, trajectories of disability can be expected to at least 
partially shift to older ages. It is uncertain, however, to what extent this would happen. For 
this, it is important to assess to what extent disability occurrence is related to proximity of 
death (time to death) on the one hand and to age (time since birth) on the other hand. To 
our knowledge, the two dimensions of age have not been compared with regards to their 
relationship to disability occurrence. This paper aims to assess whether disability occurrence 
is related more strongly to proximity to death than to age. 
This paper is linked to recent health economics research that assessed the extent to which 
increase of life expectancy is likely to increase health care spending. Several studies deter-
mined the association of health care costs with age and proximity to death respectively (10, 
20-22). It was found that health care costs were in part determined by proximity to death 
and that, hence, population ageing is likely to have a more moderate effect on health care 
spending than was previously assumed (11,20-22). The outcomes of our analysis may help to 
assess whether similar effects may be expected for disability occurrence.
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Study population
We used data from the (GLOBE) study, a prospective cohort study investigating the explana-
tion of inequalities in health in the Netherlands (23). The study comprised a baseline postal 
survey in 1991, conducted among a stratified random sample of 27,070 inhabitants of the city 
of Eindhoven (40%) and surrounding municipalities (60%). The age range was set at 15–74 
years with overrepresentation of 45 years and older. Institutionalised persons were excluded 
in Eindhoven but not in the surrounding municipalities. The response to the baseline ques-
tionnaire was 70.1% (n=18,973).
A subsample (n=3,968) of the initial cohort was invited for an oral interview and received 
annual follow-up questionnaires until 1997 (except for 1996). The subsample overrepresented 
subjects suffering from  asthma/chronic obstructive pulmonary disease (COPD), heart disease 
and diabetes mellitus. The response to the oral interview was 72.2% (n=2,867). All analyses in 
the current paper were based on data from the subsample.
The mean age of the subsample at baseline was 52.6 years and 8% of the subjects were dis-
abled in their activities of daily living (ADL). At the moment of the last administrative follow-
up in 2004, 16% of the sample had died. Among subjects being ADL disabled at baseline, this 
was 37% compared to 14% among non-disabled subjects (Table 3.1.1).
Table 3.1.1 Baseline characteristics of respondents and deaths during follow-up.
Respondents Deaths before end of follow-up
  Number of 
subjects (%)
Mean age 
(sd)
Number ADL 
disabled (%)
  Among all 
(%)
Among 
baseline ADL 
disabled (%)
Among not 
baseline ADL 
disabled (%)
All 2867 (100) 52.6 (14.1) 241 (8) 468 (16) 88 (37) 380 (14)
<60 yrs 1888 (66) 45.4 (0.3) 112 (6) 128 (7) 22 (20) 106 (6)
60-69 yrs 748 (26) 64.7 (0.1) 92 (12) 222 (30) 45 (49) 177 (27)
>=70 yrs 231 (8) 72 (0.2) 37 (16) 118 (51) 21 (57) 97 (50)
Asthma/COPD 588 (21) 53.1 (0.7) 75 (13) 147 (25) 33 (44) 114 (22)
Heart disease 446 (16) 61.4 (0.4) 71 (16) 178 (40) 40 (56) 138 (37)
Diabetes 262 (9) 60.2 (0.6) 36 (14)   92 (35) 20 (56) 72 (32)
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Attrition and item non response
The maximal number of questionnaires that could have been obtained during follow-up of 
the GLOBE subsample was six waves time the 2,867 initial respondents = 17,202 question-
naires. However, 3,337 questionnaires were not returned during follow-up, leaving a total of 
13,865 questionnaires. 
Among questionnaires that were returned, 403 had incomplete data on disability as mea-
sured by the Organization for Economic Co-operation and Development (OECD) indicator 
and 572 had incomplete data on ADL disability. Information was missing for only one item on 
OECD disability in 192 cases, and in 226 cases for ADL disability. In these cases, we imputed 
the missing item with the value of the preceding year or (for 1991) the next year. In total 13,654 
questionnaires with information on OECD disability were available and 13,519 with ADL dis-
ability information. Information on the presence of asthma/COPD, heart disease and diabetes 
was missing for, respectively, 50, 39 and 62 subjects.
Measures of disability
As the study results may depend on the type of disability used (24,25), we used different 
disability measures, including a measure based on 10 ADL questions, and a functional limita-
tion measure based on 8 questions of the OECD indicator of long-term disabilities (26). ADL 
items were ‘walking down/up stairs, moving outdoors, leaving/entering house, sitting down/
getting up from chair, moving on same floor, getting in/out of bed, eating/drinking, get-
ting (un)dressed, washing face/hands and washing completely’. OECD items were ‘able to 
have conversation with one person, able to have conversation with three persons or more, 
reading small letters, recognising faces, biting/chewing food, carry 5 kilos for 10 m, bending/
take something from ground, and walking 400 m’. In terms of the International Classifica-
tion of Functioning, Disability and Health (27), the OECD list focuses on impairments of body 
functions, e.g., hearing, and the ADL list focuses more on activities, i.e., the execution of a 
task or action by an individual. We preferred using these measures, instead of measures like 
disease occurrence or general self-assessed health, because of the direct implications that 
disability and impairment have for the independence of elderly and for their need for formal 
and informal care. For each ADL and OECD item, subjects were asked whether they were able 
to perform the actions ‘without difficulty’, ‘with minor difficulty’, ‘with major difficulty’, ‘not 
able to perform/only with help’. Disability was defined as having at least one item answered 
with ‘with major difficulty’ or ‘not able to perform/only with help’. In sensitivity analyses, we 
also applied an alternative cut-off point to define prevalence cases, as those who had at least 
two (instead of one) items with ‘with major difficulty’ or ‘not able to perform/only with help’ 
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Information on age, sex and presence of asthma/COPD, heart disease and diabetes mellitus 
was obtained from the baseline survey. Table 3.1.1 presents baseline characteristics of all 
respondents and of those who died during follow-up.
Data analysis
The variables ‘prevalence’, ‘incidence’, ‘severity’ and ‘proximity to death’ were created for the six 
waves of data collection separately. ‘Prevalence’ indicated whether disability was reported at 
the time the data were collected. An individual was considered ‘incident’ if disability existed 
in the year of observation but was absent in the preceding year. For all cases of disability, 
‘severity’ was calculated by counting the case in which respondents reported having ‘much 
difficulty’, ‘no/just with help’. ‘Proximity to death’ was calculated as the difference between 
the moment of death, available from linkage to population registers, and the moment of the 
survey.
For all statistical analysis, Stata 10.0 was used. Generalised Estimating Equations (GEE) models 
were used to account for the interdependence of observations from one individual. Preva-
lence data were analysed using logistic regression analysis, while incidence and severity data 
were analysed using Poisson regression. Dependent variables were ‘prevalence’, ‘incidence’ 
and ‘severity’ and independent variables were ‘age’, ‘proximity to death’ and ‘sex’. A dichoto-
mous variable was added to the models indicating whether or not subjects had died during 
follow-up, and to capture differences in disability between those who died and those who 
survived until the end of follow-up. Consequently, the relationship of disability to proximity 
to death could be estimated only from subjects who died during follow-up. 
Stratifications were applied according to age (younger than 60, 60–69 and older than 70 
years) and presence of a chronic disease (asthma/COPD, heart disease and diabetes mellitus). 
To indicate the goodness of fit of the models wald chi2 values were calculated. 
results
Figure 3.1.1 presents ADL prevalence, incidence and severity rates by 5 year age groups and by 
time to death. Disability prevalence increased from around 0.05 up to 0.35 in the oldest age 
category of 80–84 years. In relationship to proximity to death, disability prevalence increased 
from 0.12, 12 years prior to death, to 0.38 in the year prior to death. Increases of disability 
incidence were more pronounced with approaching death as compared to increasing age. 
The maximum value of disability incidence was 0.10 at the highest age group as compared 
to 0.26 within the year prior to death. Increases of severity also were more pronounced with 
approaching death. Severity was especially high the last 4 years prior to death. 
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Figure 3.1.1 Prevalence, incidence and severity of ADL disability by age and time to death. 
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Table 3.1.2 presents wald chi2 values that express the goodness of fit of regression models 
with,  respectively, age, proximity to death and these two factors combined. For OECD dis-
ability prevalence and incidence, goodness of fit values were higher for the age model (350 
and 129) as compared to the proximity to death model (220 and 80) indicating a closer rela-
tionship of OECD disability with age. ADL disability, on the other hand, showed goodness of 
fit values higher for models with proximity to death (309 and 198) as to models with age (187 
and 64), indicating that ADL disability was more closely associated with proximity to death. 
For severity of disability, goodness of fit values were the highest for models with proximity to 
death, for both OECD and ADL disability.
The regression coefficients in Table 3.1.2 show that increases of both OECD and ADL disability 
prevalence were higher with increasing proximity to death (7.1 and 20.0) as compared to 
increases with age (4.3 and 4.7). Increases of incidence and severity were also higher with 
increasing proximity to death as compared to increases with age, for both ADL and OECD 
disability. 
An additional analysis, defining disability as having at least two (instead of one) items with 
much difficulty’ or ‘no/just with help’, showed goodness of fit values of 350 (age model) and 
220 (proximity to death model) for OECD prevalence and 187 (age model) and 309 (proximity 
to death model) for ADL prevalence and values. Thus, using a more strict definition of disabil-
ity showed more clearly a stronger association with age for OECD  disability and a stronger 
association with proximity to death than with age, for ADL disability.
Table 3.1.2 Goodness of fit and regression coefficients of models relating disability to age and proximity to death.
Goodness of fit (wald chi2) Regression estimate with 95% CI  (% increase per year)
  Age
Proximity to 
death
Age + proximity to 
death   Age Proximity to death
Prevalence
    ADL 187 309 359 4.7 (3.7-5.7) 20.0 (14.8-25.4)
    OECD 350 220 424 4.3 (3.7-4.8) 7.1 (3.7-10.7)
Incidence
    ADL 64 198 214 2.7 (1.6-3.8) 18.9 (10.4-28.0)
    OECD 129 80 169 2.9 (2.4-3.6) 11.2 (4.9-18.0)
Severity
    ADL 22 44 50 0.6 (0.1-1.2) 4.1 (1.9-6.3)
    OECD 77 162 181   0.8 (0.5-1.2) 4.7 (3.4-6.1)
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In Table 3.1.3, goodness of fit values are presented for models with age and proximity to death 
among groups of patients with asthma/COPD, heart disease and diabetes. Similar estimates 
are also presented for people without any of these diseases. For all groups with a chronic 
disease, the prevalence of ADL disability showed a better fit with proximity to death than 
with age. For the prevalence of OECD disability in heart disease and diabetes patients, the 
goodness of fit was similar with age as with proximity to death, whereas for asthma/COPD 
patients the best fit was with age. With approaching death, increases of prevalence of ADL 
disability varied from 19.5 in heart disease patients to 25.1 in asthma/COPD patients. Increases 
in OECD disability prevalence varied from 4.6 in heart disease patients to 11.6 in asthma/
COPD patients. Increases with age were lower and varied from 4.7 to 6.3 for ADL disability and 
from 4.0 to 4.4 for OECD disability.
Figure 3.1.2 presents estimates of the prevalence of ADL disability over the last 12 years of 
life for asthma/COPD, heart disease and diabetes patients calculated from regression models 
including proximity to death, age and sex. For the calculations, a constant age of 70 years was 
assumed and sex was set as the average of values for male and female. The dichotomous vari-
able indicating whether subjects from the original dataset had died at the end of follow-up 
(1) or where still alive (0) was set at 0.5. From 12 years prior to death to the year prior to death, 
disability prevalence increased from around 0.10 up to 0.48 in diabetes patients, up to 0.54 in 
patients with heart disease and up to 0.60 in patients with asthma/COPD.
Table 3.1.3 Goodness of fit and regression coefficients of models relating disability to age and proximity to death, stratified to chronic disease.
Goodness of fit (wald chi2) Regression estimate with 95% CI (% increase per year)
  Age
Proximity to 
death
Age + proximity to 
death   Age Proximity to death
Asthma/COPD
    ADL 66 107 126 5.7 (3.8-7.6) 25.1 (16.4-34.5)
    OECD 101 78 128 4.4 (3.3-5.6) 11.6 (5.4-18.1)
Heart disease
    ADL 46 86 94 4.7 (2.1-7.4) 19.5 (11.9-27.6)
    OECD 43 44 62 4.1 (2.3-5.9) 4.6 (-1.1-10.7)
Diabetes
    ADL 25 39 45 6.3 (2.8-9.9) 22.7 (10.1-36.7)
    OECD 24 23 35 4.0 (1.8-6.2) 9.0 (1.0-17.7)
No disease
    ADL 47 51 76 3.8 (2.4-5.1) 11.0 (1.4-21.6)
    OECD 145 48 155   4.0 (3.2-4.7) 3.5 (-2.9-10.4)
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Table 3.1.4 presents wald chi2 values that expresses the goodness of fit of regression models 
for different age strata and for males and females separately and combined. For ADL disability 
prevalence, goodness of fit values were higher for the oldest age category (110), as compared 
to the youngest age category (67). The goodness of fit for OECD disability was better for the 
youngest age category (172) as compared to the oldest age category (24). This pattern was 
not different for males and females.
Table 3.1.4 Goodness of fit and regression coefficients of models relating disability prevalence to proximity to death, stratified to age 
categories.
Goodness of fit (wald chi2) Proximity to death regression estimate with 95% CI (% increase per year)
 
Males + 
females Males Females   Males + females Males Females
All
    ADL 343 204 176 19.1 (13.9-24.4) 27.0 (19.1-35.3) 14.2 (7.2-21.6)
    OECD 394 218 194 7.8 (6.0-9.7) 7.3 (2.9-11.9) 6.6 (1.2-12.4)
<60 years
    ADL 67 40 28 6.4 (-3.2-17.0) 9.5 (-3.3-24.0) 3.1 (-10.9-19.3)
    OECD 172 83 92 6.3 (-1.3-14.5) 5.4 (-4.4-16.2) 8.0 (-3.8-21.1)
60-69 years
    ADL 66 62 19 16.0 (8.3-24.3) 24.3 (12.8-37.0) 6.6 (-3.6-17.9)
    OECD 38 42 9 6.4 (1.1-11.9) 7.1 (0.6-14.1) 6.3 (-2.6-15.9)
>=70 years
    ADL 110 73 53 23.0 (13.9-32.7) 38.1 (21.4-57.1) 17.2 (6.2-29.3)
    OECD 24 20 9   7.5 (1.6-13.6) 10.0 (1.7-19.0) 7.0 (-1.6-16.3)
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Figure 3.1.2 Regression-based estimates of ADL disability prevalence by time to death stratified by chronic disease.
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The regression coefficients in Table 3.1.4 show that increases of the prevalence of ADL  dis-
ability with approaching death were stronger in the oldest age category (23.0) as compared 
to the youngest age category (6.4), also for males and females separately. Increases of OECD 
disability were also higher for the oldest age category (7.5) as compared to the youngest age 
category (6.3).
Figure 3.1.3 presents estimates of the prevalence of ADL disability over the last 12 years of life 
for age strata younger then 60 years, 60–69 years and older than 70 years, calculated from 
regression models including proximity to death, age and sex. For the calculations, a constant 
age of 55, 65 and 75 years was assumed for the respective age categories. Sex and the value 
indicating death at the end of follow-up were set identical as was done for Figure 3.1.2. From 
12 years prior to death to the year prior to death, disability prevalence increased from below 
0.15 up to 0.25 for ages younger than 60 years, up to 0.39 for ages 60–69 years and up to 0.59 
for ages older than 70 years.
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Figure 3.1.3 Regression-based estimates of ADL disability prevalence by tim  to death stratified by age.
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Discussion
Summary of results
The concept of proximity to death dependence has widely been applied in the field of health 
economics and has led to important new insights in expectations of future health care 
expenditures. Previous research suggested that disability occurrence is also partly related 
to approaching death. However, no previous study compared age and proximity to death 
with regards to their associations with disability occurrence. Our results showed that ADL 
disability was more strongly related to proximity to death than to age, also within specific 
patient groups and among different age groups. Functional impairments, as measured with 
the OECD list, were however more strongly related to age.
Evaluation of data and methods
Our data has some limitations that need proper attention. If non-response during follow-up 
was related to disability occurrence, this may have influenced the estimation of proximity to 
death parameters. To evaluate this possibility of attrition bias, we compared mortality during 
follow-up between non-responders and the rest of the study population. Age-standardised 
mortality among nonresponders was 12.9% versus 16.4% among the rest of the population. 
The lower mortality ratio among non-responders could be indicative of a lower disability 
prevalence among this group. In order to evaluate whether this might have biased our es-
timates of proximity to death dependence, we compared the original prevalence plots with 
plots in which missing disability values imputed from last available observations. The new 
plots hardly differed from the original plots. The relatively unchanged plots indicate that bias 
related to sample attrition or item non-response is probably small. 
Opposite to the (small) effect of attrition in our study, exclusion of part of the institutionalised
population from the baseline survey could have been associated with a lower prevalence 
of disability due to exclusion of the relatively more disabled nursing home population. As 
admission to a nursing home occurs often at the end of life, exclusion of the institutionalised
might have led to some degree of underestimation of the proximity to death dependence of 
disability. 
The use of self-reported measures of disease and disability might have led to some informa-
tion bias. This would particularly be problematic if, independent from the status of disability, 
reporting behaviour was related to proximity to death. With the available data, these effects 
cannot be studied, and, as far as we know, no studies exist that describe such effects. One 
could imagine that being in the last phase of life could both positively (by increased relativ-
ism) and negatively (by increased pessimism) affect one’s perception and reporting of dis-
ability. If the latter, pessimistic tendency were to predominate, this could
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in part explain the relationship with proximity to death observed in this study. Nevertheless, 
as the significant increases of health care costs the last years of life (11,20-22) are to at least 
some extent related to disability occurrence (28-29), it seems unlikely that reporting tenden-
cies alone would explain much of this strong increase in disability occurrence.
Comparison to previous studies
Our finding that disability prevalence increases as death approaches is in general agreement 
with a substantial amount of literature reporting terminal trajectories of functional decline 
at the end of life (12-19). Similar to our results, trajectories of functional decline were also 
reported among terminal patients with different diseases (12,17,19), e.g., COPD, diabetes and 
cerebrovascular accident (19). In line with our finding of a stronger association of disability
prevalence with proximity to death at older ages, it was found that disability rates prior to 
death were higher at increased ages of death (15). Hubert et al. (30) found increasing dis-
ability scores with approaching death as from 10 years prior to death. As with our finding of a 
relationship over 12 years of time, their results suggest that death casts its shadow
remotely over life.
In the health economics field, the principle of relating health care expenditures to proximity 
to death has been applied for more than 20 years (29). International studies found that health 
care expenditures during the last year of life are four to six times higher than expenditures for 
survivors (22,28) and ten times higher compared to expenditures 5 years earlier before death 
(21). In the Netherlands, 10% of total health expenditure has been found to be associated with 
health care use during the last year of life (20). To compare, we calculated the share of lifetime 
ADL disability burden (prevalence times severity) that occurred during the last year of life 
and during the last 5 years of life, assuming an 80 years lifespan. We estimated that 18% of 
the lifetime disability burden would occur during the last year of life and 66% of the burden 
would occur during the last 5 years of life. This suggests that ADL disability burden is at least 
as strongly related to the end of life as health care costs.
Interpretations of other findings
A remarkable difference was observed between the dominant proximity to death depen-
dence of ADL disability on the one hand and the dominant age dependence of functional 
impairments (as measured in the OECD measure) on the other hand. This difference may per-
haps be explained to the different physical domains that these scales represent: ADL mainly 
represents the locomotor domain, and functional impairments also represent visual, auditive 
and lingual domains. Ageing is associated with degeneration and lack of maintenance and 
repair of physiological and metabolic systems (31–33). As a result of damage to these systems, 
disability can occur, and, if a life maintaining system is involved, chances for death increase. 
As compared to ADL disability, functional impairments as measured in the OECD
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list may be more associated to damage to systems that are not life maintaining (e.g., hearing 
and vision) and that therefore are more dependent on age. 
Our finding that the prevalence of disability is more strongly associated to proximity to death 
in males as compared to females may be explained by the fact that females tend to suffer to a 
larger extent from non-lethal chronic disabling conditions like arthritis and back complaints 
(34–37) whereas lethal disabling conditions like cardiovascular disease and cancer are more 
common in males (34–37).
Implications
Current projection models of the future prevalence of disability either assume that age 
specific prevalence rates are constant or that past trends in age-specific disability prevalence 
rates will continue at the same rate in the future (38). Scenarios for health care expenditures 
show that age based models overestimate future expenditures as compared to models that 
take into account dependence on proximity to death. The latter models project about 10% 
less increase (20). Estimating to what extent past disability trends will be prolonged in the 
future remains a difficult exercise. In order to improve projections, we strongly recommend 
incorporating proximity of death parameters in future projection models. This would enable 
to directly relate future disability occurrence to expectations of increasing life expectancy 
(2–5) and could therefore lead to importantly improved estimations. The different results for 
ADL disability and for functional impairments, plea for incorporation of multiple domains of 
disability in projections of future trends in disability burden. 
Our results suggest that, together with ongoing increases of the life expectancy, the 
prevalence of functional limitations, as measured by the OECD list, may increase in particular. 
Thus, in the coming decades, the number of elderly people with problems in movement or 
communication is likely to increase rapidly. This would result in an increased demand for 
care and rehabilitation to compensate for such functional limitations. In addition, the pres-
ence of functional limitations may increasingly complicate treatment of other diseases in 
elderly people, due to problems of co-morbidity. Sound projections, taking into account age 
at death, are needed to explore the pace and extent to which demand for rehabilitation and 
care will expand in the next decades (39,40).
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introduction Projections of future trends in the burden of disability could be guided by 
models linking disability to life expectancy, such as the dynamic equilibrium theory. This ar-
ticle tests the key assumption of this theory that severe disability is associated with proximity 
to death, whereas mild disability is not.
methods Using data from the GLOBE study (Gezondheid en Levensomstandigheden Bevolk-
ing Eindhoven en omstreken), the association of three levels of self-reported disabilities in 
activities of daily living with age and proximity to death was studied using logistic regression 
models. Regression estimates were used to estimate the number of life years with disability 
for life spans of 75 and 85 years.
results Odds ratios of 0.976 (not significant) for mild disability, 1.137 for moderate disability, 
and 1.231 for severe disability showed a stronger effect of proximity to death for more severe 
levels of disability. A 10-year increase of life span was estimated to result in a substantial 
expansion of mild disability (4.6 years) compared with a small expansion of moderate (0.7 
years) and severe (0.9 years) disability.
conclusion These findings support the theory of a dynamic equilibrium. Projections of the 
future burden of disability could be substantially improved by connecting to this theory and 
incorporating information on proximity to death.
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introDuction
In the coming decades, human life expectancy is likely to further increase (1,2). The issue 
whether this increase of life expectancy will correlate with either compression of disability 
(3) or expansion of disability (4,5) has been the subject of debate ever since the publication 
of Fries’ (3) seminal article on compression of morbidity. A compression, that is, a decrease 
in the number of years that people may expect to live with disability, can only occur when 
the increase in life expectancy is surpassed by a stronger increase in the mean age of the 
onset of disability. When the increase in the age of the onset of disability will not keep pace 
with  rising life expectancy, expansion will occur, that is, an increase in the number of years 
that people may expect to live with disability. Explorative analyses of future compression or 
expansion in disability are needed to prepare future health care systems to cope with the 
health effects of ageing of the population.
Projections of future trends in the total burden of disability have been applied that were 
based on past trends of disability (6,7). Unfortunately, application of these methods involved 
some difficulties. Past trends of disability were often not unambiguously pointing toward 
one direction and therefore constituted a weak basis for projections (6,8). Furthermore, stud-
ies do not present univocal methods to extrapolate trends, as it is not clear to what extent 
past trends will keep pace in the future (6,7). The complex mechanisms that simultaneously 
drive the life expectancy and the expectancy of life with disability are still not fully under-
stood. This complicates the modelling of the effect of increasing life expectancy on the future 
burden of disability (9).
The extent to which gained life years will be spent in disability will greatly be determined 
by the relative part of disability in the population that is specifically related  to end-of-life 
processes and will therefore shift to older ages as life expectancy increases. Assuming that 
most severe disability is reserved to the end of life (10-12), but that mild disability mostly 
occurs independent to the end-of-life processes, it is to be expected that with increase of 
life expectancy most severe disability will shift to older ages, but that mild disability will 
mostly expand. This scenario, which is expressed in the theory of a dynamic equilibrium, is 
graphically represented in Figure. 3.2.1 (13).  Severe disability is fully dependent on proximity 
to death and, consequently, with increase of life expectancy, the onset of severe disability 
equivalently shifts to older ages. Mild disability is fully dependent on age and, therefore, 
the onset of mild disability does not change as life expectancy increases. The years spent in 
severe disability did not change, whereas the years in mild disability expanded.
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The present article aims to assess whether the theory of a dynamic equilibrium (13) provides 
a valid framework for projections of the future burden of disability. We will test the key as-
sumption of this theory that the occurrence of severe disability is associated with proximity to 
death, whereas the occurrence of mild disability is not. Based on estimates of associations of 
disability with age (time since birth) and proximity to death, we will calculate to what extent 
the lifetime burden of mild, moderate, and severe disability will expand in the hypothetical 
case of a 10-year increase of life span.
metHoDs
Study population
We used data from the GLOBE study (Gezondheid en Levensomstandigheden Bevolking 
Eindhoven en omstreken), a prospective cohort study investigating the explanation of in-
equalities in health in The Netherlands (14). The study comprised a baseline postal survey 
in 1991, conducted among a stratified random sample of 27,070 inhabitants of the city of 
Eindhoven (40%) and surrounding municipalities (60%). The age range was set at 15-74 years 
with overrepresentation of 45 years and older. Institutionalized persons were excluded in 
Eindhoven but not in the surrounding municipalities. The response to the baseline question-
naire was 70.1% (n=18,973). 
A subsample (n=3,968) of the initial cohort was invited for an oral interview and received 
annual follow-up questionnaires until 1997 (except for 1996). The subsample overrepresented 
subjects suffering from asthma/chronic obstructive pulmonary disease (COPD), heart disease, 
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and diabetes mellitus. The response to the oral interview was 72.2% (n=2,867). All analyses in 
the present article were based on data from the subsample.
The mean age of the subsample at baseline was 52.6 years, and 34% of the subjects had 
mild, moderate, or severe activities of daily living (ADL) disability. At the moment of the last 
administrative follow-up in 2004, 16% of the sample had died. Among subjects being ADL 
disabled at baseline, this was 26% compared with 11% among nondisabled subjects.
Attrition and item non-response
The maximal number of questionnaires that could have been obtained during follow-up of 
the GLOBE subsample was six waves times the 2,867 initial respondents = 17,202 question-
naires. However, 3,337 questionnaires were not returned during follow-up, leaving a total of 
13,865 questionnaires.
Among questionnaires that were returned, 572 had incomplete data on ADL disability. In-
formation was missing for only one item of ADL disability in 226 cases. In these cases, we 
imputed the missing item with the value of the preceding year or (for 1991) the next year. 
Single instead of multiple imputation was justified because of the small amount of missing 
values. Three hundred forty-six cases with information missing for more than one item were 
excluded from the analysis. In total, 13,519 questionnaires with information on ADL disability 
were available.
Disability measure
Disability was measured by means of 10 ADL items. The items were ‘‘walking down/upstairs, 
moving outdoors, leaving/entering house, sitting down/getting up from chair, moving on 
same floor, getting in/out of bed, eating/drinking, getting (un)dressed, washing face/hands 
and washing completely.’’ For each item, subjects were asked whether they were able to per-
form the actions ‘‘without difficulty,’’ ‘‘with minor difficulty,’’ ‘‘with major difficulty,’’ ‘‘only with 
help.’’ Mild disability was defined as at least one item answered with ‘‘with minor difficulty,’’ 
moderate disability as at least one item answered with ‘‘with major difficulty,’’ and severe dis-
ability as at least one item answered with ‘‘only with help.’’ Overall disability was considered 
as at least one item answered with any of these three categories.
Data analysis
The variables ‘‘mild disability,’’ ‘‘moderate disability,’’ ‘‘severe disability,’’ ‘‘overall disability,’’ and 
‘‘proximity to death’’ were created for the six waves of data collection separately. The four 
disability variables indicated whether mild, moderate, severe, and overall disability were 
reported at the time the data were collected. ‘‘Proximity to death’’ was calculated as the dif-
ference in time between the moment of death, available from linkage to population registers, 
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and the moment of the survey. Information on age and sex was obtained from the baseline 
survey.
For all statistical analyses, Stata 10.0 was used (Stata-Corp, College Station, TX, USA). Gen-
eralized estimating equations (GEE) models were used to account for the interdependence 
of observations from one individual that would not be possible by using Cox proportional 
hazards models. Logistic regression analyses were applied using an exchangeable correlation 
matrix. By subsequently using overall, mild, moderate, and severe disabilities as dependent 
variables, four different models were fitted. All models included ‘‘age’’ and ‘‘proximity to 
death’’ as independent continuous variables, and all were adjusted for sex. Furthermore, a 
dichotomous variable was added to the models indicating whether or not subjects had died 
during follow-up and to capture differences in disability between those who died and those 
who survived until the end of follow-up. Consequently, the relationship of disability to prox-
imity to death could be estimated only from subjects who died during follow-up. Following 
the approach in previous studies on disability trajectories in the GLOBE cohort, no weights 
were applied (15,16).
Using the different regression models and drawing on associations with age and proximity 
to death, we estimated age-specific prevalence rates for mild, moderate, severe, and overall 
(sum of mild, moderate, and severe) disability for life spans of 75 and 85 years. A Sullivan type 
of method was used to estimate the total number of years that a person might expect to live 
with disability over a life span of 75 and 85 years, respectively. In this particular approach, the 
years of life lived was assumed to be the same for each age-group considered. That is, the 
age-specific prevalence rates were summed to estimate the total number of years that are ex-
pected to be lived in disability (life with disability, LED). Confidence intervals (CI) around the 
estimated years with disability were estimated using probabilistic sensitivity analyses (17-19). 
That is, thousand times, regression coefficients were drawn randomly from each regression 
model, assuming multivariate normal distribution. For each draw, the corresponding transi-
tion rates and years with disability were calculated. The 25th and 975th of the ordered values 
indicated the boundaries of the CI’s.
results
Table 3.2.1 shows the odds ratios (ORs) for all variables that were included in the models 
to estimate the prevalence of mild, moderate, severe, and overall disability. In case of the 
continuous variables age and proximity to death, the ORs indicate the extent to which the 
o odds for disability increase if age or proximity to death increases with one year. Results 
from models with and without proximity to death are shown together with their goodness 
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Table 3.2.1 Parameter estimates from models with and without proximity to death predicting the prevalence of overall, mild, moderate and 
severe ADL disability.
  Mild disability Moderate disability Severe disability Overall disability‡
age and proximity to death model
OR age (continuous) 1.027 (1.022 – 1.032) 1.032 (1.022 – 1.042) 1.095 (1.072 – 1.117) 1.039 (1.033 – 1.044)
OR proximity to death (continuous) 0.976 (0.945 – 1.009) 1.137 (1.081 – 1.196) 1.231 (1.144 – 1.326) 1.108 (1.075 – 1.143)
OR deceased (dummy; 0=survived, 1=died) 1.479 (1.127 – 1.941) 0.967 (0.609 – 1.535) 0.500 (0.227 – 1.106) 1.072 (0.823 – 1.397)
OR sex (dummy; male=0, female=1) 1.134 (0.999 – 1.287) 1.387 (1.111 – 1.733) 2.110 (2.110 – 0.421) 1.353 (1.185 – 1.544)
Goodness of fit (wald chi2) 152 182 215 422
age model
OR age (continuous) 1.029 (1.024 – 1.034) 1.045 (1.035 – 1.054) 1.126 (1.104 – 1.149) 1.046 (1.041 – 1.052)
OR sex (dummy; male=0, female=1) 1.114 (0.983 – 1.263) 1.228 (0.989 – 1.524) 1.740 (1.186 – 2.550) 1.244 (1.092 – 1.417)
Goodness of fit (wald chi2) 143 90 150 332
‡Based on estimates from separate model
Table 3.2.2 Life years in mild, moderate and severe disability for life spans of 75 and 85 years and percentages of disability occurring the last 
and last five years of life.
  Mild disability Moderate disability Severe disability Overall disability‡
age and proximity to death model 
Years with disability, 75 yrs lifespan 11.6 (8.0 – 18.7) 2.4 (0.9 – 5.6) 0.8 (0.5 – 1.3) 14.8 (10.7 – 20.0)
Years with disability, 85 yrs lifespan 16.2 (10.7 – 28.0) 3.1 (1.1 – 6.8) 1.7 (1.1 – 2.7) 21.0 (15.0 – 34.0)
Increase 4.6 (2.5 – 9.4) 0.7 (0.3 – 1.2) 0.9 (0.5 – 1.5) 6.2 (3.9 – 11.1)
% in last life year, 75 yrs lifespan 1.4 (0.5 – 3.1) 12.6 (9.9 – 13.9) 23.6 (18.2 – 28.4) 4.4 (2.5 – 6.8)
% in last life year, 85 yrs lifespan 1.3 (0.4 – 2.9) 12.0 (9.7 – 13.2) 21.3 (16.2 – 26.1) 4.5 (2.5 – 6.7)
% in last five life years, 75 yrs lifespan 7.1 (2.6 – 14.6) 50.2 (41.0 – 54.5) 75.3 (64.5 – 82.3) 17.8 (9.9 – 27.8)
% in last five life years, 85 yrs lifespan 6.4 (2.2 – 13.8) 48.9 (40.5 – 52.9) 72.7 (61.3 – 80.5) 18.0 (10.0 – 27.6)
age model
Years with disability, 75 yrs lifespan 14.9 (14.8 – 15.1) 2.9 (2.5 – 3.4) 0.8 (0.6 – 1.1) 18.6 (17.4 – 20.0)
Years with disability, 85 yrs lifespan 19.2 (17.9 – 20.4) 4.4 (3.8 – 5.1) 2.5 (1.9 – 3.2) 26.0 (24.5 – 27.6)
Increase 4.2 (3.9 – 4.6) 1.5 (1.2 – 1.8) 1.6 (1.2 – 2.2) 7.4 (6.8 – 8.1)
% in last life year, 75 yrs lifespan 2.6 (2.4 – 2.9) 4.2 (3.5 – 4.9) 10.7 (9.1 – 12.3) 3.2 (2.9 – 3.5)
% in last life year, 85 yrs lifespan 2.4 (2.2 – 2.6) 4.0 (3.4 – 4.7) 9.9 (8.5 – 10.9) 3.4 (3.0 – 3.7)
% in last five life years, 75 yrs lifespan 12.5 (11.5 – 13.7) 19.3 (16.5 – 22.5) 43.6 (38.1 – 48.4) 15.0 (13.9 – 16.2)
% in last five life years, 85 yrs lifespan 11.5 (10.6 – 12.6) 18.6 (15.8 – 21.6) 41.3 (36.5 – 44.9) 15.5 (14.2 – 16.9)
‡Based on summed estimates for mild, moderate and severe disability.
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of fit. As represented by ORs of 0.976 for mild disability, 1.137 for moderate disability, and 1.231 
for severe disability, the effect of proximity to death was stronger for more severe levels of 
disability. Only for mild disability, the association with proximity to death was not statistically 
significant. Compared with the models that did not include proximity to death, the goodness 
of fit of the model with proximity to death was only slightly better for mild disability, whereas 
the fit substantially improved for moderate and severe disability. 
Table 3.2.2 shows calculated LEDs for mild, moderate, and severe disability for life spans of 75 
and 85 years and percentages during the last and last five years of life, based on the respective 
regression models. For a life span of 75 years, it was estimated that 11.6 (8.0-18.7) years were 
spent with mild disability, 2.4 (0.9-5.6) years with moderate disability, and 0.8 (0.5-1.3) years 
with severe disability. A 10-year increase in life span resulted in 4.6 (2.5-9.4) extra years in mild 
disability, 0.7 (0.3-1.2) extra years in moderate disability, and 0.9 (0.5-1.5) extra years in severe 
disability. Models with information on age only (thus excluding time to death) projected a 
much smaller increase in LED with mild disability, whereas they projected larger increases in 
LED with moderate or severe disability.
Percentages of LED occurring in the last year of life ranged from 1.4% for mild disability to 
12.6% for moderate disability to 23.6% for severe disability, for life spans of 75 years. A 10-year 
increase of life span resulted in lower percentages of LED occurring in the last year of life for 
mild (0.1% lower), moderate (0.6% lower), and severe disability (2.3% lower). The percentages 
of LED occurring in the last five years decreased with 0.7% for mild disability, 1.3% for moder-
ate disability, and 2.6% for severe disability. 
Figure. 3.2.2 visually represents the calculated prevalence of mild, moderate, severe disability 
for life spans of 75 and 85 years. To also display the prevalence of overall disability, the preva-
lences for the different levels of severity are shown cumulatively. Increase of life span resulted 
in a strong shift of the burden of disability to older ages, especially for moderate and severe 
disability. Thirteen percent of LED mild was spent during the 10 years that were gained, as 
compared with 75% and 94% for LED moderate and LED severe, respectively. Age-specific 
prevalences of disability at younger ages generally declined.
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Discussion
Summary of results
Our results confirm the hypothesis that the occurrence of severe disability is associated with 
proximity to death and the occurrence of mild disability is not. Based on the associations 
with age and proximity to death and assuming a 10-year increase of life span, we showed 
that mild disability greatly expanded, but that moderate and severe disability showed much 
lesser expansion. Current findings support the theory of a dynamic equilibrium (13). 
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figure 3.2.2 Age-specific prevalence of ADL disability by level of severity for life spans of 75 and 85 years. Estimates derived from 
regression models.
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Evaluation of data and methods 
Our data has some limitations that need proper attention. If non-response during follow-up 
was related to disability occurrence, this may have influenced the estimation of proximity-to-
death parameters. To evaluate this possibility of attrition bias, we compared mortality during 
follow-up between non-responders and the rest of the study population. Age-standardized 
mortality among non-responders was 12.9% vs. 16.4% among the rest of the population. 
The lower mortality ratio among non-responders could be indicative of a lower disability 
prevalence among this group. To evaluate whether this might have biased our estimates of 
proximity-to-death dependence, we compared the original regression estimates with esti-
mates in which missing disability values were imputed from last available observations. The 
new estimates hardly differed from the original one. This indicates that bias related to sample 
attrition is probably small.
Exclusion of part of the institutionalized population from the baseline survey could have 
been associated with a lower prevalence of disability because of exclusion of the relatively 
more disabled nursing home population. As admission to a nursing home occurs often at the 
end of life, exclusion of the institutionalized population might have led to some degree of 
underestimation of the relationship between proximity to death and disability, especially for 
moderate and severe disability.
The use of self-reported measures of the different levels of disability might have led to some 
information bias. This would particularly be problematic if, independent from the status of 
disability, reporting behaviour was related to proximity to death. Again, especially moderate 
and severe levels of disability may have been influenced, because these levels are more likely 
to occur close to death. With the available data, these effects cannot be studied, and, as far as 
we know, no studies exist that describe such effects. One could imagine that being in the last 
phase of life could both positively (by increased relativism) and negatively (by increased pes-
simism) affect one’s perception and reporting of disability. If the latter pessimistic tendency 
were to predominate, this could in part explain the relationship with proximity to death 
observed in this study. Nevertheless, also in view of an increase of health care costs during 
the last years of life (20-23), it seems unlikely that reporting tendencies alone would explain 
much of this strong increase in disability occurrence.
The association of proximity to death and disability is likely to be mediated by other factors, 
such as health status/disease and demographic factors. If our aim had been to gain insight 
into causal chains that relate disability with time to death, or to provide a model with an 
optimal predictive power, it would have been useful to include more covariates. However, our 
aim was only to demonstrate the relevance of proximity to death for predicting the preva-
lence of disability. To keep the models simple and transparent, we decided not to include any 
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other covariates except sex. Moreover, variables other than sex, age, and time to death are 
not routinely distinguished in projections of future demographic trends of many countries.
We chose to use GEE instead of other statistical models, for example Cox proportional haz-
ards or ordered logit models, because this allowed us to account for interdependence of 
observations. Postestimated intraindividual correlations that were 0.442 for mild disability, 
0.407 for moderate disability, and 0.675 for severe disability, showed that interdependences 
were strong. Using statistical models that did not account for these interdependences would 
have substantially affected the model estimates. 
To test whether adding polynomial terms on age or proximity to death would have improved 
the fit of the models, we used quasi-information criterion (QIC). QIC is a Stata program that 
has been developed as an aid for model selection in GEE analyses (24). Adding polynomial 
terms did not substantially improve the goodness of fit for models of overall, moderate, and 
severe disability. For mild disability, however, the model fit did improve by adding a quadratic 
term for proximity to death (the QIC value decreased from 16062 to 15050). Nevertheless, to 
use the same model for different types of severity, we decided not to include any polynomial 
terms.
We modelled the prevalence of disability as dependent on proximity to death, but the 
converse may also be applied, that is, modelling proximity to death as dependent on the 
prevalence of disability. This raises the issue of reverse causality that is relevant especially to 
studies that construct statistical models with the aim of identifying associations and mak-
ing inferences about the causality of the associations observed. Our aim, however, was not 
to make inferences about causality but to test for the existence of a set of associations as 
predicted by a descriptive theory (i.e., the theory of a dynamic equilibrium). 
In the article in which Manton introduced his theory of a dynamic equilibrium, he stated that 
slowing down the progression rate of a disease would lead to a longer life, an increasingly 
longer period spent in disease, but a relatively constant number of years spent in ‘‘highly 
morbid’’ state. Although Manton did not define this ‘‘highly morbid’’ state, we applied a 
distinction according to the severity of disability. Similar distinctions have been applied by 
other researchers (25). In our calculations, mild disability showed rapid expansion, whereas 
the occurrence of moderate and severe disability shifted toward older ages with increase of 
life span. This shift resembles the trends in the ‘‘highly morbid state’’ that Manton postulated.
Comparison with past trends
Between 1990 and 2003, life expectancy has increased by approximately 1 year in females and 
2.5 years in males (26,27). In accordance with the theory of a dynamic equilibrium, one would 
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expect an increasing life expectancy in mild disability but much smaller increases for more 
severe disability. In addition, if disability occurrence would be strongly related to proximity 
to death, one would expect increasing of life expectancy to be related to decreasing age-
specific disability prevalence rates (instead of constant prevalences; see Figure. 3.2.2).
Although the evidence is not completely unambiguous, generally, stable or decreasing age-
specific disability prevalence rates were observed for a variety of disability indicators (6,8). 
Simultaneous trends of increasing life expectancy and decreasing age-specific disability 
rates were also found for the United States, Japan, and various European countries (6,28-30). 
Thus, evidence from The Netherlands and other countries generally supports the expectation 
of decreasing age-specific prevalence rates. 
Studies for The Netherlands estimate that between 1989 and 2000 a gain in life expectancy 
in males from 14.3 to 15.3 years at age 65 was accompanied by an increase of years in mild 
disability from 3.7 to 6.2 years, whereas the number of years in moderate and severe disability 
decreased from 5.1 to 4.5 years (31). Similar patterns were observed for females (31). Research 
from other countries showed similar results. In the United States, between 1992 and 2002, a 
half-year gain in life expectancy at age 65 was accompanied with constant expectations of 
years in instrumental activities of daily living (IADL) disability and moderate ADL disability 
and a decrease of life expectancy in severe ADL disability from 2.1 to 1.7 years (32). In New 
Zealand, between 1981 and 1996, life expectancy at age 65 increased from 13.3 to 15.5 in males 
and from 17.2 to 19.0 years in women. During the same period, the life expectancy with major 
mobility restrictions in male remained 0.8 years, but life expectancy with moderate mobility 
restrictions more than doubled from 0.7 to 1.6 years. In females, the life expectancy with major 
mobility restrictions moderately increased from 2.0 to 2.6 years, whereas the life expectancy 
with moderate mobility restrictions sharply increased from 1.2 to 2.7 years (33).
Cohort differences
We found that disability is associated with age and proximity to death. In theory, these as-
sociations may partially reflect cohort effects. Cohort differences could for instance occur if 
differences in living conditions at birth substantially affect the onset of disability and mortal-
ity within specific generations. In a study on cohort differences in disease and disability in 
the young-old (in the United Kingdom), Jagger et al. (34) showed that the number of chronic 
conditions and especially the presence of arthritis and COPD were reported more frequently 
in more recent cohorts. Nevertheless, these cohort differences did not appear to be reflected 
in similar  differences in functional limitation or disability, whereas survival too was similar 
between cohorts. This suggested that cohort effects in disability occurrence might be only 
small. However, more definite answers should be derived from studies that, like in the field 
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of mortality (35), could distinguish between period and cohort effects by using long observa-
tion periods.
Implications for modelling future developments in disability
Together with evidence from past disability trends, the results from the present article provide 
empirical support to the theory of a dynamic equilibrium. This theory may provide a useful 
framework for projecting changes in disability occurrence in relationship to increases in life 
expectancy. Prediction models could connect to this framework by incorporating informa-
tion on proximity to death. Using a proximity-to-death term would allow the modelling of a 
shift of disability toward older ages when life expectancy increases. To further connect to the 
theory of a dynamic  equilibrium, prediction models should distinguish for different levels of 
severity of disability. According to our estimates, these new prediction models are likely to 
predict a smaller increase in the burden of moderate and severe disability than traditional 
age-based models.
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introduction Population ageing is expected to lead to strong increases in the number of 
persons with one or more disabilities, which may result in substantial declines in the quality 
of life. To reduce the burden of disability and to prevent concomitant declines in the quality 
of life, one of the first steps is to establish which diseases contribute most to the burden. 
Therefore, this paper aims to determine the contribution of specific diseases to the preva-
lence of disability and to years lived with disability, and to assess whether large contributions 
are due to a high disease prevalence or a high disabling impact. 
methods Data from the Dutch POLS-survey (Permanent Onderzoek Leefsituatie, 2001-2007) 
were analyzed. Using additive regression and accounting for co-morbidity, the disabling 
impact of selected chronic diseases was calculated, and the prevalence and years lived with 
ADL and mobility disabilities were partitioned into contributions of specific disease.
results Musculoskeletal and cardiovascular disease contributed most to the burden of dis-
ability, but chronic non-specific lung disease (males) and diabetes (females) also contributed 
much. Within the musculoskeletal and cardiovascular disease groups, back pain, peripheral 
vascular disease and stroke contributed particularly by their high disabling impact. Arthritis 
and heart disease were less disabling but contributed substantially because of their high 
prevalence. The disabling impact of diseases was particularly high among persons older than 
80. 
conclusion To reduce the burden of disability, the extent diseases such as back pain, periph-
eral vascular disease and stroke lead to disability should be reduced, particularly among the 
oldest old. But also moderately disabling diseases with a high prevalence, such as arthritis 
and heart disease, should be targeted.
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introDuction
Population ageing is expected to lead to a sharp increase in the occurrence of disability. Dis-
ability is associated with an increased need for social services, e.g. healthcare, and a loss in 
quality of life (1-3). To enable the future health care system to cope with increasing demands, 
and to avoid strong decrements in the quality of life, it is crucial to develop strategies that 
effectively lead to reductions in the burden of disability. One of the first steps crucial in de-
veloping these strategies is to identify which diseases contribute most to the total burden of 
disability, but also to clarify whether large contributions are related with a high prevalence 
of disease or with a high disabling impact, i.e. a high extent the disease leads to disability.
To date, only a limited number of studies have assessed the contribution of specific diseases 
to the burden of disability (4-14). Unfortunately, most of these studies were based on relatively 
old data (4-9). As both the prevalence of chronic diseases and their disabling impacts change 
over time, the results of these studies may be outdated (13,14). Furthermore, only two studies 
explicitly addressed the role of disease prevalence and disabling impact in contributions 
to disability (5,6). The most comprehensive study assessing burden of disease has probably 
been WHOs Global Burden of Disease study (GBD) (12). In this study, however, disease burden 
is quantified on the basis of panel valuations of health states rather than actual presence of 
physical or mental disabilities (12). 
Most of the previous studies were based on cause elimination techniques, which provide 
outcome measures that reflect the reduction in the prevalence of disability if the disease 
would no longer be present (4,7,8,11). Drawbacks of this method are that the results may be 
inconsistent in a situation of co-morbidity, as they depend on the ordering of the elimination, 
and that contributions of all diseases do not add up to the total disability prevalence. Recently, 
Nusselder et al. developed a methodology, based on an additive regression technique, that 
enables exact partitioning of the burden of disability into additive contributions of disease in 
the presence of co-morbidity (5,15). 
The aim of this study was to investigate the current contribution of specific chronic diseases 
to the total burden of disability in mobility and activities of daily living among the elderly, 
both in terms of disability prevalence and years lived with disability. This study is among the 
first to highlight the role of both the prevalence and the disabling impact of specific diseases 
to determine their contribution to the burden of disability.
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Study population
The study population consisted of subjects from seven successive years (2001-2007) of the 
POLS health and labour survey, which is being conducted by Statistics Netherlands. The sur-
vey does not include the institutionalized population. To account for selective non-response 
and to ensure representativeness for the Dutch non-institutionalized population, weights 
were used that were attached to the data. 
Information on disabilities in mobility and activities of daily living was collected through 
face-to-face interviews and information on the presence of chronic disease through written 
questionnaires. From 2001-2007, 110,766 subjects were approached and the response was 
62%. For our analyses selected elderly subjects who were 55 years and older (n = 17,404) were 
selected. 22% of these subjects could not be included in the study population because they 
lacked disease information. Table 4.1 provides further detailed information on numbers of 
persons in the study population and Figure 4.1 on the difference between the source and 
study population. 
Table 4.1 Numbers of subjects in the study sample. 
Males Females
  55-64 65-79 >=80   55-64 65-79 >=80
Total 3412 2873 478 3187 3005 680
Elementary education 531 695 149 680 1160 359
Secondary education 1928 1499 232 2003 1546 265
Tertiary education 932 656 95 495 286 52
Education missing 21 23 2 9 13 4
DM 262 365 55 168 353 97
Stroke 130 233 50 88 159 53
Heart disease 330 599 116 107 297 100
PVD 119 207 50 72 183 67
Cancer 130 278 66 244 306 80
CNSLD 229 283 61 239 314 67
Back pain 414 258 46 380 407 102
Arthritis 580 629 147 868 1254 358
Disorder neck/arm 432 316 46 623 577 127
Other 600 487 118 918 906 269
No disease reported 1620 1014 119 1283 845 131
ADL disabled 137 263 96   200 472 254
Abbreviations: CNSLD = chronic non-specific lung disease; DM = diabetes mellitus; PVD = peripheral vascular disease (upper extremity 
excluded). Numbers of persons with diseases do not add up to total because of co-existence of diseases.  
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Disability 
Subjects were asked if they were able to ‘walk up and down the stairs’, ‘walk outside’, ‘enter/
leave the house’, ‘sit down/get up from a chair’, ‘move around on the same floor’, ‘get in/out of 
bed’, ‘eat/drink’, ‘get dressed/undressed’, ‘wash face/hands’ and ‘wash completely’ and could 
answer with ‘without difficulty’, ‘with minor difficulty’, ‘with major difficulty’ and ‘only with 
help’. Someone was considered disabled if he or she opted for one of the latter two answers 
at least once. 
Definition of disease groups
Information on the presence of a range of diseases was collected in the questionnaire. From 
the original questions ‘cardiovascular disease’ (CVD) was compiled, containing ‘stroke’, ‘heart 
disease’ and ‘peripheral vascular disease (PVD)’, and ‘musculoskeletal disease’ was compiled, 
containing ‘back pain’, ‘arthritis’ and ‘disorder neck/arm’. Furthermore, ‘diabetes mellitus (DM)’, 
‘cancer’, ‘chronic non-specific lung disease (CNSLD)’ and ‘other’ were distinguished. Appendix 
4.1 shows the original questions and the diseases that were distinguished. Skin cancer was 
not included because it is not associated with disability. PVD did not include vascular disease 
of the upper extremity. In subjects who had suffered from back pain or disorders of the neck/
arm but indicated that they currently did not suffer anymore, the condition was regarded as 
no longer present. If a disease was defined on the basis of multiple questions and informa-
tion on any of the questions was missing while none of the questions indicated the presence 
of a disease, the disease information was considered missing. 
Statistical methods
Disability prevalence by cause was estimated from individual information on the presence 
or absence of disability, the presence or absence of the selected disease groups, gender 
and age. A method based on a multivariate additive regression model was used, which is 
described in more detail elsewhere (5,6,16). This method takes into account that persons 
who do not report a disease may be disabled (this risk is referred to as “background”) and 
that persons can have more than one disease (co-morbidity). Disability in persons without 
a reported disease is entirely attributed to background. Disability in persons with at least 
one disease is attributed partly to background and partly to the disease(s). We assume that 
causes of disability (diseases and background risk) act as independently competing causes. 
Assuming independence, the hazard of someone having disease A and B (and zero back-
ground risk) equals hazard A + hazard B. In a situation of no competing risk (one disease and 
zero background risk) the hazard can be easily converted to a probability of being disabled 
(1-exp(- disease hazard)). When more causes are competing, the probability of being disabled 
from the specific disease is lower than in the situation of no competition. In the footnote of 
Table 4.2, a calculation example is given of how was dealt with co-morbidity.  
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To estimate cause-specific disability prevalence from cross-sectional data the following as-
sumptions were made. First, the distribution of disability by cause is explained entirely by 
diseases that are (still) present at the time of the survey and the risk of disability in absence of 
any reported diseases. Second, this distribution is proportional to the distribution of the risk 
of becoming disabled in the time-period preceding the survey. Thirdly, causes of disability 
(diseases and background) act as independently competing causes. 
The regression model is specified as follows:
where ŷ  is the estimated probability that the person has disability, e is the base of the natu-
ral logarithm and  η  the linear predictor. The latter is defined as the sum of the background 
rate by age (αa) and the cause-specific rates of disability (βd, labelled as “disabling impact”) for 
the disease groups (d) that are present in the respondent (given by the dummy variables Xd). 
Background was handled as a cause that is prevalent for everyone; the rate of background 
is age dependent (5-year age groups). The disabling impact βd may also vary by age. As the 
full age-interaction term would require n (number of age classes) times m (number of 
diseases) different parameters, the rank of the interaction was reduced to one, which means 
that the age-specific disabling impact of each disease, βda  , is estimated as the product of 
an age pattern γa which is equal for each disease, and a disease effect δd  , which varies 
by disease, but not by age (Reduced Rank Regression) (17,18). While a one rank solution 
restricts the age pattern to be the same for all diseases, also second rank solutions were fitted 
(βda =  γa1.δd1 +  γa2.δd2) and scaled deviances were compared to test for differences in age 
patterns for different diseases. Adding a one rank interaction improved the fit of the model 
(log-likelihood ratio test with P-value of 0.05), indicating that the disabling impact varies by 
age. Because adding a second rank did not further improve the fit of the model, the same 
age pattern for all diseases was used. Models were fitted using a quasi-Newton method 
that was programmed for the statistical package R version 2.7.1. (19). All analyses were done 
separately for men and women, as the log-likelihood ratio test indicated that both the rates 
of background and the disease-specific rates given sex-specific rates of background differed 
significantly by sex. The significance of the differences in the disabling impact between males 
and females was assessed by assuming normal distribution of the parameters with the mean 
of the original ones as the standard error. 
ŷ = 1 - exp(–η:) Y : binomial
η = αa +Σ
d     
βd Xd
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Calculation of number of disabled by cause across subgroups
Disability prevalence by cause depends on the prevalence of the disease ( Xd ) and the dis-
abling impact of the disease ( βd  or βda  ). Analogous to using the proportional distribution 
of mortality rates to obtain probabilities of death in the presence of competing causes (so 
called “crude probabilities”), the attribution of disease d is (βda Xd /η).y  and of background 
is  (αa /η).y (5,6). Applying these formulas gives for every individual the probability of being 
disabled caused by background or disease (if present). Adding the cause-specific prob-
abilities of an individual gives the probability of being disabled for that individual. Adding 
the cause-specific probabilities of all persons in the dataset, or in a specific age group, gives 
the total number of disabled by cause in the population, or in that age group. Dividing the 
number of disabled persons by cause by the total number of persons gives the proportion of 
disability by cause.
Years lived with disability at age 55 by cause were obtained using the Sullivan method (20). 
The Sullivan method uses the prevalence of disability in each age group to divide the number 
of person-years into years lived with and without disability (20). Instead of using the age 
and sex specific prevalence of disability, we used age, sex and cause specific prevalence of 
disability, yielding the years with disability by each cause. Adding the years with disability 
by each cause yields the life expectancy with disability, as the sum of the cause-specific dis-
ability add to the total prevalence. A life table for the Dutch population 2001-2007, available 
from the EHEMU database, was used (21). 
Confidence intervals around the estimates of disabling impacts, prevalences of disability by 
cause and contributions to LED at age 55 were obtained with bootstrapping based on 1000 
replicas (22). For the disabling impacts and prevalences by cause we used non-parametric 
bootstrapping. For the bootstrap of life expectancy, which is used in combination with 
prevalence by cause to calculate LED, we used parameterized bootstrap, assuming Poisson 
distribution of the numbers of deaths.
The software for additive regression and for calculation of disability prevalence by cause is 
available from the authors on request.
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results
In males, the prevalence of disability increased from 4% at ages 55-59 to 20% at ages older 
than 80. In females, this was from 6% to 37% (Figure 4.1). Also persons without any disease 
reported disability.
The contribution of diseases to the prevalence of disability depends both on the prevalence 
and disabling impact of disease. Among males, arthritis, heart disease and other, and at 
younger ages also back pain, had the highest prevalences (Table 4.2). Among females these 
were arthritis, other, disorder neck/arm and back pain, and at older ages also DM and heart 
disease. 
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figure 4.1 Prevalence of disability by age.
The source population consisted of all respondents to the POLS health and labor survey, the Netherlands, 2001-2007, aged 55 and older 
(n=17,404). The study population equals the source population minus all subjects who had information missing on the presence of diseases 
(n=13,635). 
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Table 4.2 Prevalences and disabling impacts of disease.
Disease prevalences (%) Disabling impacts of disease (hazard)
  55-64 65-79 >=80   55-64 65-79 >=80
males
DM 7.7 (6.9-8.7) 12.6 (11.5-13.9) 10.8 (1.6-9.0) 0.01 (0.00-0.02) 0.02 (0.00-0.05) 0.03 (0.00-0.08)
Stroke 3.8 (3.2-4.4) 8.1 (7.2-9.1) 10.9 (8.4-14.1) 0.08 (0.05-0.12) 0.16 (0.10-0.23) 0.28 (0.17-0.42)
Heart disease 9.6 (8.7-10.6) 20.9 (19.4-22.4) 23.3 (19.8-27.2) 0.01 (0.00-0.03) 0.03 (0.01-0.06) 0.05 (0.01-0.10)
PVD 3.4 (2.9-4.1) 6.9 (6.1-7.9) 10.6 (8.1-13.7) 0.09 (0.05-0.13) 0.17 (0.10-0.26) 0.30 (0.17-0.47)
Cancer 3.7 (3.1-4.4) 9.7 (8.7-10.9) 14.3 (11.4-17.8) 0.01 (0.00-0.03) 0.02 (0.00-0.05) 0.04 (0.00-0.09)
CNSLD 6.6 (5.8-7.5) 10.2 (9.1-11.4) 12.6 (9.9-15.9) 0.08 (0.05-0.11) 0.15 (0.10-0.20) 0.26 (0.16-0.38)
Back pain 11.9 (10.9-13.0) 8.7 (7.7-9.8) 8.9 (6.7-11.7) 0.08 (0.05-0.11) 0.16 (0.11-0.22) 0.29 (0.17-0.42)
Arthritis 16.7 (15.5-18.0) 21.9 (20.4-23.5) 31.0 (27.0-35.3) 0.03 (0.02-0.05) 0.07 (0.04-0.09) 0.12 (0.06-0.19)
Disorder neck/arm 12.7 (11.6-13.8) 10.9 (9.8-12.1) 9.5 (7.2-12.4) 0.00 (0.00-0.02) 0.01 (0.00-0.04) 0.01 (0.00-0.08)
Other 17.3 (16.1-18.6) 17.4 (16.0-18.8) 25.1 (21.4-29.2) 0.03 (0.01-0.04) 0.05 (0.02-0.08) 0.09 (0.04-0.15)
No disease 
reported 48.1 (46.4-49.8) 35.4 (33.6-37.1) 25.8 (22.1-30.0)
females
DM 5.4 (4.7-6.2) 11.7 (10.6-12.9) 14.7 (5.9-16.0) 0.07 (0.04-0.10) 0.11 (0.06-0.16) 0.23 (0.13-0.37)
Stroke 2.6 (2.1-3.2) 5.2 (4.5-6.1) 7.9 (6.1-10.2) 0.10 (0.05-0.16) 0.16 (0.08-0.24) 0.35 (0.18-0.55)
Heart disease 3.2 (2.7-3.9) 9.9 (8.9-11.0) 14.4 (11.9-17.2) 0.06 (0.03-0.10) 0.10 (0.05-0.15) 0.22 (0.11-0.36)
PVD 2.3 (1.8-2.8) 6.4 (5.6-7.4) 9.9 (7.9-12.4) 0.11 (0.06-0.18) 0.17 (0.09-0.27) 0.38 (0.21-0.60)
Cancer 7.6 (6.7-8.5) 10.2 (9.2-11.4) 11.5 (9.3-14.0) 0.01 (0.00-0.03) 0.01 (0.00-0.04) 0.03 (0.00-0.09)
CNSLD 7.4 (6.6-8.4) 10.5 (9.4-11.6) 10.2 (8.1-12.8) 0.06 (0.03-0.10) 0.10 (0.05-0.15) 0.22 (0.10-0.34)
Back pain 12.1 (11.0-13.3) 13.7 (12.5-15.0) 15.3 (12.7-18.2) 0.12 (0.09-0.16) 0.20 (0.14-0.26) 0.44 (0.30-0.60)
Arthritis 27.1 (25.6-28.7) 41.6 (39.9-43.4) 53.6 (49.9-57.3) 0.07 (0.05-0.09) 0.11 (0.08-0.14) 0.24 (0.17-0.32)
Disorder neck/arm 19.8 (18.4-21.2) 19.4 (18.0-20.8) 19.7 (16.8-22.9) 0.03 (0.01-0.05) 0.04 (0.01-0.07) 0.09 (0.03-0.17)
Other 29.3 (27.7-30.9) 30.4 (28.8-32.1) 39.0 (35.4-42.7) 0.04 (0.02-0.05) 0.06 (0.03-0.09) 0.13 (0.07-0.20)
No disease 
reported 40.0 (38.3-41.7) 27.9 (26.4-29.6) 19.7 (16.8-22.8)        
Abbreviations: CNSLD = chronic non-specific lung disease; DM = diabetes mellitus; PVD = peripheral vascular disease (upper extremity 
excluded). 
5 year age groups were used to calculate the disabling impact of diseases and the prevalence of disability by cause (table 3). To summarize and 
as is shown in the table, disabling impacts were also calculated using three age-aggregated groups (55-64.9, 65-79.9, >=80). ‘Background’, 
representing presence of disability irrespective of disease presence, is preferably modelled according to 5 year age groups and could therefore 
not be shown in the table.
The disabling impact represents the rate of disability from a specific cause given that the disease is present. Adding these specific disability rates 
for the diseases present and the background rate of disability (by age and gender) gives the total disability rate for a specific exposure group. 
The proportion of the cause-specific rate in total rate is used to divide the probability of disability in this group by cause. For example, for males 
aged 75-79 with PVD and arthritis, adding the background rate (0.03), the rate for PVD (0.17), and the rate for arthritis (0.07) yields a total 
disability rate of 0.27 and a total probability of disability of 0.24 (1 − exp(−0.27) = 0.24). The probability of disability from background in this 
group is 0.03 (0.03 / 0.27 * 0.24), that of PVD is 0.15 (0.17 / 0.27 * 0.24), and that of arthritis is 0.06 (0.07 / 0.27 * 0.24). 
The disabling impact for males and females was significantly different (P<0.05) for DM, heart disease, cancer, arthritis and disorder neck/arm.
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Among males, PVD had the highest disabling impact (Table 4.2). Furthermore, stroke, CNSLD 
and back pain showed high disability risks. Among females, back pain had the highest dis-
abling impact, but stroke and PVD also showed high impacts. In both sexes, cancer did not 
lead to much disability, as was the case for DM and heart disease in males. The disabling 
impacts of DM, heart disease, arthritis and disorder neck/arm were significantly higher 
among females than among males (p<0.05). Although the disabling impact of cancer was 
low, it was significantly higher among males. The disabling impact of the diseases increased 
with age (P<0.05). 
Table 4.3 Contributions of disease to prevalence of disability and to life expectancy with disability at age 55. 
Contribution to prevalence of disability (% points) Contribution to LED at 
age 55 (years)  55-64 65-79 >=80  
males
DM 0.08 (0.00-0.19) 0.24 (0.00-0.55) 0.33 (0.00-0.77) 0.06 (0.00-0.14)
Stroke 0.28 (0.17-0.42) 1.14 (0.73-1.58) 2.27 (1.37-3.26) 0.34 (0.23-0.46)
Heart disease 0.16 (0.06-0.30) 0.66 (0.27-1.15) 1.17 (0.46-2.02) 0.18 (0.08-0.31)
PVD 0.28 (0.15-0.42) 1.07 (0.63-1.51) 2.34 (1.33-3.38) 0.33 (0.20-0.46)
Cancer 0.04 (0.00-0.09) 0.19 (0.00-0.42) 0.44 (0.00-1.08) 0.06 (0.00-0.13)
CNSLD 0.45 (0.30-0.66) 1.35 (0.92-1.84) 2.49 (1.49-3.63) 0.40 (0.27-0.53)
Back pain 0.92 (0.62-1.26) 1.25 (0.84-1.72) 1.91 (1.09-2.86) 0.39 (0.27-0.52)
Arthritis 0.55 (0.31-0.81) 1.41 (0.83-1.92) 3.07 (1.59-4.74) 0.45 (0.26-0.62)
Disorder neck/arm 0.04 (0.00-0.23) 0.07 (0.00-0.38) 0.09 (0.00-0.60) 0.02 (0.00-0.11)
Other 0.41 (0.19-0.67) 0.82 (0.38-1.31) 1.82 (1.82-1.82) 0.27 (0.12-0.45)
Back ground 0.73 (0.28-1.20) 0.97 (0.43-1.61) 4.37 (1.36-7.91) 0.51 (0.29-0.77)
Total 3.93 (3.33-4.62) 9.07 (8.08-10.18) 20.37 (16.98-24.24) 3.01 (2.68-3.31)
females
DM 0.33 (0.18-0.51) 1.14 (0.62-1.66) 2.45 (1.30-3.78) 0.44 (0.24-0.65)
Stroke 0.21 (0.10-0.35) 0.69 (0.37-1.08) 1.65 (0.89-2.46) 0.28 (0.15-0.42)
Heart disease 0.17 (0.08-0.28) 0.85 (0.41-1.30) 2.04 (0.90-3.18) 0.34 (0.16-0.52)
PVD 0.19 (0.08-0.31) 0.86 (0.41-1.30) 2.12 (1.08-3.27) 0.35 (0.18-0.52)
Cancer 0.05 (0.00-0.19) 0.11 (0.00-0.41) 0.22 (0.00-0.83) 0.04 (0.00-0.16)
CNSLD 0.42 (0.21-0.63) 0.93 (0.47-1.43) 1.52 (0.77-2.44) 0.32 (0.17-0.48)
Back pain 1.30 (0.94-1.74) 2.30 (1.70-2.94) 4.07 (2.92-5.44) 0.86 (0.64-1.08)
Arthritis 1.72 (1.27-2.17) 4.35 (3.36-5.25) 9.72 (7.27-12.17) 1.75 (1.36-2.11)
Disorder neck/arm 0.46 (0.13-0.84) 0.72 (0.21-1.28) 1.25 (0.35-2.33) 0.27 (0.07-0.48)
Other 1.06 (0.66-1.49) 1.78 (1.13-2.58) 3.97 (2.38-5.94) 0.75 (0.46-1.09)
Back ground 0.61 (0.21-1.07) 2.04 (1.21-3.00) 8.96 (5.18-13.35) 1.23 (0.82-1.72)
Total 6.48 (5.66-7.40) 15.65 (14.39-16.99) 38.07 (34.48-41.80)   6.64 (6.20-7.06)
Abbreviations: CNSLD = chronic non-specific lung disease; DM = diabetes mellitus; PVD = peripheral vascular disease (upper extremity 
excluded).
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In males, the most important contributors to the prevalence of disability were musculosk-
eletal disease and CVD (Table 4.3, Figure 4.2). Musculoskeletal disease accounted for 40% of 
the prevalence of disability below age 65, which was about twice the contribution of CVD. 
At older ages the two conditions contributed equally. Most of the disability attributed to 
CVD was caused by stroke and PVD. In males younger than 65, most disability attributed to 
musculoskeletal disease was caused by back pain. At older ages, the largest part was caused 
by arthritis. CNSLD contributed less than musculoskeletal disease and CVD, but was still 
responsible for 10-15%. In females, musculoskeletal disease was by far the most important 
contributor and accounted for 40-50% of the disability burden. Disability attributed to 
musculoskeletal disease was mostly caused by arthritis, but back pain was also an important 
cause. The second important cause was CVD, contributing more than 15% in females aged 80 
and older. Stroke, heart disease and PVD all three contributed importantly to the disability 
attributed to CVD. DM was also important and contributed 5-8%. 
Diseases contributions to years lived with disability were similar to contributions to the 
prevalence of disability (Table 4.3, Figure 4.3). Of the 3.01 years with disability in males, 0.85 
were contributed by CVD and 0.86 by musculoskeletal disease. CNSLD contributed 0.40 
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Figure 4.2 Prevalence of disability by cause.
Abbreviations: CNSLD = chronic non-specific lung disease; CVD = cardiovascular disease; DM = diabetes mellitus; PVD = peripheral vascular 
disease (upper extremity excluded). Contributions of specific diseases to the prevalence of disability were estimated on the basis of diseases 
prevalence and disabling impact in the study sample from the POLS health and labor survey, the Netherlands, 2001-2007. The disabling impact 
represents the rate of disability from a specific cause given that the disease is present. Adding specific disability rates for the diseases present 
and the background rate of disability (by age and gender) gives the total disability rate for a specific exposure group. The contributions of 
specific diseases presented in the figure add up to the total prevalence of disability. 
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years. In females, musculoskeletal diseases were responsible for 2.93 of the 6.64 life years 
with disability. The contribution of arthritis alone (1.75 years) was about 0.8 years more than 
the contribution of all CVDs together (0.97 years). DM contributed 0.44 years. 
Discussion
This study is among the first to investigate contributions of various chronic diseases to 
the prevalence of disability and is the first to present years lived with disability by cause. 
Musculoskeletal disease is the main contributor and CVD, particularly important among 
males, is a second. CNSLD is the third contributor among males and DM among females. 
Within the group of musculoskeletal disease, arthritis-disorder neck arm contributes mostly 
by a high prevalence and back pain by a high disabling impact, although the prevalence of 
this condition is also high. Within the group of CVD, heart disease contributes mostly by its 
high prevalence and PVD and stroke by its high disabling impact. The disabling impact of all 
diseases increases with age.
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figure 4.3 Life expectancy with disability at age 55 by cause.
Abbreviations: CNSLD = chronic non-specific lung disease; CVD = cardiovascular disease; DM = diabetes mellitus; PVD = peripheral vascular 
disease (upper extremity excluded). Contributions of specific diseases to the life expectancy with disability were estimated on the basis of 
estimated contributions of specific disease to the prevalence of disability in the study sample from the POLS health and labor survey, the 
Netherlands, 2001-2007, in combination with life table information for the Dutch population 2001-2007, available from the EHEMU database. 
Methods of decomposition are described elsewhere (5). 
95
The contribution of chronic disease to the burden of disability 
4
Evaluation of data and methods/limitations
Selection bias may limit the external validity of the results. Possible selection bias caused 
by non-response (38%) was minimized by using individual weights to adjust for selection 
effects by age, gender, marital status, urbanization grade, province, employment, health- and 
smoking status (23). 
Twenty two percent of all subjects aged 55 and older lacked disease information and were 
excluded from the analysis, which led to a slight underestimation of disability in our study 
(Figure 4.1). The higher prevalence of disability among non-responders may suggest a slight 
underestimation of the prevalence and/or disabling impact of some diseases, and hence, that 
our results should be regarded as conservative. 
Our results may not be generalizable to the institutionalized population, which has a higher 
prevalence of disability and also the relative contribution of specific diseases to the total 
burden of disability inside institutions may differ from our estimates (24,25). However, in the 
Netherlands only a minor part of elderly people lives in an institution (i.e. 90% of those aged 
80-85 still live at home), hence, bias due to excluding the institutionalized population is prob-
ably small and negligible at younger ages (25). 
Due to differences in the extent diseases have remained undiagnosed in the population and 
due to differences in the reference periods used in the questionnaire, some variation may 
exist in the extent the prevalences derived from the POLS survey reflect true prevalences. Pre-
vious literature showed that self-report of most chronic conditions is fairly accurate, except 
for arthritis, which may be underestimated as well as overestimated (26). If the prevalence 
of arthritis or another disease in our study was underestimated, subjects with less severe 
forms of the disease would be most likely to be uncounted and, hence, the disabling impact 
would be overestimated. This implies that although there may be some bias in the estimates 
of disease prevalence, this is nullified by a bias in opposite direction in the disabling impact. 
Hence, the bias in the estimates of contributions of specific diseases to the prevalence of dis-
ability and life expectancy with disability is likely to have remained small. Self-report of ADL 
disability has been found to correlate well with performance based measures and, hence, is 
expected not to have affected the results substantially (27). 
Using a less stringent definition of disability, defined as one or more items answered with “at 
least minor difficulty” resulted in a lower percentage of disability explained by the diseases 
included. Our substantive conclusions regarding which diseases contributed most remained 
unaffected. Due to a lack of power, using a more stringent cut-level could not be evaluated.
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The cross-sectional nature our methods and data did not allow identifying cases in which 
disability was present prior to the onset of the disease. In these cases the disability might be 
falsely attributed to the disease. 
It was decided not to exclude conditions such as ‘dizziness with falling’ and ‘involuntary loss of 
urine’, which have an intermediate position between diseases and disability, but to add them 
in a separate category. Adding this group mainly reduced the contribution of background, 
but did not affect the contribution of the other diseases substantially. In both sexes only ‘diz-
ziness with falling’ and ‘involuntary loss of urine’ had a high disabling impact and therefore 
accounted for most of the contribution of other (data available on request). 
Mental health conditions are a strong predictor of disease burden and disability onset (12,28). 
Unfortunately, mental conditions were not included in the checklist of diseases in the POLS 
survey. To obtain an impression of the extent mental health issues contribute to the bur-
den of disability, in an additional analysis, we included a score of 60 or lower on the RAND 
Mental Health Inventory (MHI-5) to the diseases, representing (light or severe) mental health 
problems (29). In this analysis, 8-13% of the prevalence of disability was attributed to mental 
health conditions, at the expense of contributions of most other disease groups and back-
ground (Figure S4.4). Together with findings from previous studies, these results suggest that 
a substantial part of the burden of disability may be associated with mental health problems 
(10,12). However, as the MHI-5 is particularly useful for assessing mental health status of the 
general population and may lack validity to diagnose individual cases, the results need to 
be interpreted with caution. We decided to provide the results including mental health as 
supplementary material instead of presenting them in the main analysis. 
Comparison with previous studies
In most previous studies musculoskeletal and cardiovascular disease were reported as the 
most important contributors to disability (4-9,11). Our study confirmed these results also 
for the oldest old (80+). Additionally, it was shown that the high prevalence of disability 
at this age is caused by a high prevalence of diseases, but even more by the high extent 
these diseases lead to disability at older age. This age dependence was not studied in most 
earlier studies. Furthermore, the current study was the first to identify PVD as an important 
contributor to the burden of disability, which is associated with much disability mainly by a 
high disabling impact. 
Compared with WHOs Global Burden of Disease study, our method was substantially different 
(12). Most importantly, WHOs approach uses disability weights to quantify burden of disease 
that are based on panel valuations and do not refer to physical (or mental) disabilities only, 
but represent a broader spectrum of health loss. Additionally, in this approach, each case of 
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disease is assigned a disability weight, irrespective of individual factors such as age and sex 
which may affect disabling consequences of diseases, and, hence, the estimated burden of 
disease. In the Global Burden of Disease study, unipolar depressive disorders, alcohol use 
disorders, hearing loss (adult onset) and Alzheimer and other dementias were associated 
with most years lost due to disability in high income countries (12). Differences in methodol-
ogy and diseases included hampers further comparison with our results.
Interpretation of results
The high prevalence of disability at older ages reflects both an increase in the presence of dis-
abling diseases with increasing age and an increase of the disabling impact. The increasing 
contributions of background suggest that at older ages also frailty or age-related diseases 
not included in our study may have contributed (30). This could for instance be dementia, of 
which the prevalence by age shows considerable resemblance with the pattern of disability 
attributed to background in our study (31). Also conditions that caused persisting disability 
but are no longer ‘present’, e.g. falls, might have contributed (32).
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Figure S4.4 Prevalence of disability by cause, including ill mental health.
Abbreviations: CNSLD = chronic non-specific lung disease; CVD = cardiovascular disease; DM = diabetes mellitus; PVD = peripheral vascular 
disease (upper extremity excluded); MHI-5 = RAND mental health inventory. Contributions of specific diseases to the prevalence of disability 
were estimated on the basis of diseases prevalence and disabling impact in the study sample from the POLS health and labor survey, the 
Netherlands, 2001-2007. The disabling impact represents the rate of disability from a specific cause given that the disease is present. Adding 
specific disability rates for the diseases present and the background rate of disability (by age and gender) gives the total disability rate for 
a specific exposure group. The contributions of specific diseases presented in the figure add up to the total prevalence of disability. The total 
prevalence for females aged>=80 is higher than in the original analysis, which may be related with exclusion of subjects who had information 
missing on items for MHI-5.
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Gender differences in the disabling impact of heart disease, DM, cancer, arthritis and disorder 
neck/arm were found. In addition to differences by gender in self-reporting behaviour, differ-
ences in physiological, psychosocial and environmental factors may explain these variations. 
For heart disease, a higher disabling impact among females may be related to a more pro-
nounced decline in lethality among females than males during the last decades, or to gender 
differences in the nature of heart disease causing better survival among disabled females 
than among disabled males (33,34). For DM, a more negative interference of the disease with 
protective mechanisms in the vascular wall causing thrombogenesis, and a negative influ-
ence of female gender on the effect of some cardiovascular risk factors are potential causes of 
the greater risk for vascular complications in females than in males (35-37). Via cardiovascular 
complications, these mechanisms may also be responsible for the larger disabling impact 
among females. Due to differences in hormonal factors, coping styles and anxiety, females 
are more sensitive to pain than males (38-40). These differences therefore may also explain 
the differences in the disabling impact of arthritis and disorder neck/arm. 
imPlications; conclusion
This study clearly shows that diseases contribute to the burden of disability by high disabling 
impacts, e.g. stroke in males, by moderate disabling impacts but high prevalences, e.g. ar-
thritis, or by both high prevalences and disabling impacts, e.g. back pain in females. Diseases 
that only have a high disabling impact, e.g. stroke in females, or only a high prevalence, e.g. 
heart disease in males, do not necessarily contribute much to the burden of disability. The 
current results showed that the largest contributors are musculoskeletal disorders, particu-
larly arthritis, and CVD. For policy makers this means that the largest reductions in the burden 
of disability can be obtained by interventions that prevent the primary cause of disability, 
i.e. that prevent disease onset. Further reductions can be achieved by diminishing disabling 
impacts. Evidence is accumulating that effective interventions to reduce the extent diseases 
cause disability, such as home visit and exercise programs, are increasingly available (41,42). 
As frail elderly are particularly vulnerable to disability, this group should receive priority 
(43,44). The coming decades, the population of oldest old will increase massively, i.e. in 2050 
about a quarter of the population of 50 years and older is expected to be older than 80 (45). 
The large burden of disability at this age shows that reductions are urgently needed. 
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Appendix 4.1 Disease groups and original questions they were compiled from. 
Disease group Original questions
Diabetes mellitus (DM) 1. Do you have diabetes?
CV
D
Stroke 2. Have you ever had stroke, cerebral bleeding or cerebral infarction?
Heart disease
4. Have you ever had a myocardial infarction?
5. Have you suffered from any  severe myocardial disorder (e.g. cardiac failure or angina 
pectoris)
Peripheral vascular disease 
(PVD)
6. Have you suffered from narrow arteries in legs or abdomen during past twelve months?
Cancer
7. Have you ever had any form of cancer?
8. Have you suffered from cancer during past twelve months? (please indicate the type)
Chronic non-specific lung 
disease (CNSLD)
9. Have you suffered from asthma, chronic bronchitis, emphysema of lung or CNSLD during 
past twelve months?
M
us
cu
lo
sk
el
et
al
Back pain
10. Have you suffered from severe or persistent back disorder during past twelve months? Are 
you still suffering?
Arthritis
11. Have you suffered from joint degeneration during past twelve months?
12. Have you suffered from chronic joint inflammation during past twelve months?
Disorder neck/arm
13. Have you suffered from any disorder of neck or shoulder during past twelve months? Are 
you still suffering?
14. Have you suffered from any disorder of elbow, wrist or hand during past twelve months? 
Are you still suffering?
Other
15. Have you suffered from migraine or frequent severe headache during past twelve 
months?
16. Have you suffered from dizziness with falling during past twelve months?
17. Have you suffered from severe or persistent disorder of intestine for more than three 
months during past twelve months?
18. Have you suffered from involuntary loss of urine (incontinence) during past twelve 
months?
19. Have you suffered from psoriasis during past twelve months?
20. Have you suffered from chronic eczema during past twelve months?
RAND Mental Health 
inventory (MHI-5; only used 
in supplemental analysis)
During the past four weeks, how much of the time…
21. have you been a nervous person?
22. have you felt so down in the dumps that nothing could cheer you up?
23. have you felt calm and peaceful?
24. have you felt downhearted and blue?
25. were you a happy person?
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introduction Although socioeconomic inequalities in non-fatal health outcomes such as 
disabilities are large, explanations including the role of chronic conditions have remained 
limited. We investigated to what extent specific chronic conditions contribute to educational 
inequalities in the prevalence of disability. As diseases may contribute to disability inequali-
ties either through prevalence differences or through differences in disabling impact we also 
assessed to what extent contributions are due to differences in diseases’ disabling impact.
methods Pooled data from seven subsequent years (2001-2007) of the Dutch POLS-survey 
were used, comprising self-reported information on disability (including mobility, hearing 
and seeing limitations), selected chronic diseases and the highest completed level of educa-
tion for 24,833 subjects aged 40-97. A multivariate additive regression model that accounted 
for co-morbidity was used to calculate disabling impacts of selected diseases by age, sex and 
level of education. These disabling impacts and information on individual disease presence 
were used to calculate the contribution of diseases to the prevalence of disability. It was 
assessed to what extent contributions were explained by differences in the disabling impact.
results Large absolute differences in the prevalence of disability of 18% (points) in males 
and 15% in females existed between the highest and lowest level of education. 64% of the 
inequalities in males and 69% in females were due to the diseases included. For mobility 
limitations only, these percentages were 90% and 84%. In males, diseases that contributed 
most to the inequalities were back pain (17 %), disorder neck / arm (13%), other (11%) and 
peripheral vascular disease (7%). In females, arthritis (18%), other (17%), back pain (13%) and 
chronic non-specific lung disease (7%) contributed most. In males and females, 49% and 51% 
of the total inequality in disability prevalence was explained by diseases’ disabling impact.
conclusion Disability inequalities can substantially be reduced by preventing the onset of 
back pain, disorder neck /arm, other and peripheral vascular disease in males and of arthritis, 
other, back pain, and chronic non-specific lung disease in females among low educated 
groups. When disease prevention is not completely feasible, further substantial reductions 
can be achieved by reducing the disabling impact of these conditions.  
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introDuction
Social inequalities in health are large and are one of the main challenges in public health 
(1-3). In the Netherlands, females with an elementary education only can currently expect to 
live 6.4 years less than their tertiary educated counterparts and for males the difference is 
even more than 7 years (1). A first step important for reducing inequalities is to assess which 
diseases contribute most to the health differences. Studies that aimed to resolve this issue 
show that inequalities in total mortality are explained by mortality differences for a variety 
of diseases, but that cardiovascular disease, cancer, HIV, trauma, diabetes mellitus and COPD 
contribute most to the inequalities (2-4). Other studies show that mortality inequalities have 
recently not declined, but persisted, mainly due to a relative stagnation of cardiovascular 
mortality declines among low socioeconomic groups (5). 
Although health inequalities are large in terms of mortality, they are often even larger when 
also non-fatal health outcomes are included. Nonetheless, studies aiming to explain inequali-
ties in non-fatal health outcomes, such as disabilities, have remained limited (6). A number 
of studies show substantial differences in the prevalence and incidence of various diseases 
according to socioeconomic position (7-10). Studies investigating to what extent these differ-
ences in disease occurrence contribute to socioeconomic inequalities in the burden of dis-
ability suggest that knee and hip osteoarthritis and cardiovascular disease contribute most 
in females and that musculoskeletal conditions contribute most in males (11-12). However, 
diseases may not only contribute to disability inequalities by differences in their occurrence, 
but also by differences in the extent they lead to disability once present (disabling impact). 
Until now, only one study assessed disease contributions to the burden of disability while 
taking into account these both aspects (13). This study showed that, indeed, substantial dif-
ferences exist in the prevalence as well as in the disabling impact of chronic conditions and 
that both contribute to inequalities in the years lived with disability (13). Unfortunately, also 
this study did not investigate what percentage of the inequalities is due to differences in 
disease prevalence and what percentage due to differences in disabling impact (13). Such in-
sight would importantly help to target public health interventions as it would show whether 
interventions should fully focus on disease prevention or whether health inequalities may 
also be reduced by targeting disease impacts. 
The aim of the current study is to assess the contribution of specific diseases to educational 
inequalities in the prevalence of disability (14). Another aim is to assess to what extent dis-
ease contributions are due to differences in the disabling impact. Using an approach that is 
based on competing risks, we estimate disabling impacts while adjusting for co-morbidity 
and attribute the prevalence of disability to selected chronic conditions. Attributions by level 
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of education are performed for OECD disability, including limitations in mobility, hearing and 
seeing, and for mobility limitations in isolation. 
metHoDs
Study population
The study population consisted of subjects from seven successive years (2001-2007) of the 
POLS survey, which is being conducted by Statistics Netherlands. The survey does not in-
clude the institutionalized population. To account for selective non-response and to ensure 
representativeness for the Dutch non-institutionalized population, weights were used that 
were attached to the data. The POLS data are available via Data Archiving and Networked 
Services (DANS; http://www.dans.knaw.nl/).
Information on education was collected trough face-to-face interviews and information on 
disability and the presence of chronic disease through written questionnaires. From 2001-
2007, 110,766 subjects were approached and the response was 62%. For our analyses, subjects 
who were 40 years and older (n=32,233) were selected. 23 % of these subjects could not be 
included to the study population because they lacked information on education (n=186), 
disability (n=4,761) or disease (n=6,681). Table 5.1 provides further detailed information of the 
study population.  
Table 5.1 Numbers in study population, and numbers disabled and diseased. 
Males Females
  Tertiary
Upper 
secondary
Lower 
secondary Elementary   Tertiary
Upper 
secondary
Lower 
secondary Elementary
Total 3381 4350 2583 1874 2214 3527 4092 2862
Disabled 260 550 449 554 231 496 843 1173
DM 169 273 174 217 38 123 220 327
Stroke 83 153 115 123 32 65 116 150
Heart disease 228 374 273 294 46 118 170 232
PVD 62 114 102 142 27 61 120 159
Cancer 138 180 113 107 146 217 279 227
CNSLD 179 289 191 219 149 248 306 320
Back pain 221 461 284 261 202 368 443 418
Arthritis 355 618 446 397 403 729 1050 1035
Disorder Neck/arm 256 474 332 304 320 663 749 603
Other 581 800 474 382 667 1169 1267 1044
Abbreviations: DM = diabetes mellitus, PVD = peripheral vascular disease, CNSLD = chronic non-specific lung disease.
Numbers diseased do not add up to total because of co-existence of conditions.
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Disability 
Subjects were asked if they were able to ‘follow a conversation in a group of 3 persons’, ‘have 
a conversation with one other person’, ‘(is your vision sufficient to) read the small letters in the 
newspaper’, ‘recognize someone at 4 meters distance’, ‘carry a 5 kg object for 10 meters’, ‘from 
an upward position, bend forward and take something from the ground’, ‘walk 400 meters 
without interruption’. To the vision questions ‘using spectacles or contacts if necessary’ was 
added and to the hearing questions ‘using hearing aids if necessary’. Persons could answer 
‘without difficulty’, ‘with minor difficulty’, ‘with major difficulty’ and ‘no, I can’t’ and someone 
was considered disabled if he or she opted for one of the latter two answers at least once. 
In an additional analysis, mobility disability was assessed in isolation excluding hearing and 
seeing problems. 
Definition of disease groups
Information on the presence of a range of diseases was collected in the questionnaire. From 
the original questions ‘cardiovascular disease’ (CVD) was compiled, containing ‘stroke’, ‘heart 
disease’ and ‘peripheral vascular disease (PVD)’, and ‘musculoskeletal disease’ was compiled, 
containing ‘back pain’, ‘arthritis’ and ‘disorder neck/arm’. Furthermore, ‘diabetes mellitus (DM)’, 
‘cancer’, ‘chronic non-specific lung disease (CNSLD)’ and ‘other’ were distinguished. Appendix 
5.1 shows the original questions and the diseases that were distinguished. Skin cancer was 
not included because it is not associated with disability. PVD did not include vascular disease 
of the upper extremity. If subjects suffered from back pain or disorders of the neck/arm but 
indicated that they were currently free of complaints, the condition was regarded as no 
longer present. If a disease was defined on the basis of multiple questions and information 
on any of the questions was missing while none of the questions indicated the presence of a 
disease, the disease information was considered missing. 
Education was measured according to the highest completed level and was classified as 
‘elementary’, ‘lower secondary’, ‘upper secondary’ and ‘tertiary’.
Statistical analysis
Disability prevalence by cause was estimated from individual information on the presence 
or absence of disability, the presence or absence of the selected disease groups, gender, age 
and level of education. A method based on a multivariate additive regression model was 
used, which is described in more detail elsewhere (13-15). This method takes into account that 
persons who do not report a disease may be disabled (this risk is referred to as “background”) 
and that persons can have more than one disease (co-morbidity). Disability in persons with-
out a reported disease is entirely attributed to background. Disability in persons with at least 
one disease is attributed partly to background and partly to the disease(s). We assume that 
causes of disability (diseases and background risk) act as independently competing causes. 
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Assuming independence, the disability hazard of someone having disease A and B (and zero 
background risk) equals hazard A + hazard B. In a situation of no competing risk (one disease 
and zero background risk) the hazard can easily be converted to a probability of being dis-
abled (1-exp(- disease hazard)). When more causes are competing, the probability of being 
disabled from a specific disease is lower than in a situation of no competition. In the footnote 
of Table 5.3, a calculation example is given of how was dealt with co-morbidity.  
To reconstruct the process of one or more diseases leading to disability, taking into account 
the competing risk principle and using cross-sectional data, additive hazards can be estimat-
ed. To estimate cause-specific disability prevalence from cross-sectional data the following 
assumptions were made. First, the distribution of disability by cause is explained entirely by 
diseases that are (still) present at the time of the survey and the background risk of disability. 
Second, this distribution is proportional to the distribution of the risk of becoming disabled 
by the diseases in the time-period preceding the survey. Thirdly, causes of disability (diseases 
and background) act as independently competing causes. 
The regression model is specified as follows:
where ŷ  is the estimated probability that the person has disability, e is the base of the 
natural logarithm and η  the linear predictor. The latter is defined as the sum of the back-
ground hazard by age and education (αae) and the cause-specific hazards of disability ( βAde 
, labelled as “disabling impact”) for the disease groups (d) that are present in the respondent 
(given by the dummy variables Xd). Background was handled as a cause that is prevalent 
for everyone; the hazard of background is age (5-year age groups) and education depen-
dent. As a likelihood ratio test indicated that disease hazards differed significantly by age, 
the disabling impact βAde was modelled varying by age. As the full age-interaction term 
would require n (number of age classes) times m (number of diseases times 4 education 
groups) different parameters, the rank of the interaction was reduced to one, which means 
that the age- and education-specific disabling impact of each disease, βAde , is estimated as 
the product of an age pattern γA  (three age categories) which is equal for each disease, and 
a disease effect δde , which varies by disease and education, but not by age (Reduced Rank 
Regression) (16-17). All analyses were done separately for men and women, as the likelihood 
ŷ = 1 - exp(–η:)  Y ~ binomial
η = αae +Σ
d     
βAde Xd
βAde = γA .δde
111
The contribution of chronic disease to educational inequalities in the burden of disability 
5
ratio test indicated that both the hazards of background and the disease-specific hazards 
given sex-specific hazards of background differed significantly by sex. The significance of 
differences in the disabling impact between males and females was assessed by assuming 
normal distribution of the parameters with the mean of the original ones as the standard 
error. Using a likelihood ratio test, it was tested whether an RRR improved the model and if 
the disabling impact varied by age. Because adding parameters indicating variation in the 
age pattern by level of education did not further improve the fit of the model, the same age 
pattern γA  was used for each level of education. Models were fitted using a quasi-Newton 
method that was programmed for the statistical package R version 2.7.1. (18).  
Calculation of the proportion disabled by cause across subgroups
Disability prevalence by cause depends on the prevalence of the disease (Xd) and the 
disabling impact of the disease (βAde). Analogous to using the proportional distribution 
of mortality rates to obtain probabilities of death in the presence of competing causes (so 
called “crude probabilities”), the attribution of disease d is (βAde Xde  / η).y  and of background 
is (αae  / η).y  (13,15). Applying these formulas gives the probability of being disabled caused 
by background or disease (if present) for every disabled individual. Adding the cause-specific 
probabilities of all persons in a group with a specific age and level of education, gives the 
total number of disabled by cause in that group. Adding the number of disabled persons by 
cause gives the total number disabled by cause. Dividing this number by the total number of 
persons gives the proportion of disability by cause. Standard methods were used to calculate 
confidence intervals and p-values for differences by level of education in disease prevalence 
and disabling impact. Confidence intervals around diseases’ contributions to the prevalence 
of disability could not be provided as no standard methods are available and bootstrapping 
would require excessive calculation time. Contributions of diseases to the prevalence of dis-
ability across education groups were age standardized to the weighted study population 
for males and females separately. The contribution of a specific disease to the educational 
inequality in disability prevalence was calculated as the difference in the contribution among 
elementary and tertiary educated persons. 
Using a counterfactual approach, it was calculated to what extent disease contributions 
to the total difference in disability prevalence are due to differences in diseases’ disabling 
impact. In this approach, it was assumed that the disabling impact among persons with an 
elementary education was equal to that among those with a tertiary education. 
The software for additive regression and for calculation of disability prevalence by cause is 
available from the authors on request.
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results
Large differences by level of education existed in the prevalence of disability (Figure 5.1). 
Diseases contributed to these inequalities by differences in their prevalence as well as in their 
disabling impact.
The prevalence of all diseases except cancer differed significantly across the four levels of 
education (Table 5.2). The absolute differences in disease prevalence for tertiary and elemen-
tary educated males were largest for disorders neck/arm (difference of 9.2% points), back 
pain (7.6% difference) and arthritis (7.4% difference). In females, these differences were larg-
est for other (7.5% difference), disorder neck/arm (6.3% difference), arthritis (6.1% difference) 
and DM (5.8 % difference). 
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Figure 5.1 Prevalence of disability by level of education.
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In males, the disabling impact was higher for lower levels of education for most diseases and 
differed significantly by level of education for cancer, back pain and disorder neck/arm (Table 
5.3). For back pain, which was the most disabling condition among elementary educated 
males, there was a gradient by level of education, which was also true for disorder neck/arm. 
The disabling impact of cancer was particularly high among males with an upper secondary 
education, which also resulted in a significant difference by education. In females, the dis-
abling impact differed significantly for back pain, arthritis and other. For these three diseases, 
there was a gradual increment in disabling impact towards lower levels of education. 
Large absolute differences in the prevalence of disability existed. That is, the prevalence for 
the highest and lowest level of education differed by 18% (points) in males and by 15% in 
females. 64% of the inequality between males and 69% between females with the highest 
and lowest level of education were due to the diseases included (Table 5.4, Figure 5.2). 31% 
of the inequality in males and 32% in females were caused by musculoskeletal disease. Car-
diovascular disease was responsible for 15% of the inequalities in males and for (only) 4% 
table 5.2 Disease prevalence with confidence intervals by level of education.
  Tertiary Upper secondary Lower secondary Primary
P-value 
overall 
difference
males
DM 5.1 (4.4 – 5.9) 6.6 (5.9 – 7.4) 6.5 (5.6 – 7.5) 9.0 (7.9 – 10.3) 0.000
Stroke 2.4 (2.0 – 3.0) 3.7 (3.1 – 4.3) 4.2 (3.5 – 5.1) 4.8 (4.0 – 5.7) 0.000
Heart disease 7.4 (6.5 – 8.4) 6.7 (5.9 – 7.6) 9.6 (8.6 – 10.7) 11.2 (10.0 – 12.5) 0.000
PVD 1.8 (1.4 – 2.3) 2.7 (2.3 – 3.3) 3.7 (3.0 – 4.5) 5.5 (4.7 – 6.5) 0.000
Cancer 4.2 (3.5 – 4.9) 4.4 (3.8 – 5.1) 4.1 (3.4 – 4.8) 3.9 (3.2 – 4.7) 0.780
CNSLD 5.4 (4.7 – 6.3) 6.7 (5.9 – 7.4) 7.5 (6.5 – 8.6) 10.3 (9.1 – 11.7) 0.000
Back pain 6.5 (5.7 – 7.4) 10.2 (9.3 – 11.1) 11.0 (9.8 – 12.3) 14.1 (12.6 – 15.7) 0.000
Arthritis 10.4 (9.4 – 11.5) 14.3 (13.3 – 15.4) 16.8 (15.4 – 18.3) 17.8 (16.2 – 19.4) 0.000
Disorder Neck/arm 7.4 (6.5 – 8.3) 10.9 (10.0 – 11.8) 13.3 (12.0 – 14.7) 16.6 (15.0 – 18.4) 0.000
Other 17.3 (16.0 – 18.6) 18.5 (17.4 – 19.7) 19.3 (17.8 – 20.9) 21.1 (19.3 – 23.0) 0.009
females
DM 2.3 (1.7 – 3.2) 4.4 (3.7 – 5.2) 5.4 (4.7 – 6.1) 8.1 (7.3 – 9.0) 0.000
Stroke 1.9 (1.3 – 2.6) 2.3 (1.8 – 2.9) 2.7 (2.3 – 3.3) 3.7 (3.1 – 4.3) 0.001
Heart disease 2.9 (2.2 – 3.8) 4.4 (3.7 – 5.3) 4.2 (3.6 – 4.8) 5.3 (4.6 – 6.0) 0.001
PVD 1.7 (1.2 – 2.5) 2.3 (1.8 – 3.0) 3.1 (2.6 – 3.7) 3.8 (3.2 – 4.4) 0.000
Cancer 7.5 (6.4 – 8.8) 7.0 (6.2 – 8.0) 6.4 (5.7 – 7.2) 6.7 (5.9 – 7.6) 0.428
CNSLD 7.0 (6.0 – 8.2) 7.4 (6.6 – 8.4) 7.4 (6.6 – 8.2) 10.7 (9.6 – 11.9) 0.000
Back pain 9.7 (8.5 – 11.1) 10.9 (9.9 – 12.0) 10.8 (9.9 – 11.8) 13.5 (12.4 – 14.8) 0.000
Arthritis 22.2 (20.4 – 24.1) 24.6 (23.1 – 26.1) 25.3 (24.0 – 26.6) 28.3 (26.7 – 29.8) 0.000
Disorder Neck/arm 14.7 (13.3 – 16.3) 19.5 (18.2 – 20.9) 18.4 (17.2 – 19.6) 21.0 (19.6 – 22.5) 0.000
Other 29.6 (27.7 – 31.5) 32.8 (31.3 – 34.4) 31.9 (30.5 – 33.4) 37.1 (35.3 – 38.9) 0.000
Abbreviations: DM = diabetes mellitus, PVD = peripheral vascular disease, CNSLD = chronic non-specific lung disease.
Estimates are age-standardized to the male and female study populations 
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in females. In males, diseases that contributed most to the inequalities in males were back 
pain (18 %), disorder neck / arm (13%), other (11%) and peripheral vascular disease (7%). In 
females, arthritis (18%), other (17%), back pain (13%) and chronic non-specific lung disease 
(7%) contributed most. 
Table 5.3 Disabling impact with confidence intervals by level of education.
  Tertiary Upper secondary Lower secondary Primary
P-value overall 
difference
males
DM 0.00 (0.00 – 0.00) 0.05 (-0.01 – 0.11) 0.03 (-0.05 – 0.10) 0.07 (-0.03 – 0.18) 0.091
Stroke 0.14 (0.02 – 0.26) 0.22 (0.10 – 0.33) 0.23 (0.08 – 0.39) 0.31 (0.13 – 0.50) 0.503
Heart disease 0.06 (0.00 – 0.12) 0.03 (-0.02 – 0.07) 0.15 (0.06 – 0.23) 0.12 (0.02 – 0.22) 0.086
PVD 0.08 (-0.04 – 0.20) 0.23 (0.08 – 0.38) 0.24 (0.06 – 0.42) 0.38 (0.18 – 0.57) 0.139
Cancer 0.01 (-0.05 – 0.06) 0.13 (0.04 – 0.22) 0.00 (0.00 – 0.00) 0.03 (-0.08 – 0.14) 0.011
CNSLD 0.12 (0.04 – 0.19) 0.07 (0.01 – 0.13) 0.14 (0.04 – 0.24) 0.16 (0.05 – 0.28) 0.473
Back pain 0.05 (-0.01 – 0.11) 0.20 (0.13 – 0.27) 0.24 (0.14 – 0.34) 0.41 (0.25 – 0.56) 0.000
Arthritis 0.03 (-0.01 – 0.08) 0.13 (0.07 – 0.18) 0.04 (-0.02 – 0.11) 0.04 (-0.04 – 0.12) 0.064
Disorder Neck/
arm 0.02 (-0.02 – 0.07) 0.07 (0.02 – 0.13) 0.09 (0.01 – 0.17) 0.23 (0.11 – 0.35) 0.006
Other 0.05 (0.01 – 0.08) 0.06 (0.03 – 0.10) 0.06 (0.01 – 0.11) 0.18 (0.09 – 0.28) 0.085
females
DM 0.00 (0.00 – 0.00) 0.08 (-0.03 – 0.19) 0.17 (0.07 – 0.28) 0.14 (0.04 – 0.25) 0.198
Stroke 0.17 (-0.07 – 0.40) 0.30 (0.09 – 0.51) 0.14 (0.00 – 0.28) 0.29 (0.10 – 0.48) 0.688
Heart disease 0.30 (0.06 – 0.54) 0.22 (0.07 – 0.37) 0.18 (0.06 – 0.30) 0.22 (0.07 – 0.36) 0.859
PVD 0.19 (-0.06 – 0.31) 0.13 (0.19 – 0.57) 0.38 (0.19 – 0.57) 0.27 (0.06 – 0.48) 0.501
Cancer 0.02 (-0.04 – 0.08) 0.07 (0.00 – 0.13) 0.07 (0.00 – 0.15) 0.23 (0.10 – 0.36) 0.053
CNSLD 0.09 (0.02 – 0.16) 0.09 (0.02 – 0.16) 0.12 (0.04 – 0.20) 0.22 (0.09 - 0.34) 0.102
Back pain 0.15 (0.07 - 0.24) 0.25 (0.16 - 0.33) 0.36 (0.26 - 0.47) 0.49 (0.34 - 0.63) 0.002
Arthritis 0.07 (0.01 - 0.12) 0.16 (0.11 - 0.21) 0.16 (0.11 - 0.21) 0.25 (0.18 - 0.33) 0.003
Disorder Neck/
arm 0.10 (0.04 - 0.16) 0.11 (0.06 - 0.16) 0.18 (0.11 - 0.24) 0.09 (0.00 - 0.18) 0.444
Other 0.01 (-0.02 - 0.03) 0.03 (0.00 - 0.05) 0.06 (0.02 - 0.09) 0.14 (0.08 - 0.21) 0.001
Abbreviations: DM = diabetes mellitus, PVD = peripheral vascular disease, CNSLD = chronic non-specific lung disease.
Age specific disabling impacts for the age groups 40-54, 55-69 and >=70 can be obtained by multiplying with 0.781, 0.735 and 1.483 for 
males and with 0.822, 0.843 and 1.335 for females. The disabling impact represents the hazard of disability from a specific cause given that 
the disease is present. Hazards are used to reconstruct the occurrence of disability during the life courses prior to the survey, assuming that the 
entire population was initially non-disabled. Adding these specific disability hazards for the diseases present and the background hazard of 
disability (by age and gender) gives the total disability hazard for a specific exposure group. The proportion of the cause-specific hazard in total 
hazard is used to divide the probability of disability in this group by cause. For example, for tertiary educated males aged 70-74, the hazard for 
background is 0.040 (not shown), the hazard for PVD is 0.120 (0.081*1.483), and the hazard for arthritis is 0.050 (0.033*1.483). Adding these 
hazards yields a total hazard of 0.210 (0.040+0.120+0.050) and a total probability of disability of 0.188 (1-exp(-0.210)). The probability of 
disability from background in this group is 0.036 (0.040/0.210*0.188), that of PVD is 0.107 (0.120 /0.210 * 0.188), and that of arthritis is 0.045 
(0.050/0.210*0.188). 
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When hearing and seeing limitations were excluded and mobility disabilities were investi-
gated in isolation, the contribution of each disease remained about equal, but the percent-
age of disability attributed to background decreased substantially (Figure 5.2). That is, 90% of 
the mobility inequalities in males and 84% of the inequalities in females were explained by 
the diseases. Thus, a substantial part of the inequality attributed to ‘background’ was related 
with disabilities in the hearing and seeing domain.  
Table 5.4 Contribution of diseases to educational differences in prevalence of disability.
 
Contribution to prevalence of disability 
(%points)  
Contribution to total inequality in disability 
prevalence (elementary-tertiary)
Tertiary
Upper 
secondary
Lower 
secondary Elementary
Total contribution, 
by difference in 
prevalence and 
disabling impact*
Contribution by disabling 
impact only‡
males
DM 0.00 0.31 0.14 0.48 0.48 (3%) 0.48 (3%)
Stroke 0.35 0.65 0.75 1.11 0.76 (4%) 0.50 (3%)
Heart disease 0.39 0.21 1.12 0.98 0.58 (3%) 0.39 (2%)
PVD 0.14 0.52 0.63 1.40 1.26 (7%) 1.02 (6%)
Cancer 0.03 0.50 0.00 0.10 0.08 (0%) 0.08 (0%)
CNSLD 0.53 0.40 0.80 1.16 0.63 (4%) 0.22 (1%)
Back pain 0.28 1.46 1.77 3.51 3.24 (18%) 2.96 (16%)
Arthritis 0.32 1.46 0.58 0.55 0.23 (1%) 0.06 (0%)
Disorder Neck/arm 0.13 0.60 0.85 2.46 2.33 (13%) 2.17 (12%)
Other 0.69 0.90 0.88 2.62 1.92 (11%) 1.82 (10%)
Background 5.01 6.25 9.40 11.84 6.83 (37%) -0.78 (-4%)
Total (disability 
prevalence) 7.88 13.25 16.92 26.22 18.34 (100%) 8.93 (49%)
females
DM 0.00 0.29 0.75 0.87 0.87 (4%) 0.87 (4%)
Stroke 0.27 0.53 0.31 0.71 0.44 (2%) 0.23 (1%)
Heart disease 0.76 0.81 0.60 0.82 0.06 (0%) -0.43 (-2%)
PVD 0.28 0.25 0.83 0.68 0.40 (2%) 0.09 (0%)
Cancer 0.12 0.39 0.39 1.03 0.91 (5%) 0.93 (5%)
CNSLD 0.13 0.53 0.66 1.48 1.35 (7%) 1.29 (6%)
Back pain 1.19 2.02 2.64 3.88 2.69 (13%) 2.31 (11%)
Arthritis 1.33 3.21 3.15 4.93 3.60 (18%) 3.41 (17%)
Disorder Neck/arm 1.18 1.64 2.31 1.26 0.08 (0%) -0.36 (-2%)
Other 0.13 0.73 1.43 3.59 3.46 (17%) 3.44 (17%)
Background 8.58 6.65 8.29 15.15 6.57 (32%) -1.39 (-7%)
Total (disability 
prevalence) 13.97 17.03 21.35 34.41   20.44 (100%) 10.40 (51%)
Abbreviations: DM = diabetes mellitus, PVD = peripheral vascular disease, CNSLD = chronic non-specific lung disease.
Estimates are age-standardized to the male and female study populations 
‡Percentages are relative to the total inequality in disability prevalence, i.e. 18.34 for males and 20.44 for females.
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In males and females, 49% and 51% of the inequalities in the total prevalence of disability 
were explained by differences in the disabling impact of diseases (Table 5.4). In males, the 
difference in the disabling impact of back pain and disorders neck/arm together was respon-
sible for 28% of the total inequality in disability prevalence. In females, 28% of the inequality 
in the prevalence of disability was due to the difference in the disabling impacts of arthritis 
and back pain. 
Discussion
Summary of most important findings
The aim of this study was to investigate to what extent chronic conditions contribute to 
educational inequalities in the prevalence of disability and to what extent contributions are 
explained by differences in diseases’ disabling impacts. Large absolute inequalities in the 
prevalence of disability exist that, to a large extent, are explained by differences in disease 
prevalence and disabling impact. Diseases that contribute most to the inequalities in males 
are back pain, disorder neck/arm, other and peripheral vascular disease. Arthritis, other, back 
pain and chronic non-specific lung disease contribute most in females. About half of the 
disability inequality is due to differences in diseases’ disabling impact. 
Evaluation of data and methods
Selection bias may limit the external validity of the results. Possible selection bias caused 
by non-response (38%) was minimized by using individual weights to adjust for selection 
effects by age, gender, marital status, urbanization grade, province, employment, health- and 
smoking status (19). 
Item non-response was 23% and possible bias associated was evaluated by comparing self-
assessed health and ADL disability (55+) in the source and study population. The prevalence 
of less than good self-assessed health and ADL disability was slightly higher in the source 
population, suggesting that the prevalence estimates of disability are conservative in our 
study. However, the level of underestimation did not differ substantially by level of education, 
suggesting that selection bias has not affected our substantive conclusions to a great extent. 
Our study population did not include persons living in institutions. As the burden of disease 
and disability is expected to be higher in institutions, our results may not be generalizable to 
the institutionalized population (20-21). However, in the Netherlands, only a minor part of the 
population lives in institutions (i.e. 90% of those aged 80-85 still live at home) and there is no 
consistent evidence that institutionalization is affected by educational level (21-22). Hence, 
bias due to excluding the institutionalized population has probably remained small. 
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Studies investigating the validity of self-report of chronic conditions show that this is gener-
ally fairly accurate and that level of education has no significant effect on reporting behaviour 
(23-25). Self-report of disability has been shown to strongly correlate with performance-based 
measures independent of the level of education (26-28). Therefore, self-report is expected not 
to have affected our substantive conclusions regarding which disease contributed most to 
the inequalities.  
Using a less stringent definition of disability, defined as one or more items answered with “at 
least minor difficulty” resulted in a larger part of the inequalities explained by background. 
Relative contributions of diseases to educational inequalities in the burden of disability, 
however, remained unchanged. Due to a lack of power, using a more stringent cut-level could 
not be evaluated.
The cross-sectional nature of our methods and data did not allow identifying cases in which 
disability was present prior to the onset of the disease. In these cases the disability might 
be falsely attributed to the disease. However, as the risk for disability prior to the onset of a 
particular disease is equal to among persons without onset of this disease, such false attribu-
tion is expected not to have biased our results.
It was decided not to exclude conditions such as ‘dizziness with falling’ and ‘involuntary loss of 
urine’, which have an intermediate position between diseases and disability, but to add them 
in a separate category. The main contributors to the educational inequalities in males were 
‘dizziness with falling’, ‘migraine or frequent severe headache’ and ‘involuntary loss of urine’. 
In females, these were ‘involuntary loss of urine’ and ‘migraine or frequent severe headache’ 
(data available on request). 
Mental health problems are a strong predictor of disability and are unequally distributed 
across the social spectrum, and therefore may contribute to educational inequalities in the 
burden of disability (29-30). Unfortunately, we lacked a valid indicator of mental conditions in 
the data used. To obtain an impression of the contribution of mental health issues to disability 
inequalities, we included a score of 60 or lower on the RAND Mental Health Inventory (MHI-5) 
as a disease, representing (light or severe) mental health problems (31). In this analysis, 19% 
of the inequalities in males and 18 % in females were attributed to ill mental health (Figure 
5.2). Contributions of the original diseases were all attenuated, except for back pain in males 
and contributions of background and other were attenuated most strongly. We conclude 
that ill-mental health may contribute substantially to educational inequalities in disability. 
However, these results should be interpreted with caution as the MHI-5 was designed to 
assess mental health status at population level and may lack validity to diagnose individual 
mental disorders.  
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Comparison with previous studies
In earlier studies, Nusselder et al. found that back complaints (2.1 years) and arthritis (1.3 
years) in males and arthritis (2.2 years) and CNSLD (1.3 years) in females contributed most to 
educational inequalities in the life expectancy with functional mobility limitations (13). In a 
study of Sainio et al., diabetes contributed most to inequalities in stair climbing limitations 
in males and osteoarthritis of the knee and angina pectoris contribute most in females (17). 
In another study by Koster et al. knee pain contributed most to an excess hazard for mobil-
ity limitations among low educated persons (11). Similar to earlier studies, we show large 
contributions of back pain and arthritis, but, in addition, we show that disorders of the neck 
and upper extremity contribute much (12-13). Contrasting with findings from Sainio et al., our 
study suggests that PVD contributes importantly in males, and in agreement with Nusselder 
et al. we show that CNSLD is important in females (12-13). What has not been investigated 
in earlier studies is to what extent contributions to inequalities in disability burden are due 
to differences in the disabling impact of diseases, as opposed to contributions due to dif-
ferences in disease prevalence. Our study reveals that for most diseases and particularly for 
diseases that contribute most, a very substantial part of the contribution is due to differences 
in the disabling impact. Furthermore, our study shows a gradient by level of education in 
disease contributions for the diseases that contribute most. 
Interpretation of findings
The significantly higher disabling impact of back pain and disorder neck/arm in males and 
of back pain and arthritis in females has been reported before and has been suggested to 
reflect increased disease activity and disease severity among less affluent groups (32-37). 
For the increased disease severity, a variety of explanations have been suggested, includ-
ing a stronger exposure to behavioural and environmental risk factors, more burdensome 
occupations, worse adaptation to stress, and less access to and utilisation of health services 
(38-39). A study of Eachus et al. showed that rheumatoid arthritis patients living in less afflu-
ent areas had similar disease processes and equal severity of joint degeneration as compared 
to patients in more affluent areas, but nonetheless had more disability (33). It was suggested 
that the excess disability in less affluent areas could be explained by a lower confidence in 
ones ability to influence the disease, which may lead to worse adaptive strategies (33). Similar 
mechanisms might have played a role in our study. An unexpected study result was the high 
disabling impact of cancer in males with an upper secondary education, which resulted in 
a significant difference of the disabling impact by level of education. We are not aware of 
similar results in other studies, but we suspect that “cancer” in this group may contain a high 
proportion of types of cancer that are particularly disabling. Furthermore, differences in 
cancer incidence and mortality across socioeconomic groups may have contributed to the 
typical pattern of disabling impacts (40-41). A large part of the disability burden could be 
attributed to diseases in spite of the lack of longitudinal information but the disability in-
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equalities were not completely explained by the diseases included. Factors that may further 
explain the disability inequality are health behaviours (9, 11-12, 42-43); biomedical factors (11); 
psychosocial factors (43); work related factors (12,42); and material problems (42). 
Implications; conclusion 
Our study shows that back pain, disorder neck/arm, other and PVD contribute most to edu-
cational inequalities in the burden of disability in males, that arthritis, other, back pain and 
CNSLD contribute most in females, and that a substantial part of the disability inequality 
is due to differences in the disabling impact. For health policy aiming to reduce disability 
inequalities, this implies that a multi focal approach would probably most effective. First, ac-
tions are needed to prevent or delay the onset of diseases with a high prevalence among low 
socioeconomic groups, such as back pain, disorder neck/arm, arthritis etc. Second, for the 
part that prevention is not completely feasible, efforts are required to reduce the disabling 
impact of chronic conditions that contribute much to the inequalities. In the hypothetical 
situation that reducing disease occurrence among low socioeconomic groups would be 
completely unsuccessful, reducing disabling impacts could still lead to a reduction of the 
disability inequality of around 50%. Evidence for interventions that effectively may reduce 
diseases’ disabling impacts is becoming increasingly available (44-47). Among others, inpa-
tient rehabilitation for geriatric patients has been shown to improve functional outcomes 
and community based interventions and home visitation programs can lead to disability 
reductions (44-47). To be effective among low socioeconomic groups, such interventions 
would preferably be multidimensional, include multiple follow-up visits and be tailored to 
meet individual needs and preferences (45-47).  
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Appendix 5.1 Disease groups and original questions they were compiled from. 
Disease group Original questions
Diabetes mellitus (DM) 1. Do you have diabetes?
CV
D
Stroke 2. Have you ever had stroke, cerebral bleeding or cerebral infarction?
Heart disease
4. Have you ever had a myocardial infarction?
5. Have you suffered from any  severe myocardial disorder (e.g. cardiac failure or angina 
pectoris)
Peripheral vascular disease 
(PVD)
6. Have you suffered from narrow arteries in legs or abdomen during past twelve months?
Cancer
7. Have you ever had any form of cancer?
8. Have you suffered from cancer during past twelve months? (please indicate the type)
Chronic non-specific lung 
disease (CNSLD)
9. Have you suffered from asthma, chronic bronchitis, emphysema of lung or CNSLD during 
past twelve months?
M
us
cu
lo
sk
el
et
al
Back pain
10. Have you suffered from severe or persistent back disorder during past twelve months? Are 
you still suffering?
Arthritis
11. Have you suffered from joint degeneration during past twelve months?
12. Have you suffered from chronic joint inflammation during past twelve months?
Disorder neck/arm
13. Have you suffered from any disorder of neck or shoulder during past twelve months? Are 
you still suffering?
14. Have you suffered from any disorder of elbow, wrist or hand during past twelve months? 
Are you still suffering?
Other
15. Have you suffered from migraine or frequent severe headache during past twelve 
months?
16. Have you suffered from dizziness with falling during past twelve months?
17. Have you suffered from severe or persistent disorder of intestine for more than three 
months during past twelve months?
18. Have you suffered from involuntary loss of urine (incontinence) during past twelve 
months?
19. Have you suffered from psoriasis during past twelve months?
20. Have you suffered from chronic eczema during past twelve months?
RAND Mental Health 
inventory (MHI-5; only used 
in supplemental analysis)
During the past four weeks, how much of the time…
21. have you been a nervous person?
22. have you felt so down in the dumps that nothing could cheer you up?
23. have you felt calm and peaceful?
24. have you felt downhearted and blue?
25. were you a happy person?
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introduction To avoid strong declines in the quality of life due to population ageing, and to 
ensure sustainability of the health care system, reductions in the burden of disability among 
elderly populations are urgently needed. Life style interventions may help to reduce the years 
lived with one or more disabilities, but it is not fully understood which life style factor has the 
largest potential for such reductions. Therefore, the primary aim of this paper is to compare 
the effect of BMI, smoking and alcohol consumption on life expectancy with disability, using 
the Sullivan life table method. A secondary aim is to assess potential improvement of the 
Sullivan method by using information on the association of disability with time to death.
methods Data from the Dutch Permanent Survey of the Living Situation (POLS) 1997-1999 
with mortality follow-up until 2006 (n=6 446) were used. Using estimated relative mortality 
risks by risk factor exposure, separate life tables were constructed for groups defined in terms 
of BMI, smoking status and alcohol consumption. Logistic regression models were fitted to 
predict the prevalence of ADL and mobility disabilities in relationship to age and risk factor 
exposure. Using the Sullivan method, predicted age-specific prevalence rates were included 
in the life table to calculate years lived with disability at age 55. In further analysis we assessed 
whether adding information on time to death in both the regression models and the life 
table estimates would lead to substantive changes in the results.
results Life expectancy at age 55 differed by 1.4 years among groups defined in terms of BMI, 
4.0 years by smoking status, and 3.0 years by alcohol consumption. Years lived with disability 
differed by 2.8 years according to BMI, 0.2 years by smoking and 1.6 by alcohol consumption. 
Obese persons could expect to live more years with disability (5.9 years) than smokers (3.8 
years) and drinkers (3.1 years). Employing information on time to death led to lower estimates 
of years lived with disability, and to smaller differences in these years according to BMI (2.1 
years), alcohol (1.2 years), and smoking (0.1 years).
conclusion Compared with smoking and drinking alcohol, obesity is most strongly associ-
ated with an increased risk of spending many years of life with disability. Although employing 
information on the relation of disability with time to death improves the precision of Sullivan 
life table estimates, the relative importance of risk factors remained unchanged.
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introDuction 
Due to ageing of the populations, the burden of disability is likely to further increase in the 
next decades [1]. Persons with one or more disabilities often experience declines in the qual-
ity of life and have an increased need for health care services [2-5]. As elderly people often 
spend at least part of their life while having one or more disabilities, declines in the quality of 
life are commonly associated with old age, as well as substantial health care expenditures at 
the end of life [6-9]. To avoid strong declines in the quality of life and to ensure sustainability 
of the health care system, reductions in the burden of disability are urgently needed.   
Such reductions may be achieved by interventions that help persons adopting more healthy 
lifestyles, as is suggested by studies showing associations between lifestyle factors and years 
lived with disability [10-6]. Although the results of these studies are promising, there are 
some caveats. That is, almost all of these studies analyzed one single risk factor in isolation 
and did not compare effects of risk factors [10. 12-13, 15-16]. Moreover, estimates of the effects 
of smoking were inconsistent and, to date, estimates for alcohol consumption are lacking 
[12-14]. Consequently, it is still not fully understood which factor has the largest potential for 
achieving reductions in years lived with disability. Therefore, the primary aim of the study 
was to compare the effect of BMI, smoking and alcohol consumption on the life expectancy 
with disability. 
Two standard methods for calculating the life expectancy lived with disability are the Sullivan 
life table and the multistate life table. The latter method is considered as most appropriate 
for modelling risk factor and population health dynamics [17-20]. However, the multistate 
life table method requires data on disability incidence, which are often unavailable or too 
imprecise due to small numbers of cases [19]. For these situations, one has to recur to the Sul-
livan life table method. Commonly, the input to the Sullivan table consists of a series of age-
specific disability prevalence rates, multiplied with a factor to quantify the effect of exposure 
to a risk factor. Recently, however, it was demonstrated that the prevalence of ADL disability 
is not simply a function of age (i.e. time since birth) but that it is even more strongly associ-
ated with approaching death (i.e. time to death) [21-22]. The occurrence of disability sharply 
increases in the about 10 last years of life, and especially in the 5 last years. Using information 
on disability occurrence in relationship to end of life could result in more realistic estimates 
of the occurrence of disability across the life course. Consequently, Sullivan life tables could 
gain in precision by employing this additional information [21-22]. A secondary aim of the 
study was to assess whether employing information on time to death in the Sullivan life table 
may lead to substantively different estimates of the relative importance of these risk factors. 
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metHoDs
Study population
The study population consisted of respondents to three successive years (1997-1999) of the 
POLS health interview survey, which was conducted by Statistics Netherlands. The survey 
was representative for the Dutch population excluding the institutionalized population. 
Information was collected through face to face interviews. From 1997-1999, 52 198 subjects 
were approached and the response was 58%. For our analyses we selected elderly subjects 
who were 55 years and older (n=6 446) at the time of the survey. Mortality among these 
subjects was registered until 2006 through linkage with the Dutch causes of death registry. 
The mean BMI in the study population was 25.0 kg/ m2 and the mean number of alcohol 
consumptions per week was 6.0. Further characteristics are presented in Table 6.1. The POLS 
surveys and mortality data are administered by Statistics Netherlands and Data Archiving 
and Networked Services (DANS; www.dans.knaw.nl/). 
Disability
Respondents were asked if they were able to ‘walk up and down the stairs’, ‘walk outside’, 
‘enter/leave the house’, ‘sit down/get up from a chair’, ‘move around on the same floor’, ‘get 
in/out of bed’, ‘eat/drink’, ‘get dressed/undressed’, ‘wash face/hands’ and ‘wash completely’. 
For each item, respondents could answer with ‘without difficulty’, ‘with minor difficulty’, ‘with 
major difficulty’ and ‘only with help’. We considered respondents disabled if they reported 
“with major difficulty” or “only with help” for at least one item. 
table 6.1 Characteristics of the study population.
 
Number of 
respondents 
(%)
Mean age
Percentage 
males
Percentage 
married
Number 
disabled
Number of 
deaths
Normal weight 2814 (43.7) 67.4 46.9 69.9 293 762
Overweight 2699 (41.9) 66.7 53.5 72.8 297 673
Obese 704 (10.9) 66.2 37.2 66.5 147 179
Missing/other 229 (3.6) 72.3 23.3 48.5 68 113
Never smoker 2041 (31.7) 69.1 16.7 61.3 318 510
Former smoker 2686 (41.7) 67.0 64.4 77.1 289 714
Current smoker 1524 (23.6) 64.9 59.8 68.8 181 445
Missing 195 (3.0) 67.0 50.0 72.8 17 58
1-14 alc cons/wk 3937 (61.1) 66.5 52.2 74.2 330 917
>14 alc cons/wk 647 (10.0) 64.5 78.2 76.7 47 160
Non drinker 1859 (28.9) 69.5 27.6 58.7 428 650
Missing 3 (0.0) 66.0 33.3 100.0 0 0
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Risk factors
BMI was calculated as body weight/body length2 and was classified as ‘normal weight’ 20-
24.9 kg/m2; ‘overweight’ 25-29.9 kg/m2; and ‘obesity’ ≥30 kg/m2. On the basis of the questions 
‘do you smoke?’ and ‘did you smoke in the past?’ subjects were classified as ‘never smoker’, 
‘former smoker’ or ‘current smoker’. A question ‘do you ever drink alcohol?’ and two questions 
asking for the number of alcoholic consumptions in the week and at weekends were used to 
construct the categories ‘no drinker’, ‘1-14 alcoholic consumptions per week’ and ‘more than 
14 alcoholic consumptions per week’. Together with age and sex, we controlled for marital 
status (‘married’, ‘divorced’, ‘widower’ and ‘never married’) in all analyses. Further analyses 
revealed that control for educational level or household income level would not substantially 
change the results.
Mortality analyses
Poisson regression methods were used to calculate the relative risk (RR) for mortality by BMI, 
smoking and alcohol. Univariate models were fitted that included dummy variables represent-
ing the different categories of BMI, smoking and alcohol, respectively. Normal weight, never 
smoker and 1-14 alcohol consumptions/week were chosen as reference categories. Missing 
values, and for BMI missing values and BMI<20 kg/m2, were treated as a separate group and 
were modelled in the regression models using dummy variables. Each model was adjusted 
for age (continuous), sex, and marital status. The RRs for mortality were used to calculate 
conversion factors that express the mortality level of exposed individuals in relationship 
to the average Dutch mortality levels. The conversion factors were applied to age-specific 
mortality rates for the Netherlands in the period 2000-2004 to construct separate life tables 
for each category of BMI, smoking and alcohol consumption. 
Disability analysis
Univariate logistic regression models were fitted in which disability (a dichotomous variable) 
was predicted as a function of risk factor exposure (dummies) and age (continuous). Sex and 
marital status were included to the models as control variables. Quadratic terms on age were 
significant and were therefore added to the prediction models. Interactions between age and 
risk factor exposure were not significant and were not included. The fitted models were used 
to predict the age specific prevalence of disability for each risk factor exposure category. In 
these predictions, the values of the control variables (sex and marital status) were set at the 
study population averages. 
In further analysis, the age schedules of disability were not predicted on the basis of associa-
tions with age only, but also on the basis of associations with both age and time to death. For 
this analysis, regression models were fitted that were similar to the original models but also 
contained a variable measuring the time to death for each person that died during follow-up 
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until 2006. Time to death was defined as the difference in time between the moment of the 
survey and the moment of death. Further details on this method, including ways to take into 
account survivors, are given elsewhere [21-22]. 
Life table analysis
Sullivan life tables were constructed to calculate the years lived with disability (i.e. life expec-
tancy with disability at age 55) for each risk factor exposure category [20]. For constructing 
these life tables, we utilized the estimated age schedules of mortality and disability, stratified 
by risk factor exposure category (see above). 
In most analyses, the common version of the Sullivan life table method was applied. How-
ever, in the additional analyses aimed to take into account relationships between disability 
and time to death, a refined approach had to be taken. In this approach, annual age specific 
disability prevalences were estimated conditional on remaining years of life, and remaining 
years of life adjusted estimates of the age specific disability prevalence were used as input 
to the life table. As a first step, we stratified the life table population into subpopulations ac-
cording to their age at death (or length of life). The number of people in subpopulation with 
length of life x was equal to the number who would die at age x according to the life table. 
Next, for each population with the same age at death, we estimated the age-specific schedule 
of disability, using the estimates of the logistic regression models described above. Finally, 
we estimated the age-specific prevalence rates of disability for the total life table population 
as the population-weighted sum of the age-specific prevalence rates in all subpopulations. 
The total life expectancy and the years lived with disability were calculated for the aggregate 
life table population. The years lived without disability (i.e. disability free life expectancy) 
were calculated as the difference between the total life expectancy and the life expectancy 
with disability. Confidence intervals (CI) around the estimated life expectancy and years lived 
with and without disability were estimated using probabilistic sensitivity analyses [23-25]. 
That is, thousand times, regression coefficients were drawn randomly from each regression 
model, assuming multivariate normal distribution. For each draw, a life table was set up and 
total life expectancy and years lived with and without disability were calculated. The 25th and 
975th of the ordered values indicated the boundaries of the CIs. 
Regression analyses were performed using Stata 10.0 and life tables were constructed in 
Microsoft Excel 2002.  
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results
Of the three factors compared, smoking had the largest effect on mortality (Table 6.2; RR 
current smoker: 1.62). The effects of alcohol consumption and BMI were substantially smaller 
(RR >14 cons/wk: 1.19; RR obese: 1.15, not significant). 
BMI had a substantial effect on the odds of disability (Table 6.2; OR obese: 2.73). The effect of 
smoking was smaller but still significant (OR current smoker: 1.58), while the effect of drinking 
alcohol was not significant. In models that include time to death, the estimated odds ratios 
were slightly smaller for smoking and alcohol, but not for BMI. 
Figure 6.1 estimates how the prevalence of disability increases during the last years of life. 
These estimates were derived from models that include both age and time to death. For 
persons who died at age 75, the prevalence of disability increased from below 0.05 to about 
0.25 or 0.35 among drinkers and smokers, and to 0.50 among obese persons. Persons who 
died at an older age (i.e. age 85) had a different age pattern of disability. Their prevalence 
was about 60% lower at age 75, but towards the end of life, their chances of disability were 
substantially higher compared with younger decedents’ chances at the end of life. 
Table 6.2 Relative risks for mortality and odds ratios for disability according to risk groups.
 
RR mortality 
with 95% CI
OR disability in models without 
time to death with 95% CI
OR disability in models with 
time to death with 95% CI
Normal weight 1.00 1.00 1.00
Overweight 0.97 (0.87-1.07) 1.24 (1.03-1.48) 1.26 (1.05-1.52)
Obese 1.15 (0.98-1.36) 2.73 (2.16-3.46) 2.76 (2.17-3.51)
Never smoker 1.00 1.00 1.00
Former smoker 1.18 (1.03-1.35) 1.25 (1.02-1.53) 1.19 (0.96-1.46)
Current smoker 1.62 (1.40-1.87) 1.58 (1.25-2.82) 1.36 (1.07-1.72)
1-14 alc cons/wk 1.00 1.00 1.00
>14 alc cons/wk 1.19 (1.00-1.41) 1.17 (0.84-1.62) 1.11 (0.80-1.56)
Non drinker 1.43 (1.29-1.59) 2.38 (2.01-2.82) 2.17 (1.83-2.58)
Separate models were fitted for BMI, smoking and alcohol consumption, but control for age, sex and marital status.
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Table 6.3 shows the results of life table calculations. The difference in total life expectancy 
at age 55 was largest according to smoking (4.0 years between). The differences by alcohol 
consumption (3.0 years) and BMI (1.4 years) were smaller but were still substantial. 
The difference between groups in years lived with disability was largest according to BMI (2.8 
years between). The difference according to alcohol consumption (1.6 years) was smaller but 
still substantial and the difference according to smoking was only small (0.2 years). Obese 
persons spent a much longer period in disability (5.9 years), as compared to smokers and 
drinkers (3.8 and 3.1 years). 
Estimates of the years lived with disability and differences according to risk factor were 
mostly smaller when calculated using regression models and life tables including time to 
death. According to this method the difference according to BMI was 2.1 years and according 
to smoking or alcohol consumption 0.1 and 1.2 years. Obese persons lived 4.3 years with dis-
ability, smokers 2.7 years and drinkers 2.3 years. The results regarding which factor was most 
important remained unchanged.
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Figure 6.1 Estimated prevalence of disability by age of death and according to risk factor.
Estimates were based on univariate models, controlled for sex and marital status.
135
Obesity, smoking, alcohol consumption and years lived with disability
6
Discussion
Summary of results 
The current paper is among the first to compare the effect of different life style factors on 
years lived with disability. Compared with smoking and drinking alcohol, obesity is more 
strongly associated with an increased risk of spending many years in disability during life. 
Using information on time to death in the Sullivan life table does not lead to substantively 
different estimates of the relative importance of the risk factors.
Evaluation of data and methods
Among all subjects approached in the baseline survey, the non-response was 42%. We could 
not directly evaluate the effect of selective response on our estimates of years lived with 
disability, but the total mortality in our study sample (3.15% per year) was comparable to the 
total mortality in the Dutch population (1997-2006) aged 55 and older (3.21% per year) [26]. 
Although non-response is likely to lead to biased estimates of the prevalence of smoking 
and alcohol intake, it may not substantially affect associations between these risk factors 
and health outcomes [27]. None the less, we cannot exclude that selective non-response may 
have biased our estimates of effects of risk factors on years lived with disability. 
The use of self reported measures of disability may have caused some reporting bias, par-
ticularly if risk factor exposure was related to reporting behaviour, independently from status 
of disability. However, in previous studies it was shown that self report of ADL disabilities 
Table 6.3 Total life expectancy at age 55 and years lived with and without disability.
Calculations without time to death Calculations with time to death
 
Total life 
expectancy
Years without 
disability
Years with 
disability
Years without 
disability
Years with 
disability
Normal weight 26.0 (25.6 - 26.5) 22.9 (22.4 - 23.3) 3.2 (2.8 - 3.5) 23.8 (23.3 - 24.3) 2.3 (2.0 - 2.6)
Overweight 26.3 (25.8 - 26.8) 22.5 (22.0 - 23.0) 3.8 (3.4 - 4.3) 23.6 (23.0 - 24.1) 2.7 (2.4 - 3.1)
Obese 24.9 (23.8 - 26.1) 18.9 (17.9 - 19.9) 5.9 (5.1 - 6.9) 20.5 (19.5 - 21.6) 4.3 (3.7 - 5.0)
Variation by BMI 1.4 (0.1 - 2.9) 4.0 (2.8 - 5.2) 2.8 (1.9 - 3.8) 3.3 (1.9 - 4.4) 2.1 (1.4 - 2.7)
Never smoker 27.6 (26.9 - 28.5) 23.8 (23.1 - 24.5) 3.8 (3.4 - 4.4) 24.9 (24.2 - 25.7) 2.7 (2.3 - 3.1)
Former smoker 26.2 (25.8 - 26.8) 22.2 (21.7 - 22.7) 4.0 (3.6 - 4.5) 23.4 (22.8 - 23.9) 2.8 (2.5 - 3.2)
Current smoker 23.6 (23.1 - 24.3) 19.8 (19.2 - 20.4) 3.8 (3.3 - 4.4) 20.9 (20.3 - 21.5) 2.7 (2.3 - 3.2)
Variation by 
smoking 4.0 (2.8 - 5.2) 3.9 (2.9 - 4.9) 0.2 (-0.5 - 0.8) 4.0 (2.9 - 5.1) 0.1 (-0.4 - 0.6)
1-14 alc cons/wk 27.0 (26.7 - 27.4) 23.9 (23.5 - 24.3) 3.1 (2.8 - 3.5) 24.8 (24.3 - 25.2) 2.2 (1.9 - 2.6)
>14 alc cons/wk 25.6 (24.3 - 26.9) 22.5 (21.2 - 23.6) 3.1 (2.4 - 4.2) 23.3 (22.1 - 24.5) 2.3 (1.7 - 2.9)
Non drinker 24.1 (23.5 - 24.6) 19.3 (18.7 - 19.9) 4.8 (4.3 - 5.2) 20.6 (20.0 - 21.2) 3.4 (3.1 - 3.8)
Variation by alcohol 3.0 (2.1 - 3.9) 4.6 (3.8 - 5.4) 1.6 (1.0 - 2.2) 4.2 (3.3 - 5.0) 1.2 (0.8 - 1.6)
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correlates strongly with performance based measurement of disability [28], suggesting that 
it is unlikely that reporting bias could have substantially biased our results.  
Self-reported BMI tends to be underreported, particularly by those who have a high BMI 
[29-30]. Therefore, the risk of disability among persons who had a high BMI may have been 
overestimated. However, the potential bias has been shown to be acceptable for correlation 
analyses like in our study [30]. Underreporting in self-reported alcohol consumption may af-
fect prevalence rates, but does not appear to have substantially bias effect on the association 
between heavy drinking and harmful consequences [31].   
The institutionalized population, an old population with a high disability prevalence, was not 
included in the baseline survey [32-33]. It cannot be excluded that this exclusion may have led 
to some bias in our estimates of risk factors in relation to years lived with disability. However, 
in the Netherlands, only a minor part of elderly people live in an institution, e.g. 90% of those 
aged 80-85 still live at home. Hence, the bias because of excluding the institutionalized 
population will probably be small [32-33]. 
Our choice of disability cut-off level was arbitrary. Using a more stringent cut-off level of 
having “with major difficulty” or “only with help” for at least two items resulted in (non-signif-
icantly) higher odds ratios for disability for BMI (OR obesity = 2.96) and alcohol consumption 
(OR >14 alc cons/wk = 1.52), but in a lower odds ratio for smoking (OR current smoker = 1.48). 
Years lived with disability differed by 2.0 years according to BMI, 0.2 years by smoking and 1.4 
by alcohol consumption. Including time to death to the calculation yielded similar results. It 
can be concluded that the cut-off level to define disability has had no major influence on our 
substantive conclusions. 
The association of BMI, smoking and alcohol with disability is likely to be mediated by the oc-
currence of specific diseases or other risk factors such as physical activity. If our aim had been 
to gain insight into causal chains that relate risk factor exposure with disability, it would have 
been useful to include more covariates. However, as our analysis had a descriptive purpose, 
and adjusting for co-morbidities or physical activities would take out part of the effect of 
lifestyle on disability, we used simple and transparent univariate regression models, adjusted 
for age, sex and marital status only, to estimate the years lived with and without disability.  
Comparison with previous studies
A few other studies compared lifestyle factors with respect to their effect on years lived 
with disability. Most studies used other outcome measures [14, 34-36]. Comparable with our 
results, these studies found that, compared to heavy drinking or regular smoking, obesity 
had a much greater effect on the number of years that people could expect to live with 
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long-standing illness, with reduced quality of life, or with less than good self-assessed health 
[34-36]. The only study that compared effects of different lifestyle factors on years lived with 
disability confirmed our key finding that obesity is more important than smoking [14]. 
The obesity paradox
We found that smoking is associated with shorter life, whereas obesity is associated with 
spending more life years with disability. This difference is likely to be related to the fact that a 
high BMI is more strongly associated with non-lethal disabling diseases, such as osteoarthri-
tis and chronic back pain, whereas smoking is more strongly associated with a series of fatal 
diseases with a relatively short period of disablement, such as lung cancer and other types 
of cancer [37-39]. 
Compared with other risk groups, obese persons on average spend a larger part of their last 
years of life with disability (Figure 6.1). This observation represents another side of the ‘obesity 
paradox’, which refers to the fact that increased BMI is an independent risk factor for heart 
failure, but that among patients with established heart failure, those who are overweight 
or obese are at decreased risk for death [40-44]. This suggests that obesity is a ‘stretcher of 
disease and disability’, which results in a high prevalence of disability prior to death among 
obese persons.  
Time to death in the Sullivan life table
The occurrence of ADL disability is not only associated with age (time since birth), but even 
more strongly with time to death [21-22]. A substantial part of disability occurs in relation 
with end-of-life processes [21-22]. As a result, a longer life is likely to be associated with a 
shift of the burden of disability towards older ages [21-22]. Conventional Sullivan life table 
methods do not account for possible shifts of disability towards older ages, but use one age 
schedule of disability, irrespective of the length of life (i.e. age of death) of individual people. 
Using an innovative approach, we accounted for the association of disability with length of 
life by defining schedules of disability not only as a function of age, but also as a function 
of age of death (Figure 6.1). The new estimates of the number of years lived with disability 
differed substantially from the original estimates. As expected, the expected years lived with 
disability were lower according to the new estimates. However, the relative importance of 
risk factors remained unchanged. 
Therefore, this new methodology may be useful for obtaining more precise estimates of the 
occurrence of disability across the life cycle. It may be especially useful to assess the effect 
of increasing life expectancies on years with disability, which may have been overestimated 
in conventional methodologies. On the other hand, conventional methods appear to have 
yielded valid estimates of the relative importance of different risk factors. 
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conclusion
Of all risk factors, the variation in years lived with disability was largest for BMI. The largest 
reductions in the years that are spent with disability can in principle be achieved among 
obese people. Consequently, curtailing the obesity epidemic is urgently needed to prevent 
strong increases in the future burden of disability and to increase the prospects for healthy 
ageing for future generations of elderly. 
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Population ageing is one of the great successes of public health, but also poses great chal-
lenges to current societies. Among the main challenges are how to secure the sustainability 
of the health care system and pension system and how to preserve the health and quality of 
life of the elderly population. Participation of elderly individuals in social and work environ-
ments has been proposed essential to a possible solution. The ability to participate and the 
quality of life of future populations of elderly, however, will greatly depend on the health 
of these populations and on whether persons will not only live longer, but also longer in 
good health. For insight in future developments of morbidity and to develop interventions 
that effectively reduce the burden of disability among the elderly, it is essential to know the 
current burden of disease and disability, particularly in relationship with the end of life and 
to know which determinants explain the current burden of disability. 
The research questions addressed in this thesis were:
1. What is the current burden of disease and disability?
2. Which determinants explain the current burden of disability? 
main finDinGs
Part i Disease and disability occurrence
Sub question 1: What is the prevalence of diseases and co-occurrences in the last two years of life?
Using individually linked information including multiple causes of death and hospital diag-
noses within two years prior to death, it was shown that, in males, diseases most prevalent 
at the end of life were pneumonia, cancer of trachea, bronchus and lung, acute myocardial 
infarction, COPD and bronchiectasis, and cerebrovascular disease. In females, these were 
cerebrovascular disease, pneumonia, dementia, diabetes, and heart failure. The vast majority 
of all deaths had one or more concurrent condition. It was shown that multiple causes of 
death do not provide complete information regarding disease occurrence prior to death. 
Using additional information regarding hospital diagnoses affected the ranking of the most 
common conditions but did not lead to substantially different conclusions which diseases 
are most important.
Sub question 2: To what extent is the occurrence of disability associated with age (time since birth) 
and time to death?
The occurrence of disability was investigated in relationship with age (time since birth) and 
time to death for ADL disability and OECD disability (functional limitations). Within the last 
ten years of life, and particularly within the last five years, the prevalence and incidence of 
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disability increased substantially, but also the severity of disability increased, as the time to 
death decreased. It was shown that the occurrence of ADL disability is more strongly associ-
ated with time to death than with age. This was true among groups in presence of various 
diseases (chronic non-specific lung disease, heart disease and diabetes) and among various 
age groups. The association was stronger towards older ages. OECD disability was more 
strongly related to age. When ADL disabilities were assessed according to level of severity, 
severe disability defined as major difficulty with one (or more) out of ten ADL activities was 
particularly associated with approaching death, whereas mild disability, defined as minor 
difficulty with at least one activity was not at all related with time to death. As was shown in 
a calculation example, these associations are in accordance with the hypothesis of dynamic 
equilibrium. This hypothesis poses that when the life expectancy continues to increase, 
particularly the years lived with mild forms of disability will increase, whereas the years with 
severe disability will increase to a smaller extent.  
Part ii explaining the burden of disability
Sub question 3: Which diseases contribute most to the burden of disability?
To investigate which diseases contribute most to the prevalence of ADL disabilities, data from 
the Dutch POLS-survey were analyzed. The disabling impact, that is, the extent a disease 
leads to disability once present, was calculated for a variety of diseases using an additive 
regression model. This model accounted for possible disability without any disease reported 
and for competing causes of disability. Musculoskeletal and cardiovascular disease contrib-
uted most to the burden of disability, but also chronic non-specific lung disease (males) and 
diabetes (females) contributed much. Within the musculoskeletal and cardiovascular disease 
groups, back pain, peripheral vascular disease and stroke contributed particularly by their 
high disabling impact. Arthritis and heart disease were less disabling but contributed sub-
stantially because of their high prevalence. The disabling impact of diseases was particularly 
high among persons older than 80. 
Sub question 4: Which diseases contribute most to educational inequalities in the burden of dis-
ability?
Disease contributions to educational inequalities in the prevalence of OECD disability were 
calculated using a model similar to that used for sub question 3. In the analysis for sub 
question 4, however, disease contributions to the burden of disability were estimated for 
groups that differed according to the highest obtained level of education. Large absolute 
inequalities in the prevalence of disability existed. These differences were largely explained 
by the diseases included. When disabilities in hearing, seeing were not included to the OECD 
measure of disability and mobility limitations were assessed in solitude, almost all of the 
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differences were explained by the diseases. In males, diseases that contributed most to the 
inequalities were back pain, disorder neck / arm, other and peripheral vascular disease. In fe-
males, arthritis, other, back pain and chronic non-specific lung disease contributed most. Half 
of the total inequality in disability prevalence was explained by diseases’ disabling impacts. 
Sub question 5: Which lifestyle factor is most important for spending many years with disability: 
obesity, smoking or heavy drinking?
The analysis for sub question 5 was based on data from the POLS-survey 1997-1999 with 
mortality follow-up until 2006. Poisson regression methods were used to estimate mortality 
risks among obese persons, smokers and heavy drinkers. Particularly smoking was associ-
ated with a high mortality, whereas the mortality risk for obesity and heavy drinking was 
only slightly elevated. The odds for ADL disability were high for obese persons, moderate 
for heavy drinkers and low for smokers. Using the mortality and disability risks in Sullivan 
life tables, it was estimated that the years lived with disability differed most according to 
BMI, least according to smoke status, and in between according to alcohol consumption. 
Obese persons could expect to live at least two years more with disability than smokers and 
drinkers. Employing information on time to death led to lower estimates of years lived with 
disability, and to smaller differences in these years according to BMI, alcohol, and smoking. 
Conclusions regarding which risk factor is most important, however, remained unchanged.
evaluation of Data anD metHoDs
Report of disability, disease and life style variables
Except for chapter 2, the presence or absence of disability, disease and specific lifestyles was 
assessed on the basis of self-report. Self-reported measures of disability may, in theory, not 
merely reflect the objective status of disability, but also to some extent the subjective experi-
ence of health and disability. This may have introduced some bias to our analyses. However, 
various studies show that self-report of disability correlates sufficiently well with objective 
measures of disability, suggesting that the bias related with self-report has remained limited 
in our study (1-3). In addition, it has been shown that the accuracy of self-report of disability 
is not influenced by level of education, suggesting that also the possible differential bias by 
education in chapter 5 has remained small (4). Self-report of most chronic conditions is fairly 
accurate, except for arthritis, which may be overestimated as well as underestimated (5). Level 
of education has no significant effect on disease reporting behaviour (6-7). If the prevalence of 
arthritis or another disease was underestimated in chapters 4 and 5, subjects with less severe 
forms of the disease would be most likely to be uncounted and, hence, the disabling impact 
would be overestimated. This implies that although there may be some bias in the estimates 
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of disease prevalence, this is nullified by a bias in opposite direction in the disabling impact. 
Thus, the bias in the estimates of contributions of specific diseases to (inequalities in) the 
prevalence of disability and life expectancy with disability is likely to have remained small. As 
self-reported BMI tends to be underreported, particularly by those who have a high BMI, the 
risk of disability among persons who had a high BMI may have been overestimated in chapter 
6 (8-9). However, the potential bias has been shown to be acceptable for correlation analyses 
like in our study (9). Underreporting in self-reported alcohol consumption may have affected 
prevalence rates, but does not appear to have lead to substantially bias in the association 
between heavy drinking and harmful consequences (10). In summary, potential bias related 
with self-reporting of disability, disease and lifestyle is expected to have remained limited 
and has probably not affected our substantive conclusions.  
In chapter 2, disease prevalence was estimated using medical information from cause of 
death and hospital registries. Cause of death registration comprises the diagnostic process, 
completion of a death certificate, and coding of the statements on the death certificate (11). 
It has been shown that some diseases such as cancers are more adequately certified than 
others, such as COPD, but that cause of death coding practices partly adjusted for inaccurate 
certification (12). The inter coder agreement of the registration of underlying causes of death 
such as cancers and acute myocardial infarction is high (>= 90%), but for diseases such as 
diabetes and hypertension, the agreement is relatively low (53% and 71%) (13). A study on the 
reliability of the Dutch National Medical Registration showed that that 99% of the diagnoses 
of discharge was recorded correctly in the register (14). Aiming at information regarding 
disease presence prior to death as complete as possible, we used nationwide data sources 
linked at the individual level. As expected, we showed that some non-fatal conditions which 
were hardly mentioned as a cause of death had a high prevalence according to the full linked 
data. Nonetheless, as chances for hospitalization are probably lower for conditions that are 
not very lethal than for highly lethal conditions, it cannot be excluded that the prevalence of 
some non-lethal conditions to some extent remained underestimated in the full linked data. 
A decline in the mean number of conditions at age 85 and older suggests that the diagnostic 
process among the oldest old is less extensive or less accurate than it is for younger persons. 
ADL versus OECD disability
Disabilities were assessed as disabilities in ADL (and mobility) (chapters 3.1, 3.2, 4 and 6) and as 
functional limitations according to the OECD long term indicator of disabilities (chapters 3.2 
and 5) (15). In the OECD indicator, mobility, hearing and seeing disabilities are distinguished 
and hearing and seeing are assessed possibly using hearing aids or spectacles/contacts. ADL 
disability is a quite severe form of disability and is associated with substantial declines in 
quality of life and increased demands for health care (16-17). Functional limitations are less 
severe and generally occur in an earlier stage of the disablement process (18). In each of our 
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analysis, ADL disabilities were assessed, except for the analysis investigating disease contri-
butions to educational inequalities in the prevalence of disability in chapter 5. In this analysis, 
there was a lack of power to use ADL disabilities and we decided to use the less severe OECD 
measure. To analyse the overlap between ADL and OECD disability we selected persons from 
the POLS survey 2001-2007 who were older than 55 and had complete data for both disability 
measures. In this sample, 25% was OECD disabled and 11% was ADL disabled. Most persons 
(81%) who were ADL disabled were also disabled according to the OECD measure, but 64% of 
those with OECD disability were not disabled according to the ADL measure. Of the persons 
who only had OECD disability, 41% were disabled in the mobility domain, 46% were disabled 
in the hearing/seeing domain, and 13% were disabled in both. It was concluded that, the 
OECD measure largely includes the ADL measure, but expands it with disabilities in mobility 
and hearing/seeing. 
In Figure 7.1, disease contributions to the prevalence of ADL disability are compared with 
contributions to OECD disability. The prevalence of OECD disability is higher than that of ADL 
disability, but the largest part of the difference is not due to different disease contributions 
but due to differences in ‘background’ which represents disability attributed to other causes 
than the diseases included. As was explained in chapter 4, the largest part of the OECD dis-
ability attributed to background is related with disabilities in hearing/seeing. In males and 
females aged 60-69, musculoskeletal conditions contribute slightly more to OECD disability 
than to ADL disability and in females, the contribution of CVD is slightly larger. Given that 
most of the ADL disabilities are also included in the OECD measure, and that hearing and 
seeing disabilities are particularly represented as ‘background’ in the prevalence of OECD 
disability, these larger contributions are most likely associated with less severe mobility dis-
abilities. In the figure, rather similar conclusions can be drawn for ADL and OECD disabilities. 
That is, in males, musculoskeletal disease and CVD contribute most to the prevalence of 
disability and in females, musculoskeletal disease contributes most. The distribution across 
educational groups of OECD disability was relatively similar to that of ADL disabilities (Figure 
7.2). Therefore, it is not expected that using OECD instead of ADL disabilities has substantially 
affected our conclusions regarding which diseases contribute most to educational inequali-
ties in the prevalence of disability. 
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Figure 7.1 Contribution of chronic disease to ADL disability and functional limitations.
Results are for weighted study populations as described in chapters 3.2 and 3.3.
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Generalizability
The study populations that were used to describe disease and disability occurrence and to 
investigate determinants of disability were not completely representative for the total Dutch 
population of elderly in the sense that the oldest old and the institutionalized population 
were not always included. In chapter 2, estimates of the prevalence of diseases and co-
occurrences at the end of life were restricted to ages younger than 84, as disease information 
for older ages was probably incomplete. If complete information at ages older than 84 would 
have been available, including deaths above age 84 would probably have resulted in a higher 
prevalence of diseases and co-occurrences (19-20). A study comparing disease prevalence for 
age 77-84 with that for age 85 and older suggests that the ranking of diseases is not very differ-
ent for ages above 84, except for mental disorders which have a particularly high prevalence 
among the oldest old (20). In chapter 3, exclusion of a part of the institutionalized population 
may have led to a conservative estimate of the association between disability occurrence 
and proximity to death, particularly for moderate and severe disability. In chapters 4 and 5, 
the results regarding disease contributions to the burden of disability, and in chapter 6, the 
estimates of risk factors in relationship with years lived with disability may not be representa-
tive for the institutionalized population. However, in the Netherlands, only a minor part of 
the elderly people lives in an institution and the bias due to excluding the institutionalized 
population is probably small and negligible at younger ages (21).  
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Figure 7.2 Prevalence of ADL and OECD disability by level of education.
Figure is based on data from the POLS-survey 2001-2007.
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Attribution method
In chapters 5 and 6, contributions of chronic diseases to the prevalence of disability were 
estimated using a methodology that was developed by Nusselder et al. (22-23). According 
to this methodology, individual cross-sectional information on the presence or absence of 
selected diseases and disability, gender and age was used to estimate the disabling impact 
of selected diseases. Estimated disabling impacts and information on diseases present in 
individuals were used to calculate the contribution of diseases to the prevalence of disability 
for the Dutch non-institutionalized population. 
In principle, there are several options to obtain disability data by cause. One option is to use 
surveys that already include self-reported information on the main condition causing disabil-
ity. However, such survey data on causes of disability are not widely available and rely on self-
report. Another option is to use prospective data, including information on the time of onset 
of chronic diseases and disability to reconstruct causes of disability. However, longitudinal 
data sets of a sufficient size and representative for the population are also scarce. Moreover, 
as disability prevalence (by cause) depends on incidence and mortality, also information 
on mortality from the different diseases is required when opting for longitudinal incidence 
data. The cross-sectional nature of our analysis may have resulted in some (false) attribution 
of disability in situations where the onset of disease followed the onset of disability. Using 
longitudinal data might have prevented such false attribution. Nevertheless, false attribution 
might still have occurred, especially in situations in which multiple diseases were present but 
only one was the actual cause of disability. Moreover, the risk for disability prior to the onset 
of a particular disease is expected equal to among persons without onset of this disease. 
Therefore, in our analysis false attribution is expected not to have biased our results to a large 
extent. As far as we are aware, no comparative research has been conducted to quantify the 
bias related with the various methods available to calculate disability data by cause.
In theory, particular combinations of diseases can have a disabling effect that is different than 
the effects of both diseases added. In other words, there may have been statistical interaction 
for the diseases. Taking into account such interaction in the model would have been possible 
by including variables representing the presence or absence of specific combinations of 
diseases. However, considering the complexity of the models that were used, and as testing 
for interactions without a priori knowledge would involve problems associated with multiple 
comparisons, we decided not to include such possible interactions. 
Our approach to estimate disease contributions to the burden of disability should be distin-
guished from Population Attributable Fractions (PAFs, also known as population attributable 
risks, PARs). PAFs are used to estimate to what extent a specific cause contributes to a burden 
of ill health assuming counterfactual scenarios (24). In our specific situation, a PAF could 
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be calculated to answer the question what proportion of disability would be prevented if 
a specific disease or the disabling effect of a disease were eliminated. However, using this 
approach to subsequently ‘eliminate’ a set of diseases from the population, for each disease, 
the effect of the elimination would depend on the diseases that remain present after elimina-
tion of a specific disease and, hence, on the order of the elimination (25). When calculating 
PAFs for a range of diseases, it is usually assumed for each disease that it is the first in the 
sequence of elimination (25). In fact, this assumption results in mutually exclusive scenarios 
that are illogical to sum. As the effect of elimination is largest when a disease is eliminated 
first in sequence (and smallest if it is eliminated last), the sum of the PAFs is an overestimate 
of the total proportion of disability prevented. Although solutions have been suggested to 
avoid this problem, in our view, they are unsatisfying, as the problem of non-additivity of 
the reductions in risk due to the elimination of different risk factors (in the same person) 
is a fundamental one, caused by competing risks. Taking an alternative approach by using 
additive rate models that take into account this competition, the problem was solved at a 
fundamental level (26). Using additive regression models, we were able to reconstruct how 
exposure to multiple diseases resulted in the current burden of disability while avoiding 
problems related with elimination scenarios. 
   
Time to death concept 
In chapter 3, the association between disability and time to death was tested and confirmed 
particularly for ADL disabilities. It may be counterintuitive to model the occurrence of disabil-
ity dependent on the time to an event occurring later in time, i.e. death. According to rules 
of causality, an event can only be the cause of a certain effect if it occurred before and not 
after the effect. In our analysis, a shorter time to death should not be regarded as a real cause 
of disability, but the association of disability with time to death existed because the occur-
rence of disability and death have a common cause, namely the deterioration of individuals’ 
health. Although time to death cannot be considered as a ‘real cause’, it has proven a valuable 
construct to investigate how health care expenditures or the burden of disability may de-
velop under the assumption of continuing mortality declines and increasing life expectancy 
(27-30). The association of disability with time to death we found is further substantiated by 
recent research showing a relationship between disability and mortality (31-32).
In health economics literature, the validity of the conclusion that the strong association of 
health care costs with time to death would result in a shift of health care costs to older ages 
rather than to an expansion was questioned, as the relationship might be endogenous (27, 
30, 33). If the dependency of health care costs and time to death would, in fact, reflect a 
delayed moment of death as a result of increased health care spending, an increase of health 
care spending, rather than postponement, would be most likely (27, 30, 33). Although our 
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time to death analysis was strongly linked to this recent health economics research, the issue 
of endogeneity is less relevant as it is unlikely that an increased risk of disability will delay the 
moment of death. 
The association of proximity to death and disability is likely to be mediated by other factors, 
such as health status/disease and demographic factors. If our aim had been to gain insight 
into causal chains that relate disability with time to death, or to provide a model with an 
optimal predictive power, it would have been useful to include more covariates. However, our 
aim was only to demonstrate the relevance of proximity to death for predicting the preva-
lence of disability. To keep the models simple and transparent, we decided not to include any 
other covariates except sex. Moreover, variables other than sex, age, and time to death are 
not routinely distinguished in projections of future demographic trends of many countries.
The both relationships of ADL disabilities with age and time to death reflect different aspects 
of the process of ageing. Conceptually, human ageing can be viewed as accumulation of 
damage due to intrinsic (genetically determined damage, biological factors) and extrinsic 
(environmental stress) factors and the lack of maintenance and repair (34). It is a continuous 
not directly observable process over increasing time and age that gives rise to observable, 
probabilistic events, i.e. the onset of disease, disability and death (34). Damage accumulated 
to non life maintaining systems is particularly associated with non-fatal disease or disability, 
whereas damage to life maintaining systems may lead to death, with or without a trajectory 
of disease and disablement. In terms of associations of disability with age and time to death, 
damage to non-life maintaining systems is mostly reflected in the association with age, 
whereas damage to life maintaining systems causing mortality is reflected in the association 
with time to death. This is also represented in the observation that ADL disabilities, which are 
quite severe and generally occur later in the disablement process, have a stronger association 
with time to death than OECD disabilities (chapter 3).
Aiming at improvement of future predictions of the burden of disability, our results suggest 
that it might be worthwhile to use the both relationships of disability with age and time to 
death. We found a strong cross-sectional relationship of disability prevalence and incidence 
with time to death. It should be noted that, similar to the association with age, the associa-
tion of disability with time to death may change over time, as was for instance suggested 
by an observed decline in mortality among those with ADL disability (31). Investigating time 
trends in the relationships of disability with age and time to death as well as investigating 
determinants (of trends) of these associations could contribute to further understanding of 
the disablement process and could provide further input to prediction models.  
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comParison to Previous stuDies
Disease at the end of life
Our study was among the first to investigate whether multiple causes of death provide 
complete information regarding disease presence prior to death and to provide estimates of 
the prevalence of diseases and co-occurrences on the basis of individually linked information 
from cause of death and hospital registrations. Our study confirmed what had been sug-
gested by a few earlier studies, namely that hospital discharge records contain information 
regarding disease presence prior to death that is not contained in cause of death registra-
tions and that the amount of extra information contained varies according to disease (35-36). 
Adding to previous studies, we showed that employing the extra information from hospital 
discharge records results in larger prevalence estimates for each of the twenty conditions 
most common at the end of life. The ranking of some diseases was substantially affected by 
including the hospital information, whereas for other diseases, the ranking hardly or not at 
all affected. Including information from hospital registrations did not lead to substantially 
different conclusions regarding which diseases are most important according to multiple 
causes of death.
Disability at the end of life
In the near future, the average length of life is expected to further increase (37-39). One 
of the key issues in public health is whether the expected extra life years will be years in 
good health, or, otherwise, will be spent in ill health or disability (40-41). Previous studies 
described end of life trajectories of functional declines and a recent study showed a strong 
relationship between disability and mortality for the Dutch population (32, 42-44). Health 
economics studies showed a strong dependency of health care costs with the end of life 
(28-30). Together with these studies our results suggest that part of the years gained may be 
years without (severe) disability. We found that OECD disabilities have a strong dependency 
with age, whereas ADL disabilities, particularly severe ADL disabilities, are most strongly as-
sociated with time to death, which connects most closely to dynamic equilibrium (chapter 2). 
This confirms findings of a study by Perenboom et al., who found increasing years with mild 
disability and decreasing years with severe disability in the Netherlands between 1989-2000 
(45). Results from a recent meta-analysis investigating trends (1990-2007), however, sug-
gested expansion of both moderate and severe levels of activity limitations in stair climbing, 
walking and getting dressed (46). Another recent Dutch study found fluctuation in the life 
expectancy with disability between 1990-2005 and estimated around 60% chance that an 
absolute compression of disability will have occurred in 2030 (47). Studies in other European 
countries found evidence for compression, expansion as well as dynamic equilibrium, but it 
is unclear to what extent these differences represent real differences or refer to differences 
in methods and disability measurement (48-52). Most studies investigating disability oc-
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currence in relationship with the end of life were restricted to a period of maximally three 
years prior to death (42, 53-54). Our finding of a relationship over 12 years of time suggests 
that death casts its shadow more remotely over life. As compared to health care costs in the 
Netherlands, ADL disability is at least as strongly related to the end of life (28).
Contribution disease to disability
The contribution of diseases to the burden of disability was assessed in a number of ear-
lier studies (22-23, 55-63). Of these studies, WHOs Global Burden of Disability study (GBD) is 
probably most comprehensive and well known. Different to our analysis (chapter 4), WHOs 
approach uses health state valuations, formerly referred to as disability weights, to quan-
tify disease burden. Health state valuations are panel valuations of the severity of a specific 
condition instead of actual presence of physical disability. This approach has the advantage 
that it allows assessing and comparing burden of disease, merely on the basis of disease 
frequencies. Our approach requires more specific data, but is expected to yield more accurate 
results as it accounts for effects of individual factors such as age and sex, which were shown 
to affect the disabling consequences of a disease. In the GBD, unipolar depressive disorders, 
alcohol use disorders, hearing loss (adult onset) and Alzheimer and other dementias were 
associated with most years lost due to disability in high income countries. Differences in 
methodology and diseases included hampers further comparison with our results. In the 
studies that assessed disability in a way more similar to ours, musculoskeletal and cardiovas-
cular disease were most often reported as the most important contributors to disability. Our 
study had special attention for variation in disease burden according to age and confirmed 
these results also for the oldest old (80+). Adding to previous studies, it was shown that the 
high prevalence of disability at this age is caused by a high prevalence of diseases, but even 
more by the high extent these diseases lead to disability at older ages. Our study was the first 
to identify peripheral vascular disease as an important contributor to the burden of disability, 
which is associated with much disability mainly by a high disabling impact. 
Contribution disease to disability inequalities
A few other studies have been conducted to assess disease contributions to disability 
inequalities (23, 64-65). The results of these studies were not completely consistent, but in 
each of the studies musculoskeletal conditions such as back complaints, knee complaints 
and arthritis were among the diseases that contributed most to the inequalities. Our study 
confirmed the large contributions of back pain and arthritis, but also demonstrated that 
disorders of the neck and upper extremity contribute substantially (chapter 5). We were the 
first to show a substantial contribution of peripheral vascular disease. What had not been 
investigated in earlier studies is to what extent contributions to inequalities in the disability 
burden are due to differences in disease prevalence or in the disabling impact. Our study 
revealed that a very substantial part of inequalities in disability is explained by differences in 
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the disabling impact of chronic conditions. Furthermore, our analysis showed that the gradi-
ent by level of education that exists in the prevalence of disability is reflected or explained by 
gradients in contributions of diseases contributing to the inequalities.   
Contribution lifestyle to disability
Studies comparing effects of lifestyle factors on years spent in ill-health found that, com-
pared to heavy drinking or regular smoking, obesity had a much stronger effect on years 
that people could expect to live with long-standing illness, with reduced quality of life, or 
with less than good self-assessed health (66-68). Together with other recent evidence, the 
results of this thesis show that, in addition, obese persons may expect to live more years with 
one or more disabilities than smokers and drinkers (chapter 6) (69-70). We were the first to 
assess potential improvement of the Sullivan method by using information on the associa-
tion of disability with time to death. It was concluded that this new method may be useful 
for obtaining more precise estimates of the occurrence of disability across the life cycle, but 
that conventional methods appear to have yielded valid estimates of the relative importance 
of different risk factors. 
Interventions to reduce disability
The results in this thesis show considerable heterogeneity in the burden of disability, sug-
gesting that there is ample room for improvement and prevention of disability. Evidence 
is becoming increasingly available that effective interventions exist to prevent or delay 
the onset of disability. In this paragraph we summarize the results of a series of reviews. 
Supplemental vitamin D reduces the risk of falling among older individuals by 19% and 
multifactorial fall prevention programmes in primary care, community, or emergency care 
settings are effective in reducing the number of fallers or fall related injuries (71-72). Exercise 
programs, particularly long-lasting and high-intensive multicomponent exercise programs 
may improve physical functioning and can prevent ADL and iADL limitations (73-76). Preven-
tive home visitation programs appear to be effective, provided that the interventions are 
based on multidimensional geriatric assessment and include multiple follow-up home visits 
and target persons at lower risk for death (77-79). Community-based multifactorial interven-
tions in elderly people can reduce the risk of not living at home, nursing-home- and hospital 
admissions and falls and can improve physical functioning (80). General or orthopaedic reha-
bilitation programmes can increase function and physical condition and can reduce disability 
(91-83). Compared with conventional care units, admission to acute geriatric units results in a 
lower risk of functional decline at discharge (84). Furthermore, a number of disease specific 
reviews suggest that the negative physical consequences of conditions such as back pain, 
arthritis and myocardial infarction can be limited by targeted interventions (85-88). 
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Implications for policy
1. The associations of disability with age and time to death suggest a development of the dis-
ability burden according to dynamic equilibrium. 
As OECD disability (functional limitations) and mild ADL disability have a particular strong 
association with age, the years lived with these relatively mild forms of disability have a 
tendency to expand when the life expectancy increases. Severe ADL disabilities are strongly 
associated with the end of life and, therefore, have a less strong tendency to expand. 
2. To reduce the burden of disability, policy should aim at preventing the onset of disabling 
conditions, as well as at reducing their disabling impact.
Diseases may contribute to the burden of disability by high disabling impacts, e.g. stroke in 
males, by moderate disabling impacts but high prevalences, e.g. arthritis, or by both high 
prevalences and disabling impacts, e.g. back pain in females. The largest reductions in the 
burden of disability can be obtained by interventions that prevent the primary cause of dis-
ability, that is, by preventing disease onset. Further substantial reductions can be achieved by 
diminishing disabling impacts. Disease specific interventions should target a broad range of 
diseases, not only diseases with a high disabling impact, but also those moderately disabling 
but frequently occurring. 
3. Curtailing the obesity epidemic is essential for reducing the years lived with disability.  
Not all primary prevention interventions that increase the life expectancy and the years lived 
without disability will at the same time reduce the years lived with disability. Our findings 
suggest that reducing obesity, smoking and heavy drinking all three will increase the life 
expectancy and the healthy life expectancy, but that only reducing obesity in the population 
will at the same time reduce the years lived with disability. 
4. Socially disadvantaged groups should be prioritized in the aim for reductions in the burden of 
disability. 
Groups with a low socioeconomic position have a substantial higher prevalence of disability 
than groups with a high socioeconomic position, also among the elderly. Therefore, targeting 
groups with a low socioeconomic position has great potential for achieving reductions in the 
burden of disability, while at the same reducing social health inequalities. Reductions among 
low socioeconomic groups can be achieved by preventing the occurrence of conditions 
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such as back pain, disorder neck/arm and peripheral vascular disease in males and arthritis, 
back pain and chronic non-specific lung disease in females. A 50% reduction in the disability 
inequality can be achieved by eliminating differences in diseases’ disabling impacts.   
5. Reducing the burden of disability among persons younger than 65 is essential to allow work-
ing until retirement. 
Although disability most occurs most frequently among elderly persons, we showed that 
the burden of disability among persons younger than 65 is substantial, particularly among 
those with a lower level of education. As the presence of disability is associated with job loss, 
preventing the onset of disabling conditions and reducing their disabling impacts among 
persons younger than 65 is essential to allow working until retirement age. Given the consid-
erable disadvantage in the occurrence of disability among groups with a low socioeconomic 
position, particular effort is required to reduce diseases and disease impact among these 
groups. 
Implications for research
1. Future projections of disability could utilise the relationship of disability occurrence with time 
to death. 
Robust estimates of the future burden of disability are scarce, among others because past 
trends do not univocally point to increased or decreased years with disability and are a weak 
basis for projections. Taking an alternative approach by assessing disability occurrence in 
relationship with age and time to death, we found evidence for a development according 
to a dynamic equilibrium. We found that models that include age as well as time to death 
give a better prediction of disability occurrence than models including age only. Therefore, 
we recommend utilising the both relationships of disability occurrence with age and time to 
death when using a Sullivan life table approach. When disability incidence data is available 
and multi state life table modelling is feasible, we recommend investigating different sever-
ity levels of disability as our results suggest that trends in disability may vary according to 
severity level. 
2. It is recommended to expand current research by investigating psychosocial, environmental 
and socioeconomic factors as determinants of the burden of disability. 
We assessed contributions of diseases and lifestyle factors to the burden of disability as 
well as socioeconomic differences in diseases’ contributions. A review of literature, however, 
showed that also environmental (neighbourhood depravation, air pollution), social (low 
frequency of social contacts, childhood living conditions) and mental factors (cognitive 
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impairment, depression) are risk factors for disability. In addition, occupation, personality, 
and hospitalisation may play a role in becoming disabled. Targeting such factors may lead to 
reductions in the prevalence of disability, but is unknown whether such interventions would 
also affect mortality and would lead to fewer or to more years lived with disability. Therefore, 
it is recommended to investigate these factors as determinants of years lived with disability 
and to compare their effects in order to identify further entry points to reduce the disability 
burden. Furthermore, research is needed to investigate how discrepancies between func-
tional abilities and the environment contribute to the burden of disability and how individual 
adaptation strategies may influence the disability burden. 
3. It should be unravelled why specific diseases lead to more disability in low socioeconomic 
groups than in high socioeconomic group. 
A key finding of this thesis was that there is large variation in the disabling impact of specific 
chronic conditions by level of education. Groups with a low socioeconomic status not only 
more frequently have conditions such as back pain, arthritis, peripheral vascular disease and 
chronic non-specific lung disease, but they also have a higher chance to become disabled 
from these conditions. It could be that groups with a low socioeconomic position tend to 
have different subtypes of a disease, or that they have more severe forms of the disease which 
may be associated with more disability. But also a more limited access to revalidation and 
rehabilitation, smaller use of adaptive device (e.g. walker), less effective coping strategies in 
general etc. could play a role. Aiming at a reduction of health inequalities, it is recommended 
to investigate which of these factors play a role and to what extent they are responsible for 
the difference in disabling impacts.
4. To reduce the burden of disability, interventions should be developed that effectively post-
pone the onset of disability, but also lead to a reduction in the years lived with disability. 
As the research presented in this thesis was observational in its nature, the effects cannot 
directly be translated into effects of interventions, but should be interpreted as maximum 
potential effects. The real effectiveness of interventions aiming at reductions in the burden of 
disability should preferably be tested in randomized controlled trials. Commonly, such trials 
have disability incidence as their main outcome measure, but reductions in the incidence of 
disability does not necessarily lead to fewer years lived with disability. Therefore, it is recom-
mended to evaluate interventions also in terms of their combined effect on disability and 
mortality, for instance by effects on years lived with disability, using life table calculations. 
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Population ageing is the shift in the distribution of a country’s population towards older ages. 
This phenomenon is currently occurring in almost all countries in the world and poses major 
challenges to current societies. These challenges are importantly related with an increasing 
group of elderly persons becoming socially and financially dependent on a decreasing group 
of younger persons. Among the main financial challenges are how to keep health care ex-
penditures within acceptable boundaries and how to ensure the sustainability of the public 
pension system. Important social challenges are how to keep the growing population of 
elderly healthy and how to prevent strong declines in the quality of life. “Active ageing” and 
“participation” have been proposed as a framework to encounter the challenges posed by 
ageing of the population. However, to remain active and to participate until old age, healthy 
ageing of individuals is crucial. Furthermore, if the life expectancy continues to increase, as 
is expected, the extra years of life gained should preferably be years that are spent in good 
health. 
To prepare future societies to cope with the expected increase in the burden of disease, it is 
essential to quantify the current burden of disease and disability and to know how these may 
develop in the future. In addition, for developing interventions that may effectively reduce 
the burden of disability and contribute to a compression of morbidity, it is essential to know 
which factors, such as diseases and life style factors, contribute most to the current burden of 
disability. The research questions addressed in this thesis were:
1. What is the current burden of disease and disability?
2. Which determinants explain the current burden of disability? 
This thesis consists of two main parts that correspond with these research questions, and 
a general discussion covering both questions. The first main part has a special focus on the 
burden of disease and disability in relationship with the end of life. The second part focusses 
on contributions of diseases and life style factors to the burden of disability and educational 
inequalities herein. Two measures of disability were used: ADL (and mobility) disability and 
disability assessed according to the OECD questionnaire (OECD disability). OECD disability is 
less severe than ADL mobility and comprises functional limitations in mobility, hearing and 
seeing. In each chapter investigating disability, disability was assessed as ADL disability (or as 
both disability measures), except for chapter 5. 
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Part i Disease and disability occurrence
chapter 2 presents a study investigating the prevalence of diseases most common at the 
end of life as well as the prevalence of their most common co-occurring conditions. In this 
study, nation-wide data was used including information on diseases present at the end of 
life available through multiple causes of death registrations and hospital discharge diag-
noses for 86,987 persons aged 50-84. We showed that, in males, diseases most prevalent 
at the end of life were pneumonia, cancer of trachea, bronchus and lung, acute myocardial 
infarction, COPD and bronchiectasis, and cerebrovascular disease. In females, these were 
cerebrovascular disease, pneumonia, dementia, diabetes, and heart failure. The vast majority 
of all deaths had one or more co-occurring conditions. We showed that cause of death data 
do not provide complete information regarding disease occurrence prior to death, even if 
information from underlying and secondary causes of death are considered jointly. Using ad-
ditional information regarding hospital diagnoses affected the ranking of the most common 
conditions but did not lead to substantially different conclusions concerning which diseases 
are most important.
chapter 3 presents two studies investigating the occurrence of disability in relationship with 
age and time to death using six annual waves of the Dutch GLOBE longitudinal study and 
a subsequent 12-year mortality follow-up. In the first study we showed that within the last 
ten years of life, and particularly within the last five years, the prevalence and incidence of 
disability increased substantially, but also the severity of disability increased, as time to death 
decreased. The occurrence of ADL disability was more strongly associated with time to death 
than with age, also among groups in presence of various diseases (chronic non-specific lung 
disease, heart disease and diabetes) and among various age groups. The association with 
time to death was stronger towards older ages. OECD disability was more strongly related to 
age. In the second study, relationships of ADL disabilities with age and time to death were as-
sessed for three levels of disability with the aim to test the key assumption of the theory of a 
dynamic equilibrium. This assumption is that mild disability is most strongly associated with 
age and severe disability most strongly with time to death. Severe ADL disability, defined 
as major difficulty with one (or more) out of ten ADL activities, was particularly associated 
with approaching death, whereas mild disability, defined as minor difficulty with at least one 
activity was not at all related with time to death. As was shown in a calculation example, 
these associations are in accordance with the hypothesis of dynamic equilibrium. This implies 
that particularly the years lived with mild disability may increase substantially when the life 
expectancy continues to increase, whereas the years with severe disability are expected to 
increase to a smaller extent.  
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Part ii explaining the burden of disability 
chapter 4 comprises a study assessing the contribution of chronic disease to the burden of 
ADL disability using data from the Dutch POLS survey 2001-2007. In the research presented, 
the disabling impact, which refers to the extent a disease leads to disability, was calculated 
for a variety of diseases using an additive regression model. This model accounted for pos-
sible disability without any disease reported and for competing causes of disability. Mus-
culoskeletal and cardiovascular diseases contributed most to the burden of ADL disability, 
but also chronic non-specific lung disease (males) and diabetes (females) contributed much. 
Within the musculoskeletal and cardiovascular disease groups, back pain, peripheral vascular 
disease and stroke contributed particularly by their high disabling impact. Arthritis and heart 
disease were less disabling but contributed substantially because of their high prevalence. 
The disabling impact of diseases was particularly high among persons older than 80.
In chapter 5 a study is presented investigating to what extent diseases contribute to educa-
tional inequalities in the prevalence of OECD disabilities. A method similar to that in chapter 
4 was used. In this analysis in chapter 5, however, disease contributions to the prevalence 
of OECD disability were estimated for groups differing according to the highest obtained 
level of education. Furthermore, it was investigated to what extent disease contributions to 
inequalities in disability are due to differences in the disabling impact. Large absolute differ-
ences in the prevalence of OECD disability of 18% (points) in males and 15% in females existed 
between groups with the highest and lowest level of education. 64% of the inequalities in 
males and 69% in females were due to the diseases included. For mobility limitations only, 
these percentages were 90% and 84%. In males, diseases that contributed most to the in-
equalities were back pain (17 %), disorder neck/arm (13%), other (11%) and peripheral vascular 
disease (7%). In females, arthritis (18%), other (17%), back pain (13%) and chronic non-specific 
lung disease (7%) contributed most. In males and females, 49% and 51% of the total inequal-
ity in disability prevalence was explained by diseases’ disabling impacts.
chapter 6 presents a study that aimed to resolve which lifestyle factor (obesity, smoking or 
heavy drinking) is associated most with living many years with ADL disability, using a Sullivan 
life table approach. A secondary aim of the study was to assess whether Sullivan life table 
estimates could be improved by stratification according to age at death. Data from the Dutch 
POLS Survey, 1997-1999, with mortality follow-up until 2006 were used. Particularly smoking 
was associated with a high mortality, whereas mortality risks for obesity and heavy drinking 
were only slightly elevated. The odds for ADL disability were high for obese persons, mod-
erate for heavy drinkers and low for smokers. Using the estimated mortality and disability 
risks, Sullivan life tables were constructed. It was estimated that the years lived with disability 
differed most according to BMI, least according to smoke status, and in between according 
to alcohol consumption. Obese persons could expect to live at least two years more with 
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disability than smokers and heavy drinkers. Employing information on time to death led to 
lower estimates of years lived with disability, and to smaller differences in these years accord-
ing to BMI, alcohol, and smoking. Conclusions regarding which risk factor is most important, 
however, remained unchanged.
In chapter 7 the main findings of this thesis are summarized, the data and methods used are 
discussed, the results are compared to previous studies and new findings are highlighted. The 
chapter is concluded with recommendations for practice and research. The main conclusions 
of this thesis are as follows. Multiple causes of death, including underlying and secondary 
causes of death, provide underestimates of the end of life prevalence of some diseases. Using 
additional information regarding hospital diagnoses affects the ranking of the most com-
mon conditions but does not lead to substantially different conclusions concerning which 
diseases are most important. Mild disability is most strongly associated with age, whereas 
severe disability is particularly associated with time to death. Therefore, the years lived with 
mild disability will most likely expand when the life expectancy further increases. The years 
lived with severe disability, however, are less likely to expand due to an expected increase 
in the age of onset of severe disability. Given that diseases contribute to the burden of dis-
ability by high prevalences as well as by high disabling impacts, policy aimed at reducing 
the burden of disability should aim at preventing the onset of disabling conditions, as well 
as at reducing their disabling impact. Reductions in the prevalence and disabling impact 
of diseases among groups with a low education could lead to substantial reductions in the 
social inequality in the burden of disability. If the inequality in the prevalence of diseases 
would remain unchanged, eliminating the inequality in disabling impacts would still reduce 
the disability inequality by 50%. Reducing obesity, smoking and heavy drinking all three will 
increase the life expectancy and the disability free life expectancy, but only reducing obesity 
in the population will reduce the years lived with disability.
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Vergrijzing is de opwaartse verschuiving in de leeftijdsverdeling van een populatie. Dit 
fenomeen vindt momenteel plaats in bijna alle landen ter wereld en plaatst huidige 
samenlevingen voor grote uitdagingen. Deze uitdagingen zijn in essentie gerelateerd aan 
een groter wordende groep ouderen die sociaal en financieel afhankelijk is van een kleiner 
wordende groep jongere personen. Belangrijke financiële uitdagingen zijn onder andere hoe 
de uitgaven voor gezondheidszorg binnen acceptabele grenzen kunnen worden gehouden 
en hoe het voortbestaan van het publieke pensioenstelsel kan worden gegarandeerd op 
de lange termijn. Belangrijke sociale uitdagingen betreffen het behoud van een goede 
gezondheid van een toenemende groep ouderen en het voorkomen van een sterke afname 
in de kwaliteit van leven in de bevolking. Als kader voor een aanpak van de uitdagingen van 
vergrijzing zijn “actief ouder worden” en “participatie” voorgesteld. Echter, om actief te blijven 
en te kunnen participeren tot op hoge leeftijd is het behoud van een goede gezondheid 
essentieel. Verder is het van groot belang dat wanneer de levensverwachting blijft stijgen, 
zoals wordt verwacht, de gewonnen levensjaren jaren zijn in goede gezondheid. 
Om toekomstige samenlevingen in staat te stellen zich voor te bereiden op een verwachte 
toename van de ziektelast is het essentieel de huidige last van ziekten en beperkingen te 
kwantificeren en om inzicht te krijgen in mogelijke ontwikkelingen in de toekomst. Voor het 
ontwikkelen van interventies die op een effectieve manier de beperkingenlast kunnen terug-
dringen en kunnen bijdragen aan een compressie van morbiditeit is het noodzakelijk inzicht 
te krijgen in welke factoren, zoals ziekten en leefstijl, het meest bijdragen aan de huidige 
beperkingenlast. De onderzoeksvragen van dit proefschrift waren:
1. Wat is de huidige last van ziekten en beperkingen?
2. Welke determinanten verklaren de huidige beperkingenlast? 
Dit proefschrift bestaat uit twee delen die samenhangen met deze onderzoeksvragen en 
een algemene discussie die beide vragen betreft. Het eerste deel betreft de last van ziekten 
en beperkingen, in het bijzonder in relatie met het levenseinde. Het tweede deel betreft de 
bijdragen van ziekten en leefstijlfactoren aan de beperkingenlast en aan opleidingsverschil-
len in de beperkingenlast. In de studies die worden beschreven werden twee maten van 
beperkingen gebruikt: ADL (en mobiliteits) beperkingen, en beperkingen vastgesteld op 
basis van de OESO vragenlijst (OESO beperkingen). OESO beperkingen zijn in het algemeen 
minder ernstig dan ADL beperkingen en omvatten functionele beperkingen in mobiliteit, ho-
ren en zien. In ieder hoofdstuk waarin beperkingen worden onderzocht zijn deze onderzocht 
als ADL beperkingen (of als beide maten), behalve in hoofdstuk 5.
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Deel i: optreden van ziekten en beperkingen
In hoofdstuk 2 wordt een studie gepresenteerd waarin de prevalentie van de meest 
voorkomende ziekten aan het einde van het leven werd onderzocht, evenals de prevalentie 
van de bij deze ziekten meest voorkomende co-morbiditeiten. In deze studie werd gebruik 
gemaakt van informatie over ziekten aanwezig aan het einde van het leven, beschikbaar uit 
de Nederlandse doodsoorzakenregistratie, en informatie over ontslagdiagnoses uit zieken-
huizen van 86.987 personen in de leeftijd van 50-84 jaar. Bij mannen kwamen respectievelijk 
pneumonie, kanker van de trachea, bronchus en long, acuut hartinfarct, COPD en bron-
chiëctasieën, en cerebrovasculaire ziekten het meest voor aan het einde van het leven. Bij 
vrouwen waren dit cerebrovasculaire ziekten, pneumonie, dementie, diabetes en hartfalen. 
Het overgrote deel van de sterfgevallen had één of meer co-morbiditeiten. We lieten zien dat 
doodsoorzaken geen compleet beeld geven van het voorkomen van ziekten aan het einde 
van het leven, zelfs niet als onderliggende en secundaire doodsoorzaken samen worden 
genomen. Het gebruik van aanvullende informatie over ziekenhuisdiagnoses had invloed op 
de rangorde van meest voorkomende ziekten maar leidde niet tot een substantieel andere 
conclusie over welke ziekten het belangrijkst zijn. 
In hoofdstuk 3 worden twee studies gepresenteerd waarin het optreden van beperkingen in 
relatie tot leeftijd en tijd tot sterven werd onderzocht. Hierbij werd gebruik gemaakt van zes 
jaargangen van de Nederlandse longitudinale GLOBE studie met een sterfte follow-up van 12 
jaar. In de eerste studie lieten we zien dat de prevalentie en incidentie van beperkingen in 
de laatste 10 levensjaar, maar vooral in de laatste vijf jaar, aanzienlijk toeneemt. Maar ook de 
ernst van beperkingen was hoger naarmate de tijd tot sterven korter was. Het optreden van 
ADL beperkingen hing sterker samen met tijd tot sterven dan met leeftijd, ook binnen ver-
schillende ziektegroepen (chronische aspecifieke respiratoire aandoeningen, hartziekten en 
diabetes) en leeftijdsgroepen. De relatie met tijd tot sterven was sterker op hogere leeftijd. 
OESO beperkingen hingen sterker samen met leeftijd. In een tweede studie werden relaties 
van ADL beperkingen met leeftijd en tijd tot sterven onderzocht waarbij drie niveaus van 
ernst van beperkingen werden onderscheiden. Het doel was te onderzoeken of de relaties 
van milde, matige en ernstige beperkingen met tijd tot sterven in overeenstemming zijn met 
de theorie van het dynamisch equilibrium. Deze theorie stelt dat bij een stijgende levensver-
wachting vooral de jaren met minder ernstige morbiditeit zullen stijgen, terwijl de jaren met 
ernstige morbiditeit gelijk blijven. Dit impliceert dat  ernstige beperkingen sterk gerelateerd 
zullen zijn aan tijd tot sterven, maar dat milde beperkingen meer gerelateerd zijn aan leeftijd. 
Uit ons onderzoek bleek dat ernstige beperkingen, gedefinieerd als grote moeite met één 
(of meer) van tien ADL activiteiten, vooral samenhangen met tijd tot sterven, terwijl milde 
beperkingen, gedefinieerd als enige moeite met tenminste één activiteit, in het geheel niet 
samenhangen met tijd tot sterven. Zoals werd gedemonstreerd met een rekenvoorbeeld zijn 
deze relaties in overeenstemming met de hypothese van dynamisch equilibrium. Dit onder-
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schrijft de hypothese dat bij een verdere toename van de levensverwachting met name de 
jaren geleefd met een milde beperking zullen toenemen, terwijl de jaren met een ernstige 
beperking gelijk blijven. 
Deel ii: verklaring van de beperkingenlast
Hoofdstuk 4 omvat een studie waarin de bijdragen van chronische ziekten aan de last van 
ADL beperkingen werd onderzocht, waarbij gebruik werd gemaakt van gegevens van de 
Nederlandse POLS survey, 2001-2007. De beperkende impact, dit is de mate waarin een ziekte 
leidt tot beperkingen, werd berekend voor een verscheidenheid aan ziekten. Hierbij werd ge-
bruik gemaakt van een additief regressie model. Aandoeningen van het bewegingsapparaat 
en hart- en vaatziekten droegen het meeste bij aan de last van ADL beperkingen, maar ook 
chronische aspecifieke respiratoire aandoeningen (mannen) en diabetes (vrouwen) hadden 
een grote bijdrage. Van de aandoeningen van het bewegingsapparaat en hart- en vaatziek-
ten droegen rugpijn, perifere vaataandoeningen en cerebrovasculaire aandoeningen (CVA) 
veel bij, met name door hun hoge beperkende impact. Artrose/artritis en hartziekten hadden 
een kleinere beperkende impact maar droegen nog steeds aanzienlijk bij door hun hoge 
prevalentie. De beperkende impact van ziekten was vooral hoog onder personen ouder dan 
80 jaar. 
In hoofdstuk 5 wordt een studie gepresenteerd waarin werd onderzocht in welke mate 
ziekten bijdragen aan opleidingsverschillen in de prevalentie van OESO beperkingen. Hierbij 
werd gebruik gemaakt van een methode vergelijkbaar met die uit hoofdstuk 4. In de analyse 
in hoofdstuk 5 werden echter bijdragen geschat voor groepen met een verschillend oplei-
dingsniveau. Verder werd onderzocht in hoeverre bijdragen van ziekten aan verschillen in de 
beperkingenlast werden veroorzaakt door verschillen in beperkende impact. Er waren grote 
absolute verschillen in de prevalentie van OESO beperkingen van 18%(punten) voor mannen 
en 15% voor vrouwen tussen groepen met het hoogste en het laagste opleidingsniveau. 64% 
van het verschil bij mannen en 69% bij vrouwen werd veroorzaakt door de geïncludeerde 
ziekten. Voor mobiliteitsbeperkingen alleen waren deze percentages 90% en 84%. Ziekten 
die het meest bijdroegen aan de opleidingsverschillen voor mannen waren rugpijn (17%), 
nek/arm aandoeningen (13%), overige (11%) en perifere vaataandoeningen (7%). Voor 
vrouwen waren dit artrose/artritis (18%), overige (17%), rugpijn (13%) en chronische aspeci-
fieke respiratoire aandoeningen (7%). Voor mannen en vrouwen werd 49% en 51% van het 
totale opleidingsverschil in de prevalentie van beperkingen verklaard door verschillen in de 
beperkende impact van ziekten.   
Hoofdstuk 6 omvat een studie met als doel helder te krijgen welke leefstijlfactor (obesitas, 
roken of zwaar drinken) het meest gerelateerd is aan een groot aantal levensjaren met een 
ADL beperking. Hierbij werd gebruik gemaakt van Sullivan overlevingstafels. Een tweede doel 
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van de studie was te onderzoeken of schattingen op basis van de Sullivan overlevingstafel 
verbeterd kunnen worden door stratificatie naar tijd tot sterven. Er werd gebruik gemaakt van 
gegevens van de Nederlandse POLS survey, 1997-1999, met een sterfte follow-up tot 2006. Met 
name roken hing samen met een hoge sterfte, terwijl sterfte bij obesitas en zwaar drinken 
matig was verhoogd. De kans op een ADL beperking was hoog voor personen met obesitas, 
matig verhoogd voor zware drinkers en laag voor rokers. Op basis van de geschatte kansen 
op sterfte en beperkingen werden Sullivan overlevingstafels geconstrueerd. De schattingen 
wezen uit dat de jaren geleefd met een beperking het meest varieerden naar BMI, het minst 
naar rookstatus en ertussenin naar alcohol consumptie. Naar verwachting leven personen 
met obesitas minstens twee jaar meer met een beperking dan rokers of zware drinkers. Het 
gebruik van informatie over tijd tot sterven resulteerde in lagere schattingen van de jaren 
met een beperking en in kleinere verschillen in deze jaren naar BMI, alcohol consumptie en 
rookstatus. De conclusie welke factor het belangrijkst is bleef echter onveranderd. 
In hoofdstuk 7 worden de belangrijkste bevindingen samengevat, de gebruikte data en 
methoden worden bediscussieerd, de resultaten worden vergeleken met eerdere studies en 
nieuwe bevindingen worden uitgelicht. Het hoofdstuk wordt afgesloten met aanbevelingen 
voor praktijk en onderzoek. De hoofdconclusies van dit proefschrift zijn als volgt. Meer-
voudige doodsoorzaken bestaande uit onderliggende en secundaire doodsoorzaken geven 
een onderschatting van de prevalentie van sommige ziekten aan het einde van het leven. Het 
gebruik van aanvullende informatie uit ziekenhuisdiagnoses beïnvloed de rangorde van de 
meest voorkomende ziekten, maar leidt niet tot substantieel andere conclusies over welke 
ziekten het belangrijkst zijn. Milde beperkingen zijn het sterkst gerelateerd met leeftijd, 
terwijl ernstige beperkingen met name gerelateerd zijn met tijd tot sterven. Dit onderschrijft 
de veronderstelling dat de jaren geleefd met milde beperkingen zullen toenemen bij een 
verdere stijging van de levensverwachting, maar dat de jaren met ernstige beperkingen 
minder sterk zullen toenemen doordat de leeftijd waarop de eerste (ernstige) beperking 
optreedt zal stijgen. Aangezien ziekten zowel door een hoge prevalentie als door een hoge 
beperkende impact bijdragen aan de beperkingenlast, zal beleid met als doel het terugdrin-
gen van de beperkingenlast zich moeten richten op zowel het voorkómen van ziekten als 
het terugdringen van de beperkende impact van ziekten. Reducties in de prevalentie en 
beperkende impact van ziekten onder laagopgeleiden kan leiden tot een aanzienlijke ver-
mindering van de sociale ongelijkheid in de beperkingenlast. Wanneer wordt aangenomen 
dat het opleidingsverschil in de prevalentie van ziekten onveranderd blijft, kan het opheffen 
van het verschil in de beperkende impact van ziekten nog steeds leiden tot een vermindering 
van de ongelijkheid in de beperkingenlast van 50%. Het terugdringen van obesitas, roken 
en zwaar drinken zullen alle drie de levensverwachting en de levensverwachting zonder 
beperkingen verhogen, maar alleen het terugdringen van obesitas zal de jaren met één of 
meerdere beperkingen verminderen. 
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